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Abstract 
Normal germ cell development in the human testis is crucial for subsequent fertility 
and reproductive health. Disruption of testis development in fetal life can result in 
deleterious health consequences such as testicular dysgenesis syndrome (TDS), 
which includes disorders, such as cryptorchidism, hypospadias, infertility and 
testicular germ cell tumours (TGCT). A rat model of TDS in which rats are exposed 
to phthalates in utero has been validated, but does result in the development of 
TGCT. In humans, TGCTs result from transformation of pre-neoplastic carcinoma 
in-situ (CIS) cells and these CIS cells are believed to arise from human fetal germ 
cells during their transition from gonocyte to spermatogonia, based on their 
morphology and protein expression profile. It has been proposed asynchronous 
differentiation of germ cells in the human fetal testis may predispose fetal germ 
cells to become CIS cells. Studying the development of these tumours in humans is 
difficult because of their fetal origins and prolonged duration from initiation of 
impaired development to invasive disease. For this reason the use of relevant 
animal models that can mimic normal and abnormal germ cell development may 
provide new insight into how TGCT develop. The Common Marmoset monkey, a 
New World primate exhibits many similarities to the human in terms of 
reproductive biology and could represent such a model.  
 
This thesis aimed to further characterise the origins of CIS cells in the human testis 
by investigating the protein expression profile of CIS cells in patients with TGCT 
and comparing them to established markers of human fetal germ cell types using 
immunohistochemistry and immunofluorescence. Quantification of the various 
subpopulations of CIS and proliferation within these populations was performed. 
The thesis also investigated the Common Marmoset monkey as a potential model of 
normal testis and germ cell development by comparing the differentiation and 
proliferation profile of germ cells with those of the human during fetal and early 
postnatal life. During the present studies methods were successfully developed that 
enabled us to use testicular xenografts to recapitulate normal development of 
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immature testes from marmoset and human. This involved grafting pieces of testis 
tissue subcutaneously under the dorsal skin of immunodeficient mice and 
retrieving them several weeks later to investigate their development during the 
grafting period. Xenografts using tissue from fetal, neonatal and juvenile 
marmosets were performed in addition to testes from first and second trimester 
human fetuses. Finally the present studies aimed to use the marmoset and the 
xenografting approach as systems in which to examine the effects of gonadotrophin 
suppression and phthalate treatment on germ cell differentiation and proliferation, 
with particular attention to the potential for development of CIS and TGCT.  
 
Heterogeneous phenotypes of CIS cells were identified, mostly consistent with 
those seen in the normal human fetal testis, however some of these CIS cells did not 
exhibit the same phenotype as germ cells identified in normal fetal testes. In 
addition it was shown that some of the proteins considered to be ‘classical’ markers 
of CIS cells, such as the pluripotent transcription factor OCT4, were not expressed 
in a proportion of the CIS cells. The proliferation index of CIS cells is also 
significantly higher in those subpopulations with the most ‘undifferentiated’ 
phenotype (i.e. OCT4+/VASA-). The present studies have generated novel data 
showing that the marmoset is a good model of fetal and neonatal germ cell 
development, with similarities to the human in terms of an asynchronous and 
prolonged period of differentiation and proliferation of germ cells from gonocyte to 
spermatogonia. This feature is also common to the human, but not a characteristic 
of the rodent. Fetal, neonatal and pre-pubertal germ cell development can be re-
capitulated by xenografting tissue from marmoset and human testes into nude 
mouse hosts. Human fetal testis grafts produced testosterone and were responsive 
to hCG stimulation. First trimester human testis xenografts that have not developed 
fully formed seminiferous cords prior to grafting can complete the process of cord 
formation whilst grafted in host mice. In addition, germ cells in fetal human and 
marmoset xenografts can differentiate and proliferate in a similar manner to that 
seen in the intact non-grafted testis. In the intact neonatal marmoset, suppression of 
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gonadotrophins resulted in a 30% decrease in proliferation, however differentiation 
of gonocytes is not affected. In-utero treatment of neonatal marmosets with mono-
n-butyl phthalate was associated with unusual ‘gonocyte’ clusters, however, di-n-
butyl phthalate treatment of mice carrying fetal marmoset xenografts resulted in no 
visible effects on germ cell differentiation or proliferation and did not result in the 
development of CIS or TGCT.     
 
In conclusion, this thesis has shown that there are many subpopulations of CIS cells 
of which many have not been previously described. These subpopulations have 
different characteristics, such as variable proliferation rates and this may indicate 
the potential for progression or invasiveness. These subpopulations have similar 
protein expression phenotypes to normal human fetal germ cells although the 
present studies have identified some CIS cells with phenotypes that are not found 
in the normal human testis. This thesis has demonstrated that the marmoset is a 
comparable model to the human in terms of asynchronous fetal germ cell 
development, which may predispose this species to the development of CIS/TGCT. 
In addition to the use of intact marmosets, these studies have also demonstrated for 
the first time that testis xenografting provides a comparable system for testis cord 
formation, germ cell differentiation and proliferation in fetal/postnatal marmosets 
and fetal human testis. In addition the marmoset and xenografting models have 
indicated that phthalates may have minor effects on testis development in the 
human and marmoset but do not result in CIS or TGCT. These model systems are 
suitable for further investigation of normal and disrupted testis development.   
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Chapter 1 Literature review 1 
1 Literature review 
 
1.1. Introduction 
Testicular germ cell tumours (TGCT) are the most common cancer of young men 
and comprise 90% of testicular tumours (Moller, 2005). These tumours have 
increased in incidence during the last 50 years in many Western countries (Richiardi 
et al., 2004). TGCT have been postulated to arise during fetal life in humans 
(Skakkebaek, 1972a), originating from the transformation of undifferentiated fetal 
germ cells (Rajpert-De Meyts, 2006). The exact origin and subsequent development 
of these pre-neoplastic germ cells is unknown. In addition there is a lack of suitable 
animal models of fetal and early postnatal testis development in which to 
investigate the origins of these tumours.  
 
This chapter will begin with a description of normal mammalian fetal testis 
development, an understanding of which is crucial for establishing relevant animal 
models of early germ cell development and for investigation of disorders of the 
testis. 
 
1.2. The development of the bipotential gonad 
The initial stages of development of the gonad are common to both males and 
females and this results in the development of the bipotential or indifferent gonad, 
which is formed in the genital ridge (Wilhelm et al., 2007). The urogenital ridges are 
paired structures that arise on either side of the midline in the embryo and are 
divided into three segments. The pronephros includes the adrenal primordium, 
whilst the central mesopnephros is the region from which the gonad arises. 
Posteriorly the metanephros gives rise to the kidney (Wilhelm et al., 2007). The 
genital ridge is the result of a thickening of the surface coelomic epithelium adjacent 
to the mesonephros (Ross and Capel, 2005);(Brennan and Capel, 2004).  The 
mesonephros houses the primordia for the mesonephric ducts of the male and the 
Müllerian ducts of the female (Brennan and Capel, 2004). 
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1.3. Precursors of somatic and germ cells in the bipotential gonad 
The germ cells and somatic cells of the gonad arise from different sources. In the 
mouse cells arising from the surface coelomic epithelium of both sexes will 
eventually become the supporting Sertoli cells in the testis, whilst in the developing 
ovary their fate is not restricted (Karl and Capel, 1998). This occurs at 11.2-11.4dpc 
and this migration may be facilitated by a discontinuous basement membrane of the 
coelomic epithelium that has been demonstrated by laminin staining at 11.5dpc 
(Karl and Capel, 1998). Whilst the somatic cells arise from a location adjacent to the 
developing gonad, primordial germ cells (PGCs) of both sexes migrate into the 
developing gonad from a distant location (Ross and Capel, 2005). In the mouse, 
PGCs arise from cells in the proximal epiblast, adjacent to the extraembryonic 
ectoderm at 6-6.5dpc (days post-coitum) (Lawson and Hage, 1994). They can be 
identified as PGCs from 7.2dpc based on the expression of alkaline phosphatase 
(Ginsburg et al., 1990). These PGCs migrate through the gut mesentery into the 
urogenital ridge (Ross and Capel, 2005) and populate the indifferent gonad between 
10-11dpc (Fig. 1.1). In the human it has been described that PGCs migrate from the 
yolk sac and enter an indifferent gonad at 5 weeks (Waters and Trainer, 1996). The 
migration of PGCs involves a combination of intrinsic factors and extrinsic signals 
to ensure that the cells end up in the genital ridge. In the mouse this includes the c-
Kit (KIT) receptor on the surface of the germ cells and the KIT ligand from the 
surrounding cells, in addition to several other signalling and adhesion molecules 
(Richardson and Lehmann 2010).  
 
 
Figure 1.1. The migratory pathway of 
primordial germ cells. Schematic 
representation of the localisation of PGCs 
(black dots) at the base of the allantois 
around the hindgut pocket in an 8.5 dpc 
mouse embryo (left) and their migration 
along the hindgut, dorsal mesentery, and 
into the genital ridges in a 10.5 dpc 
embryo (right). Taken from (Wilhelm et 
al., 2007). 
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1.4. Sex determination 
Mammalian sex determination is the sequence of events that results in the formation 
of a testis or ovary from an undifferentiated gonad (Ostrer et al., 2007). This is 
primarily determined by the genetic sex and the presence or absence of the Y 
chromosome (Wilhelm et al., 2007). A Y-linked gene locus known as the testis 
determining factor (TDF) houses the Sry (sex determining region of the Y 
chromosome) gene (Wilhelm et al., 2007);(Lovell-Badge and Robertson, 1990). Sry 
has been shown to be the gene that dictates development of the testis. This has been 
demonstrated by the development of a testis in XX mice with transgenic expression 
of Sry (Koopman et al., 1991). The converse is also true with formation of an ovary 
when the Tdf/Sry gene is mutated to an inactive form in XY mice (Lovell-Badge and 
Robertson, 1990);(Koopman et al., 1991);(Berta et al., 1990). Expression of Sry mRNA 
in the mouse is first detected at 10.5dpc, reaching a peak at 11.5dpc and is no longer 
expressed at 12.5dpc (Hacker et al., 1995). In the human SRY mRNA expression 
begins between 7-8 weeks gestation (41-44 days post ovulation) (Hanley et al., 2000).  
 
1.5. Differentiation of pre-Sertoli cells 
Differentiation of pre-Sertoli cells under the direction of SRY is a crucial step for the 
formation of the testis.  A subset of the somatic cells that express SRY almost 
immediately begin to express Sry-related High Mobility Group (HMG)-box DNA 
binding Protein (Sox9), which is located in the long arm of human chromosome 17 
(Wilhelm et al., 2007). Sox9 is also produced initially in the female gonad but its 
expression is not reinforced by Sry and it becomes downregulated (Kim and Capel, 
2006). The formation of a testis is dependent on a critical threshold of Sertoli cell 
differentiation. In a normal testis, 90% of supporting cells are XY and hence express 
Sry as demonstrated by XX-XY chimera studies in which the ratio of XX:XY cells is 
in the region of 50% for somatic cells, whilst the mean ratio of XX:XY in  the Sertoli 
cells is 10% (Palmer and Burgoyne, 1991). The fact that approximately 10% of Sertoli 
cells are XX indicates that they have differentiated from pre Sertoli cells without 
expressing Sry. Sox9 maintains its own expression in an autoregulatory loop, but 
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can also recruit neighbouring XX somatic cells in a paracrine fashion by 
upregulating prostaglandin D2 synthase (PGDS), which leads to synthesis and 
secretion of prostaglandin D2 (PGD2). Pgd2 acts via its receptor on the 
neighbouring XX cell resulting in the production of Sox9 (Wilhelm et al., 2005).  
Despite these ‘reinforcing’ mechanisms to increase Sox9 and recruit Sertoli cells, XX-
XY chimeric studies in which differing proportions of XX or XY cells were mixed 
have shown that a threshold level of 20% of Sry expressing cells must be reached to 
result in the formation of a normal testis (Burgoyne and Palmer, 1993). The resultant 
Sertoli cells are responsible for initiating the formation of the testis cords and the 
differentiation of the other cell types within the testis (Wilhelm et al., 2005).  
 
Whilst it has previously been suggested that the female pathway of differentiation is 
a default pathway triggered by the lack of male determining factors such as SRY 
and SOX9, it is now clear that there are also factors produced by the female somatic 
cells that ‘reinforce’ female sex determination. These factors include FOXL2, WNT4 
and RSPO1 (Chassot et al., 2008). The Wnt signalling molecules Rspo1 and Wnt4 are 
expressed by XX gonadal somatic cells and can downregulate Sox9 expression 
(Chassot et al., 2008) (Kocer et al., 2009). An antagonistic mechanism occurs between 
Wnt4 and fibroblast growth factor 9 (Fgf9) to regulate Sox9 expression (Fig. 1.2). In 
the male Sox9 is involved in a feed forward loop with Fgf9 that results in inhibition 
of Wnt4, whilst in the female the absence of Sox9 allows Wnt4 to silence Fgf9 (Kim 
and Capel, 2006). In the absence of Fgf9 Sertoli cells do not form and the male 
pathway is aborted. The unopposed action of Wnt4 results in development down 
the ovarian pathway. This indicates that Sry is not sufficient to ensure the male 
pathway without Fgf9 (Kim and Capel, 2006), and indeed in XX Wnt4-/- or Rspo1-/- 
mice, Sox9 is upregulated despite the lack of Sry (Kim et al., 2006). Wnt4 is also 
required to prevent mesonephric migration of epithelial and endothelial cells that 
only occurs in males (Brennan and Capel, 2004);(Golestaneh et al., 2009).  
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Figure 1.2. Model of balanced opposing signals between Fgf9 and Wnt4 in the 
development of the male and female gonad. In XY gonads, Sry upregulates Sox9 to 
establish a feed-forward loop that upregulates Fgf9 and silences Wnt4. In XX gonads, Wnt4 
dominates and silences Fgf9 and Sox9. Taken from (Kim and Capel, 2006). 
 
1.6. Formation of the testis cords 
In the male the expression of SRY and the activation of downstream events 
determine the normal development of the testis. The first signs of testis 
differentiation can be seen at 12.5dpc in the mouse with the formation of cylindrical 
cords (Wilhelm et al., 2007);(Tilmann and Capel, 1999) (Fig. 1.3). This is under the 
control of the differentiating Sertoli cells (Tilmann and Capel, 1999) and testis cords 
can form even in the absence of germ cells (Wilhelm et al., 2007). In addition to its 
role in causing Sertoli cell differentiation, Sry is also responsible for the migration of 
mesonephric cells into the testis (Capel et al., 1999). Migration of cells from the 
mesonephros does not occur in XX gonads, but does in XY gonads (Martineau et al., 
1997). Incorporation of an Sry transgene results in migration of cells from the 
mesonephros into XX gonads (Capel et al., 1999). Migrating mesonephric cells have 
also been shown to be able to initiate cord formation in the XX gonad using 
‘sandwich studies’. For example, when the XX gonad is placed between an XY 
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gonad and mesonephros migration of cells into the XX gonad is observed with 
formation of cords containing cells that expressed Sox9 (Tilmann and Capel, 1999). 
The peritubular myoid cells surround the cords and in collaboration with the Sertoli 
cells form the basal lamina that divides the testis into the cords, containing the germ 
cells, and the surrounding interstitium (Wilhelm et al., 2007). In the human testis, 
expression of SOX9 and the process of cord formation begins between 7-9 weeks of 
gestation, occurring over a period of some weeks (Hanley et al., 2000);(Wartenberg, 
1981);(Ostrer et al., 2007).  
 
Figure 1.3. Structure of the seminiferous cords. a) At the earliest stages of testis 
organogenesis (11.75–12.0 days post coitum; dpc), Sertoli cells (blue) polarize and begin to 
aggregate around clusters of primordial germ cells (asterisk) to initiate development of testis 
cords. ce, coelomic epithelium. b) Between 11.5–12.5 dpc, the cells of the testis are 
organized into two functional compartments: testis cords (TC) and the interstitial space (I) 
outside the cords. Within testis cords, Sertoli cells (S; blue) surround germ cells (GC; green). 
A basal lamina is deposited between Sertoli cells and peritubular myoid cells (PM). The 
interstitial compartment contains Leydig cells (L; yellow) and the coelomic vessel (CV; red), 
with branches that extend between cords. Taken from (Brennan and Capel, 2004). 
 
The relative timings of some of the key events in gonadal development in the mouse 
and human are summarised in Table 1.1.  
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 Germ cell arrival 







Mouse 9.5-11 dpc 10.5 dpc 11.5-12.5 dpc 12.5 dpc 
Human 5 wks 7-8 wks 7-9 wks 7-8 wks 
 
Table 1.1. Timing of arrival of PGCs at the genital ridge, SRY mRNA expression and 
formation of the testis cords. Comparison between the human (Wartenberg, 
1981);(Hanley et al., 2000);(Ostrer et al., 2007);(Habert et al., 2001); and the mouse 
(Anderson et al., 2000);(Hacker et al., 1995);(Diaz-Hernandez et al., 2008);(Tilmann and 
Capel, 1999);(Wilhelm et al., 2007);(Habert et al., 2001). wks = weeks gestation, dpc = days 
post-coitum. 
 
1.7. Development of the internal and external genitalia 
The development of the gonad and the testis cords in the male is largely determined 
by the genetic sex and the presence of the Y chromosome as described. Once this is 
established then the phenotypic sex and the development of internal and external 
genitalia is determined (Habert et al., 2001). In the male this process is under the 
control of two hormones, anti-Müllerian hormone (AMH) and testosterone. AMH, 
also known as Müllerian-inhibiting substance (MIS), is a member of the 
transforming growth factor-beta (TGF-) family of growth and differentiation 
factors (Behringer, 1995). It is secreted by the Sertoli cells and its expression begins 
shortly after SRY expression reaches its peak (Hacker et al., 1995). This glycoprotein 
hormone is responsible for regression of the Müllerian ducts and the absence of this 
hormone was shown by Alfred Jost in the 1940’s to result in the formation of the 
fallopian tubes, uterus and upper third of the vagina (reviewed in (Rey, 2005)). 
Testosterone is a steroid hormone secreted by the Leydig cells of the developing 
testis and is responsible for masculinising the developing fetus. 
 
1.8. Leydig cells 
Leydig cells are the cells within the interstitium of the testis that are responsible for 
steroidogenesis and hence the production of the steroid hormone testosterone from 
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cholesterol (Habert et al., 2001). In addition they produce the peptide hormone 
insulin-like growth factor 3 (INSL3), which is responsible for the trans-abdominal 
phase of testicular descent in mice (Hughes and Acerini, 2008). There are at least 
two generations of Leydig cells. The fetal Leydig cells are responsible for 
masculinisation of the developing urogenital system (Svechnikov and Soder, 2008), 
whilst steroid synthesis by the adult Leydig cells is essential for the onset and 
maintenance of spermatogenesis (Habert et al., 2001).  
 
1.8.1. Fetal Leydig cells 
The origin of the fetal Leydig cell population is still uncertain although at least some 
of these cells migrate in from the mesonephric mesenchyme (Merchant-Larios et al., 
1998), whilst others may be derived from the coelomic epithelium (Svechnikov and 
Soder, 2008);(Habert et al., 2001). It is also not clear whether precursor cells specific 
to the steroidogenic lineage exist in the bipotential gonad, or whether the lineage 
differentiates from multipotent somatic precursors in response to the confluence of 
signals from supporting cells and connective/endothelial cell lineages (Kim and 
Capel, 2006). Within the developing urogenital ridge there is a single population of 
cells that express steroidogenic factor-1 (SF1). These cells separate into two 
populations in regions that will become the adrenal or the gonad (Habert et al., 
2001) and some of these SF1 expressing cells within the gonadal region will become 
the Leydig cells (Habert et al., 2001). In the mouse the fetal Leydig cells begin to 
produce testosterone once the cords have formed at 12.5 dpc (Merchant-Larios et al., 
1993) and regress after development of the urogenital system, however they remain 
in the testis in adult life (Habert et al., 2001), (Gnessi et al., 2000).  
 
In the human three phases of fetal Leydig cell development have been described 
(Svechnikov and Soder, 2008). Steroidogenic cells are present from 7-8 weeks of 
gestation (Lambrot et al., 2009) and proliferation and differentiation occurs between 
7-14 weeks gestation (Svechnikov and Soder, 2008). The fetal Leydig cells are 
mature between 14-18 weeks, followed by an involution phase extending from 18-38 
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weeks (Svechnikov and Soder, 2008). As opposed to Leydig cells in the rodent, fetal 
Leydig cells are not present in the adult human testis. The human fetal Leydig cells 
begin to secrete testosterone from 8 weeks gestation, although functional 
differentiation with production of testosterone has been described to occur in the 
precursors as early as 6-7 weeks (Tapanainen et al., 1981). Between 8-10 weeks, 
testosterone production can probably occur in the absence of stimulation by LH or 
hCG, as demonstrated by the presence of Wolffian ducts (a testosterone dependent 
process) in a patient with an inactivating mutation of their CG/LH receptor (Kremer 
et al., 1995). However masculinisation of the external genitalia does not occur in 
these patients and this indicates that LH/CG is required for masculinisation in the 
human fetus later in gestation (Kremer et al., 1995). Recent studies have shown that 
retinoic acid can result in short term stimulation of steroidogenesis by 7 week 
gestation fetal Leydig cells in culture (Lambrot et al., 2006). The findings in humans 
are in contrast to those in male mice with mutations in the LH receptor gene, in 
which masculinisation of the reproductive tract during fetal life is normal and that 
steroidogenesis can be maintained by a number of bioactive peptides in a paracrine 
fashion (reviewed in (Ahtiainen et al., 2007)). 
 
1.8.2. Adult Leydig cells 
At puberty in the rat, adult Leydig cells are derived from a distinct population of 
undifferentiated precursors rather than the pre-existing fetal Leydig cells (Habert et 
al., 2001). These mesenchymal precursors proliferate during neonatal life and 
gradually begin to express steroidogenic enzymes and undergo morphological 
changes which characterise their transition from immature to adult Leydig cell 
(Habert et al., 2001). Once they have differentiated, the adult Leydig cells rarely 
proliferate. Factors that have been implicated in the differentiation and proliferation 
of adult Leydig cells in the rat are reviewed in (Habert et al., 2001). 
 
In the human the fetal Leydig cells regress towards the end of the first year of life, 
whilst a similar population of undifferentiated mesenchymal cells as described in 
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the rat are located in the interstitium. At puberty these cells begin to proliferate and 
differentiate to adult type Leydig cells (Svechnikov and Soder, 2008). 
 
1.8.3. Steroidogenesis 
Testosterone is produced by the Leydig cells in a process known as steroidogenesis 
(Fig. 1.4). This process is responsible for the production of steroid hormones in the 
adrenal and the gonad. The production of the adrenal and sex steroids begins with a 
common precursor, cholesterol. A series of enzymes consisting of cytochrome P450 
(CYP) and hydroxysteroid dehydrogenases (HSD) catalyse the conversion of 
cholesterol to the various steroid hormones (Payne and Hales, 2004). One important 
difference between the CYP and the HSD enzymes is that each of the CYP enzymes 
is a product of a single gene, whilst there are several isoforms of the HSD enzymes 














Figure 1.4. Steroidogenesis in the gonad and adrenal. Pathways in red are common to 
both adrenal and gonad, whilst pathways in yellow take place in the adrenal and blue in the 
gonad. Testosterone and dihydrotestosterone (DHT) are androgens involved in 
masculinastion of the male (         ‘back-door’ pathway for DHT production). POR, P450 
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1.8.4. 3-HSD 
The 3-HSD enzymes catalyse the conversion of pregnenolone, 17-pregnenolone, 
and dehydroepiandrosterone to progesterone, 17-hydroxyprogesterone, and 
androstenedione, respectively. There are several isoforms of 3-HSD, which are 
expressed in a cell and tissue specific manner (Payne and Hales, 2004). Human and 
rat Leydig cells express 3-HSD during fetal (Fisher et al., 2003) and postnatal life 
(Svechnikov and Soder, 2008), and this includes the precursor population of the 
adult Leydig cells (Habert et al., 2001);(Chemes et al., 1992), although expression is 
variable at different periods of development (Habert et al., 2001). In the human 3-
HSD is first expressed between 9-14 weeks of gestation (Gaskell et al., 2004). Once 
expression has begun in early fetal life 3-HSD provides a reliable marker of the 
Leydig cell population throughout life. 
 
1.8.5. Testosterone and dihydrotestosterone 
Testosterone is the principal hormone produced from the Leydig cells of the testis. 
This hormone is converted by the enzyme 5-reductase to the more potent 
androgen dihydrotestosterone (DHT). DHT rather than testsoterone is responsible 
for most aspects of virilisation in fetal life and also at puberty (Auchus, 2004). DHT 
binds more tightly to the androgen receptor (AR) and activates transcription at 
lower concentrations than testosterone. Although there are low levels of DHT in the 
testis, expression of 5-reductase leads to local conversion of testosterone to DHT in 
target tissues such as the external genitalia, prostate and brain (Auchus, 2004).  
 
1.9. Androgen receptor 
In order for androgens to act within tissues the androgen needs to bind AR. The AR 
gene is a single copy gene that lies on the X-chromosome at Xq11–12 (Galani et al., 
2008). The AR is located in the cytoplasm in the absence of ligand. Testosterone 
diffuses in through the cell membrane and binds to the AR, causing translocation to 
the nucleus and activation of transcription (Galani et al., 2008). The receptor is 
expressed from around 9 weeks gestation in the human testis (Gaskell et al., 
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2004);(Sajjad et al., 2004). It is initially confined to the peritubular myoid cells 
(Murray et al., 2000);(Gaskell et al., 2004) and some interstitial cells (Sajjad et al., 
2004), but is expressed in Sertoli cells in postnatal life (Chemes et al., 2008). 
 
1.10. Chorionic gonadotrophin  
Human chorionic gonadotrophin (hCG) is a glycoprotein hormone composed of 
two dissimilar subunits,  and , joined noncovalently. It is produced by 
trophoblast tissue in pregnancy and trophoblast disease, and also in poorly 
differentiated cancers. hCG exerts its effect during early embryogenesis, inducing 
fetal Leydig cell differentiation and testosterone production in human and primate 
fetal Leydig cells (Rabinovici and Jaffe, 1990). The -subunit of hCG is similar to that 
of the pituitary glycoprotein hormones, whilst -subunit is specific for hCG (Cole, 
1997).  
 
1.11. The LH/CG receptor 
The human LH/CG receptor is a member of the G protein-coupled receptor family 
with two natural ligands, luteinizing hormone (LH) and hCG. During fetal life the 
human testis is exposed to high levels of hCG (Hallmark et al., 2007). The 
production of testosterone is dependent on placental hCG during the first trimester, 
whilst LH stimulation becomes increasingly important in the second trimester 
(Habert et al., 2001) and in postnatal life LH is responsible for testosterone 
production by Leydig cells, especially during puberty (Qiao et al., 2009). 
Importantly, exogenous hCG is able to stimulate testosterone production by 
postnatal human and primate Leydig cells and is used clinically both 
therapeutically and also for diagnostic evaluation of testosterone production in 
humans (Yazici et al., 2009);(Hadziselimovic et al., 2005). 
 
1.12. The male hypothalamo-pituitary-gonadal axis 
Secretion of gonadotrophins from the pituitary gland is responsible for regulating 
hormonal control of the gonad in the male (Fig. 1.5). The male hypothalamo-
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pituitary-gonadal (HPG) axis is active from fetal life and the level of hormones 
produced varies at different stages throughout life. The axis regulates the onest of 
puberty and the establishment of spermatogenesis (Sharpe, 1994), in addition to the 
production of gonadal androgens. Gonadotrophin releasing hormone (GnRH) is 
produced by the hypothalamus and stimulates the secretion of two gonadotrophins 
from the anterior pituitary. These glycoprotein hormones are LH and follicle 
stimulating hormone (FSH). LH binds to the LH/CG receptor on the Leydig cells of 
the testis to promote testosterone secretion from the Leydig cells, and FSH acts on 
the Sertoli cells to initiate spermatogenesis. Two important negative feedback loops 
exist to regulate the secretion of gonadotrophins. The testosterone negative feedback 
loop is established in fetal life and inhibits hypothalamic and pituitary production 
of GnRH and LH respectively (Forest et al., 1976). Negative feedback sensitivity of 
the HPG axis does not develop in the rat until late in gestation (in (Hallmark et al., 
2007)) as LH is not present until 16.5 dpc in the rat (Habert et al., 2001), but after 
birth testosterone secretion is LH dependent in rat, human and marmoset (Hallmark 
et al., 2007). The other negative feedback loop results from production of Inhibin-B 
by the Sertoli cell, which exerts inhibitory effects on FSH secretion from the 
pituitary gland, however this negative feedback loop is only established at around 
puberty (Anderson and Sharpe, 2000). 
 
The profile of gonadotrophins and testosterone varies depending on age and 
development (Fig. 1.6). In the human during fetal life, the levels of testosterone are 
high with a peak at 14-17 weeks gestation (Reyes et al., 1974). Following birth in 
humans and non-human primates there is an initial rise in gonadotrophins and 
testosterone that continues during early infancy, the so-called ‘mini puberty’ 
(Hadziselimovic et al., 2005). In humans the rise begins at 2 weeks of life and peaks 
between 1 and 3 months of age (Forest et al., 1973), falling to low levels at 6-8 
months. This pattern of secretion has also been demonstrated in many other 
primates, including the rhesus monkey and the marmoset (Dixson, 1986);(Mann and 
Fraser, 1996). 
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Figure 1.5. The male HPG axis. Gonadotrophins (LH and FSH) released from the anterior 
pituitary under the control of GnRH act on the testis to produce testosterone from the Leydig 
cell and Inhibin B from the Sertoli cell. Testosterone and Inhibin-B negatively feedback to the 
hypothalamus and/or pituitary. Stimulation (+) and inhibition (–) are indicated.  Taken from 
(Mitchell et al., 2009).  
 
In humans and non-human primates after the rise in gonadotrophins and 
testosterone during early infancy, there follows a period of relative ‘quiescence’ 
during which levels of these hormones are relatively low (Mann and Fraser, 1996). 
This period will be referred to as the ‘childhood period’, which lasts from the end of 
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infancy until the onset of puberty. Although this period has been described as a 
quiescent period it is clear that the testis is active. Sertoli cells actively express the 
FSH receptor, AMH and aromatase, which is the product of the CYP19 gene 
(Chemes, 2001). In addition there are periods of germ cell proliferation (Kelnar et al., 
2002) and the transient appearance of meiotic cells (Chemes, 2001). Levels of the 
gonadotrophins and testosterone rise again peripubertally and remain high during 
adult life. In rodents there is no equivalent childhood period of low gonadotrophin 




Figure 1.6. The profile of Gonadotrophin and testosterone secretion in primates. 
Taken from (Mitchell et al., 2009). 
 
1.13. Disorders of sex development 
In humans the term disorders of sex development (DSD) is used to describe a group 
of congenital conditions in which development of chromosomal, gonadal, or 
anatomical sex is atypical (Hughes, 2008). These conditions are classified according 
to karyotype as either sex chromosome DSD, XY DSD or XX DSD (Hughes, 2008). 
Most of these disorders result from failure of normal gonadal development or the 
effects of abnormal androgen production, synthesis or action. One or other of the 
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molecules and pathways already described for gonadal development (section 1.2 – 
1.8) and hormonal control of the reproductive axis (section 1.7 – 1.9) are involved in 
the pathogenenesis of these disorders (Hughes et al., 2006). This section will focus 
mainly on the 46XY causes of DSD because this thesis is concerned with the male 
gonad, however it must be noted that there are also many causes of XX DSD, some 
of which are caused by the reverse situation to those of the XY DSDs (Hughes et al., 
2006). The sex chromosome DSD’s include 45X (Turner syndrome), 47XXY 
(Klinefelter syndrome), 45X/46XY (mixed gonadal dysgenesis) and 46XX/46XY 
(chimeric). The latter two conditions result in ovotesticular DSD in which the 
gonads may contain both ovarian and testicular tissue (Hughes et al., 2006).  
 
1.13.1. Disorders of gonadal development 
During the initial stages of gonad development, lack of a functional copy of one of 
several genes have been shown to result in the complete absence of a gonad in mice. 
These include Sf1, Wt1, Lhx1, Lhx9 and Emx2 (Clarkson and Harley, 2002). In 
addition some of these genes are responsible for the development of other organs. 
Wilms’ tumor gene-1 (WT1) is also involved in kidney formation, whilst SF1 has a 
role in adrenal development (Habert et al., 2001). Wt1 is expressed in the mouse 
gonadal ridge from 9dpc in both males and females (Pelletier et al., 1991). Wt1 has 
been shown to be involved in cell autonomous regulation of Sry expression 
(Bradford et al., 2009). Mice carrying a deletion of Wt1 do not develop gonads and 
have arrested kidney development, whilst different mutations in the human WT1 
gene result in conditions that have varying degrees of renal tract anomalies and 
tumours, in addition to XY sex reversal (Swain and Lovell-Badge, 1999). These 
conditions include WAGR (Wilms tumour, aniridia, genito-urinary abnormalities 
and mental retardation), Denys-Drash and Frasier syndromes (Swain and Lovell-
Badge, 1999). SF1 is an orphan nuclear receptor that in knockout mice results in 
complete absence of adrenal glands and gonads due to apoptosis in the very early 
stages of differentiation of these tissues (Sadovsky et al., 1995). Sf1 knockout mice 
exhibit male-to-female reversal of both internal and external genital tracts (Habert et 
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al., 2001). A combination of adrenal failure and a female or ambiguous genitalia is 
also described in humans with SF1 mutations, although depending on the mutation 
there may be sex reversal without adrenal insufficiency (Correa et al., 2004). 
 
Mutations in genes involved in early testicular development, such as SRY and SOX9 
can result in XY sex reversal in which a genotypic male may be phenotypically 
female. In a study of chimeric male mice that had been constructed using XY 
embryonic stem cells infected in culture with MPSV.mos-1neo replication defective 
retroviral vector, 4% of these mice displayed a female phenotype (Lovell-Badge and 
Robertson, 1990). These mice had ovaries and some of them were fertile. The 
mutations segregated exclusively to the Tdy (TDF in humans) region of the Y 
chromosome (Lovell-Badge and Robertson, 1990). Humans with SRY/SOX9 
mutations may present with female or ambiguous genitalia in addition to 
dysgenetic testis or ovotestis (Hughes, 2008). Mutations in the SRY gene can result 
in male to female sex reversal in 46XY patients and a normal SRY gene is absent in 
many 46XY subjects with a female phenotype, whereas a translocation of this gene 
in 46XX patients is present in most 46XX patients with a male phenotype (Habert et 
al., 2001). Moreover, Sry  is the only gene needed from the Y chromosome to induce 
male development as shown by transgenic experiments in which XX mice carrying 
the Sry gene develop as males (Koopman et al., 1991). Studies of XX  XY chimeric 
mice have shown that a minimum of 20% Sry expression is required for male 
development. Below this level an ovotestis may form, whilst levels approaching 
zero result in an ovary (Polanco and Koopman, 2007). Mutations in the SOX9 gene 
have been linked to a severe dwarfism syndrome known as campomelic dysplasia 
(Foster, 1996). More than 75% of XY patients with SOX9 mutations show sex 
reversal, with a gradation of genital defects (Habert et al., 2001). Conversely in 46XX 
patients, duplication of SOX9 can result in female to male sex reversal (Huang et al., 
1999). 
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Doublesex and mab-3-related transcription factors 1 and 2 (DMRT1/2) are genes 
located on chromosome 9 and are expressed in the mammalian genital ridge prior to 
sexual differentiation (Raymond et al., 1999). XY sex-reversal has been observed in 
patients with DMRT1 mutations (Raymond et al., 1999). XY patients with mutations 
in the distal portion of 9p (incorporating the DMRT genes) have XY sex reversal 
associated with the loss of these genes (Ounap et al., 2004). 
 
Whilst the genes discussed so far are mutated in XY sex reversal there are also genes 
that when duplicated will also result in XY sex reversal. This includes the Dax1 and 
Wnt4 genes. Dax1 encodes an orphan nuclear hormone receptor (Brennan and 
Capel, 2004). In females early downregulation of Sox9 coincides with an increased 
expression of Dax1. Evidence for XY sex reversal was shown in transgenic mouse 
experiments, where overexpression of Dax1 alone was able to cause XY sex reversal 
when tested against the weak Sry allele (Swain et al., 1998).  
 
The interaction between the FGF9 and WNT4 signalling pathways as described in 
section 1.5, also plays a role in DSD. Male-to-female sex reversal results from 
mutations in Fgf9, whereas female-to-male sex reversal, albeit partial, occurs when 
Wnt4 is mutated (Hughes, 2008). Wnt4 is downregulated in the testis and therefore 
mice with a global Wnt4 mutation resulting in a likely null allele do not have testis 
abnormalities, however Wnt4 knockout in the females lack a Müllerian duct and 
have increased expression of steroidogenic enzymes such as 3-HSD and 17-
hydroxylase in their ovaries (Vainio et al., 1999). This results in production of 
inappropriate androgens that cause female masculinisation and development of the 
Wolffian duct (Habert et al., 2001). An example of how several of these factors work 
in concert can be seen in Leydig and Sertoli cells transfected with WNT4. This leads 
to upregulation of DAX1, which in turn is known to antagonize SRY, hence the XY 
sex reversed phenotype (Jordan et al., 2001). Patients with WNT4 duplications and 
XY sex reversal have also been described (Jordan et al., 2001).  
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1.13.2. Disorders of hormone synthesis or action 
There are numerous causes of XY DSD that result from disorders of hormone 
synthesis or action. These can involve defects in either signalling to the Leydig cells, 
steroidogenesis within the Leydig cells, or impaired action of androgens once they 
have been produced. 
 
Inactivating mutation of the LHCGR gene occurs as an autosomal recessive disorder 
with undervirilisation of 46 XY patients (Kremer et al., 1995). This condition is 
known as Leydig cell hypoplasia. The presentation ranges from complete XY sex 
reversal to hypospadias or micropenis, depending on the type of mutation and the 
degree of LHCGR inactivation (Qiao et al., 2009). However in approximately 50% of 
patients presenting with Leydig cell hypoplasia, an LHCGR mutation has not been 
found (Qiao et al., 2009). 
 
Mutations in several of the steroidogenic or related enzymes may result in 
undervirilisation of the XY fetus. In these cases the gonad develops as a testis, 
however the external genitalia may be abnormal (Hughes et al., 2006). These defects 
are rare autosomal recessive conditions, which often have an adrenal phenotype in 
addition to the gonadal abnormalities, because of common pathways of 
steroidogenesis that occur within these organs (Fig. 1.4). For example, defects in the 
7-dehydrocholesterol reductase DHCR7 enzyme that catalyses the final step in the 
synthesis of cholesterol results in the Smith-Lemli-Opitz syndrome (Szabo et al., 
2009) in which a variable external genitalia phenotype is seen (Hughes et al., 2006). 
In contrast, defects in delivery of cholesterol from the outer to the inner 
mitochondrial membrane of adrenal and gonadal steroidogenic cells results in XY 
sex reversal and adrenal failure, a condition known as congenital lipoid adrenal 
hyperplasia. The protein involved in this defect is the steroidogenic acute regulatory 
protein (StAR) (Lin et al., 1995). Defects in enzymes that are involved in the steroid 
biosynthetic pathway downstream of cholesterol (Fig. 1.4), including CYP11A1, 
3HSD2, CYP17 can all result in congenital adrenal hyperplasia in addition to 
Chapter 1 Literature review 20 
phenotypic abnormalities of the external genitalia (Hughes et al., 2006). Mutations 
in 17HSD3 is the most common of the disorders of androgen biosynthesis and 
results in a failure to convert androstenedione to testosterone (Faienza et al., 2008), 
however in these patients there may be partial androgenisation due to the 
androgenic properties of androstenedione and the external genitalia phenotype 
ranges from undervirilisation to complete female external genitalia (Faienza et al., 
2008). Mutations in the P450 oxidoreductase (POR) gene results in deficiencies in the 
activity of a number of enzymes in the steroidogenic pathway including CYP21 and 
CYP17 (Hughes, 2008). The POR protein acts as a cofactor for these steroidogenic 
enzymes and unlike the other single enzyme defects, can result in abnormal 
development of the external genitalia in both sexes (Hughes, 2008). 
 
5–reductase deficiency results in a failure to convert testosterone to 
dihydrotestosterone. This results in varying degree of undervirilisation in the XY 
fetus, with effects on the DHT dependent tissues such as the urogenital tubercle and 
urogenital sinus, whilst the testosterone dependent tissues such as the Wolffian duct 
develop normally (Imperato-McGinley and Zhu, 2002).  
 
Androgen insensitivity syndrome (AIS) is an X-linked disease resulting from a 
variety of mutations in the AR gene. This results in variable virilisation of 46 XY 
individuals with a range of phenotypes from a female appearance to masculinised 
genitalia and/or incompletely descended testes (Galani et al., 2008). The patients can 
be classified as having complete androgen insensitivity syndrome (CAIS) or partial 
androgen insensitivity syndromes (PAIS). CAIS usually presents at the onset of 
puberty when pubic hair and initiation of menses does not occur. Breast 
development is normal because of aromatisation of the high levels of androgen to 
oestrogen. PAIS presents with variable phenotypes of undervirilisation, often in the 
neonatal period (Galani et al., 2008). 
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1.13.3. DSD and risk of testicular germ cell tumour  
An important aspect of DSD is that some of the conditions are associated with a 
significantly increased risk of the development of testicular germ cell tumours 
(TGCT). Individuals with DSD and gonadal dysgenesis (i.e. 45,X/46,XY), XY patients 
with hypovirilisation, XX patients with Y chromosome translocations are at risk of 
TGCT, in addition to males with undescended testis (Cools et al., 2005);(Looijenga et 
al., 2007b);(Carcavilla et al., 2008). Table 1.2 shows which of the DSDs are associated 
with TGCT and the estimated risk (Looijenga 2007a).  
 
Risk group Disorder Malignancy risk (%) Studies  Patients 
High GDa (+Y)b abdominal gonad 15–35 12  >350 
 PAIS non-scrotal gonad 50 2  24 
 Frasier 60 1  15 
 Denys–Drash (+Y) 40 1 5 
Intermediate Turner (+Y) 12 11  43 
 17β-HSD 28 2  7 
 GD (+Y)c Unknown 0  0 
 PAIS scrotal gonad Unknown 0  0 
Low CAIS 2 2 55 
 Ovotestis DSD 3 3  426 
 Turner (– Y) 1 11 557 
No (?) 5α-reductase 0 1 3 
 Leydig cell hypoplasia 0 2  
 
Table 1.2. Risk of TGCT in the various categories DSD patients. Risk is classified into 
high-, intermediate-, low- and no-risk groups. Taken from (Looijenga et al., 2007b). 
a
 Gonadal dysgenesis (GD; including not further specified, 46XY, 46X/46XY, mixed, partial, 
complete).
 b 
GBY region positive, including the TSPY gene.
 c
 At time of diagnosis. 
 
In patients with gonadal dysgenesis, TGCTs arise from the pre-malignant lesion 
known as gonadoblastoma, whilst TGCT in a non-dysgenetic testis results from a 
pre-malignant lesion known as carcinoma in-situ (CIS) (Cools et al., 2006c). CIS 
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occurs more commonly in XY DSD individuals than in those with numerical and 
structural abnormalities of sex chromosomes (Slowikowska-Hilczer et al., 2003). 
 
The presence of a defined region of the Y chromosome is a prerequisite for the 
development of TGCT in DSD patients (Looijenga et al., 2007b). This has been 
determined to be the gonadoblastoma (GBY) locus and is likely to be the testis 
specific protein on the Y-chromosome (TSPY) gene (Looijenga, 2009);(Lau et al., 
2000). Evidence for the requirement for Y chromosome material in the pathogenesis 
of TGCT has been obtained from studies in patients with Turner syndrome, where 
individuals with no apparent Y chromosome material are at low risk of TGCT, 
whilst patients with Y chromosome material from a translocation are at 
intermediate risk (Looijenga et al., 2007b). Conditions that result in absence of 
testosterone or testosterone action will not have a significantly increased risk of 
development of TGCT. This explains why the risk of TGCT is much lower in 
patients with CAIS, when compared to those with PAIS. It also explains why 
patients with hypogonadotrophic hypogonadism do not develop a TGCT, despite 
being cryptorchid (Looijenga, 2009). This may be related to the induction of germ 
cell apoptosis as occurs in patients with Klinefelter syndrome and CAIS  (Looijenga, 
2009). TGCT will be discussed later in the chapter, however before that normal germ 
cell development will be described in more detail. 
 
1.14. Proteins expressed in differentiating germ cells during fetal life 
 
1.14.1. NANOG 
NANOG is a homeobox domain protein which regulates cell self renewal (Hoei-
Hansen et al., 2005);(Chambers et al., 2003). It is expressed by pluripotent cells, such 
as embryonic stem (ES) cells, embryonic germ (EG) cells, embryonal carcinoma (EC) 
cells and PGCs, but its expression is not sufficient to retain pluripotency in the 
absence of Oct4 expression in mouse ES cells (Chambers et al., 2003). Nuclear 
expression of NANOG is dependent on the formation of homodimers in the human 
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and Oct4 has been found to interact preferentially with Nanog dimers in mouse ES 
cell lines (Wang et al., 2008). Expression of both NANOG and OCT4 is down-
regulated during embryonic stem cell differentiation, with concomitant loss of 
pluripotency (Hoei-Hansen et al., 2005). 
 
1.14.2. OCT4 
OCT4 (POU5F1) is a member of the POU family of transcription factors expressed in 
pluripotent cells including mouse and human ES cells and is thought to be involved 
in PGC survival (Looijenga, 2009). Expression is downregulated during 
differentiation. In mouse ES cells it has been shown that altering the level of OCT4 
can result in three distinct fates. Repression of OCT4 can induce loss of pluripotency 
and dedifferentiation to trophectoderm, whilst an increase in expression causes 
differentiation into primitive endoderm and mesoderm (Niwa et al., 2000). 
 
1.14.3. AP-2 
AP-2 is a DNA binding transcription factor, expressed during embryogenesis and 
plays an important role in the development and differentiation of the neural tube, 
neural crest derivatives, skin, heart, and urogenital tissues in the mouse and is also 
overexpressed in neoplasia including breast cancer (Hoei-Hansen et al., 2004). 
 
1.14.4. PLAP 
Placental alkaline phosphatase (PLAP) is an alkaline phosphatase normally 
expressed in syncytiotrophoblasts (Fisken et al., 1989) and early normal (Ginsburg et 
al., 1990);(Honecker et al., 2004) and pre-neoplastic (Beckstead, 1983) germ cells. The 
function of PLAP remains uncertain, however it is expressed during migration of 
primordial germ cells in the developing fetus (Ginsburg et al., 1990). 
 
1.14.5. c-KIT 
The stem cell factor (SCF) receptor c-KIT (KIT) is a receptor tyrosine kinase that 
activates a number of signalling pathways in response to binding of its ligand SCF. 
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The pathway plays an important role in the survival of differentiating ES cells 
(Bashamboo et al., 2006). The KIT/SCF pathway is also involved in PGC migration 
with biosynthesis of SCF within the gonadal ridge implicated in attracting the 
migrating PGCs to this region (Hersmus et al., 2008) and also has a role in 
preventing germ cell apoptosis (Pesce et al., 1993);(Tu et al., 2007). 
 
1.14.6. VASA 
VASA is a member of the DEAD box family of RNA-binding proteins and a germ 
cell specific protein in both sexes (Castrillon et al., 2000). Mutation of the mouse 
VASA homologue (Mvh) gene results in male infertility and reduced fetal germ cell 
number (Tanaka et al., 2000).  
 
1.14.7. MAGE-A4 
The MAGE proteins are a family of chromosome X encoded cancer testis antigens 
(CTA). These CTAs are expressed in normal human adult testis germ cells and in 
different types of cancer (Gjerstorff et al., 2007). MAGE-A4 is thought to be involved 
in apoptosis and cell cycle progression (Gjerstorff et al., 2007). 
 
1.14.8. NANOS-1 
The NANOS proteins are a family of RNA binding proteins involved in germ cell 
formation, migration and differentiation. The protein forms a complex with 
PUMILIO-2 (Jaruzelska et al., 2003). There are three NANOS proteins identified in 
mice. Disruption of Nanos-1 does not affect germ cell development, however 
knockout of Nanos-2 and Nanos-3 results in a reduction in testis weight and loss of 
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1.15. Germ cell proliferation markers 
 
1.15.1. The cell cycle 
The cell cycle is a series of events that result in division and duplication of the cell. 
The cycle can be divided into different stages. Interphase consists of G1, S-phase and 
G2, during which DNA synthesis occurs between the two gap phases. Between 
interphase there is the M phase during which mitosis occurs. Germ cells can leave 
G1 and enter a resting phase known as G0. 
 
1.15.2. Phospho-histone H3  
Phospho-histone H3 (HH3) is a protein involved in chromatin structure. It is 
specifically phosphorylated (at serine 10) during chromatin condensation in mitosis. 
Therefore antibodies to the phosphorylated form (pHH3) can provide a reliable and 
technically robust method for identifying mitotic activity (Colman et al., 2006).  
 
1.15.3. Ki67  
The proliferation associated nuclear protein Ki67 is important in regulation of the 
cell cycle. Ki67 is expressed during G1, S, G2 and M stages (Schluter 1993), but not in 
resting cells (G0) or early G1 (Angelopoulou et al., 2008). Ki67 has a biological half-
life of 1 hour (Angelopoulou et al., 2008). 
 
1.15.4. Proliferating cell nuclear antigen  
Proliferating cell nuclear antigen (PCNA) is a nuclear protein associated with the 
cell cycle (Hall et al., 1990). PCNA is also required during DNA replication and 
nucleotide excision repair (Angelopoulou et al., 2008). It is expressed during all 
stages of the cell cycle with a maximum in S and G2 phases. The transition from the 
growing to the quiescent state of the cell cycle does not result in a rapid degradation 
of the protein and the half-life is ~20 hours (Bravo and Macdonald-Bravo, 1987).  
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HH3 identifies cells during the short mitotic phase of the cell cycle and as a result 
will be expressed in a smaller proportion of cells than Ki67 and PCNA. PCNA and 
Ki67 are expressed through the majority of the cell cycle.  PCNA has been 
demonstrated in a higher proportion of cells than Ki67 in studies including a study 
of spermatogonial proliferation in human adult testes (Steger et al., 1998). PCNA 
expression is identified in a larger proportion of cells than for Ki67 for several 
reasons. Firstly PCNA is expressed in cells throughout the cell cycle. It also has a 
longer half-life than Ki67 and finally it has been show that PCNA is also involved in 
nucleotide excision repair mechanisms (Angelopoulou et al., 2008).  
 
1.16. Primordial germ cells 
Primordial germ cells are committed to a germ cell fate in vivo (Culty, 2009), 
however they express markers of pluripotency such as OCT4 and NANOG (Perrett 
et al., 2008). Pluripotency refers to the ability of a cell to differentiate into multiple 
cell types depending on the signals that the cell receives and both Oct4 and Nanog 
are required for the maintenance of pluripotency (Loh et al., 2006).  Although these 
cells are committed to a germ cell fate in vivo, they have been shown to form 
pluripotent colonies of embryonic germ (EG) cells  in vitro (Kerr et al., 2008). In 
addition to pluripotency markers, PGCs also express placental alkaline phosphatase 
(PLAP), which has been used to trace the migration of these cells to the genital ridge 
(Ginsburg et al., 1990).  PGC numbers increase from ~155 to 1000 between e8.5 and 
e10.5 in the mouse during their migration indicating that these cells are proliferating 
(Tam and Snow, 1981). PGC number in the human embryo prior to 6 weeks has 
been estimated to be between 450-1400, with a dramatic increase in numbers after 
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1.17. Gonocytes 
 
1.17.1. Differentiation of gonocytes 
The PGCs arrive in the developing gonad at which point they are usually referred to 
as gonocytes. PGCs and gonocytes have a distinctive morphology. They are round 
cells with a prominent nucleus, containing one or two nucleoli and a characteristic 
ring of cytoplasm (Baillie, 1964). In the human male fetus gonocytes are reported to 
enter a period of mitotic arrest, whilst in the female the germ cells enter meiosis. 
Retinoic acid (RA) is thought to be responsible for this sexually dimorphic 
difference between male and female germ cells based on studies in the mouse 
(Kocer et al., 2009). Although in the mouse RA is produced in the mesonephros in 
both male and female gonads, somatic cells in the male testis also produce the 
enzyme CYP26B1, which results in degradation of RA and prevents male germ cells 
from entering meiosis (Bowles et al., 2006). During fetal and early postnatal life male 
gonocytes begin to differentiate into spermatogonia. The differentiation of germ 
cells from gonocyte into spermatogonia involves changes in the morphology and 
protein expression profile (Gaskell et al., 2004);(Wartenberg, 1981);(Holstein et al., 
1987);(Fukuda et al., 1975). Up to three distinct subpopulations of cells have been 
described during this transition and are referred to variously as gonocytes and 
prospermatogonia (Wartenberg, 1981); gonocytes and prospermatogonia (Holstein 
et al., 1987) or gonocytes, intermediate cells and fetal spermatogonia (Fukuda et al., 
1975). The prospermatogonia have also been categorised according to their 
proliferative activity. These have been described as M prospermatogonia 
(mitotically active), T1 prospermatogonia (nondividing/resting), and T2 
prospermatogonia (those that had resumed mitotic activity) (Wartenberg, 1981). In 
these original publications these distinctions were based on morphological 
differences, however we have characterised the cells as gonocytes, intermediate cells 
and prespermatogonia based on the expression profile of various germ cell proteins 
(Gaskell et al., 2004) (Fig. 1.7).  
 
Chapter 1 Literature review 28 
 
Figure 1.7. Identification of germ cells with differing morphology in second-trimester 
human fetal testis. Three different populations were identified. Population 1 (gonocyte): 
small, round cells; high nuclear:cytoplasmic ratio: prominent nucleolus: usually single cells, 
often in the centre of a cord. Population 2 (intermediate): round nuclei, usually in pairs, more 
cytoplasm/irregular outline compared with population 1. Population 3 (prespermatogonia): 
largest of the germ cell types, irregular outline, clear cytoplasm, usually in groups at the 
periphery of a cord. Taken from (Gaskell et al., 2004). 
 
The transition between these cell types can be followed by the loss of expression of 
pluripotency proteins and the increasing expression of germ cell specific proteins 
characteristic of differentiated germ cells (Gaskell et al., 2004). Proteins associated 
with pluripotency (OCT4 and NANOG) and in addition proteins such as PLAP and 
AP-2 are downregulated and disappear completely over the course of 
differentiation from gonocyte to spermatogonia (Gaskell et al., 2004);(Honecker et 
al., 2004);(Kerr et al., 2008);(Looijenga et al., 2003a);(Pauls et al., 2006);(Rajpert-De 
Meyts et al., 2004);(Jorgensen et al., 1995);(Hoei-Hansen et al., 2004);(Jorgensen et al., 
1993). As expression of these proteins are downregulated, other proteins indicative 
of more differentiated germ cells, such as VASA and MAGE-A4 can be detected 
(Anderson et al., 2007);(Aubry et al., 2001);(Honecker et al., 2004);(Castrillon et al., 
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2000) (summarised in Fig. 1.8). This differentiation of gonocyte to spermatogonia 
has been postulated to be triggered by the high levels of gonadotrophins and 
testosterone that occur during the neonatal period (Huff et al., 




Figure 1.8. Expression of different antigens in male germ cells during intrauterine 
development. Findings from various studies (black bars) are compared with the findings of 
Honecker, 2004 (Honecker et al., 2004) (grey bars). The sizes of the grey bars schematically 
represent the frequency of germ cells expressing the individual factor at different 
developmental ages. Adapted from (Honecker et al., 2004). 
 
Additional data relevant to this transition has also been gained by co-staining for 
OCT4/VASA (Anderson et al., 2007) and OCT4/MAGE-A4 (Gaskell et al., 2004). 
VASA mRNA and protein were low/undetectable in 1st trimester and increased in 
the 2nd trimester. During the 1st trimester, germ cells were OCT4 positive but did 
not express VASA. In the 2nd trimester germ cells with intense cytoplasmic staining 
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for VASA were OCT4 negative (Anderson et al., 2007). Expression of MAGE-A4, 
KIT and OCT4 identified three subpopulations that were described as gonocytes 
(OCT4+/KIT+/MAGE-A4-), intermediate germ cells (OCT4low/-/KIT-/MAGE-A4-), and 
prespermatogonia (OCT4-/KIT-/MAGE-A4+). The transition was described with most 
germ cells demonstrating a gonocyte phenotype in the first trimester, however, from 
18 weeks of gestation, prespermatogonia were the most abundant cell type. At a 
given age in the human fetal testis there is a mixture of germ cells at different stages 
of differentiation, ranging from gonocyte to spermatogonia (Anderson et al., 
2007);(Gaskell et al., 2004). Occasional gonocytes can be identified in the infantile 
human testis based on the expression of pluripotency markers such as OCT4 
(Looijenga et al., 2003a) and NANOG (Hoei-Hansen et al., 2005). 
 
The markers described above are either expressed early and subsequently 
downregulated, or expressed later in development and remain present in the germ 
cells. However, KIT is expressed in a bimodal pattern (Culty, 2009). In the mouse, 
KIT is expressed by gonocytes and differentiating spermatogonia but not in the SSC 
population (von Schonfeldt et al., 2004). In the human KIT is also expressed in 
gonocytes (Robinson et al., 2001) and not in the pre-spermatogonium (Gaskell et al., 
2004), but KIT mRNA (Palumbo et al., 2002) and protein are subsequently found in 
the adult human testis and localised to the spermatogonia (Unni et al., 2009).  
 
There are some key differences in gonocyte differentiation in the rodent compared 
to the human. In mice, expression of Vasa is initiated in Oct4 positive PGCs as they 
enter the gonadal ridge and persists throughout the differentiation of germ cells 
(Anderson et al., 2007). In addition Oct4 is downregulated in a synchronous fashion, 
during a short time window. In the rat this occurs between e15.5 and e19.5 (Ferrara 
et al., 2006), whilst in the mouse this takes place between 17-20dpc (Zayed et al., 
2007). Expression of gonocyte markers has ceased completely prior to birth in 
rodents (Ferrara et al., 2006);(Zayed et al., 2007). 
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1.17.2. Proliferation of gonocytes 
Gonocyte numbers have been shown to increase ten-fold between 6-9 weeks post-
coitum in the human fetal testis, rising from ~3000 to ~30 000 (Bendsen et al., 2003). 
During this period the ratio of germ cells to Sertoli cells remains constant at 1:10 
(Bendsen et al., 2003). A huge increase in germ cell number takes place between the 
first and third trimester and the estimated number of prespermatogonia in the latter 
is ~4 000 000. The ratio of germ cells to Sertoli cells has been calculated at a constant 
level of approximately 1:6 from 10-41 weeks gestation (Waters and Trainer, 
1996);(Pauls et al., 2006). In humans, it has been reported that there is only one 
mitotic phase in gonocytes, occurring between the third and sixth months of 
gestation, followed by a quiescent phase until postnatal life (Ketola et al., 
2003);(Culty, 2009), whilst other reports describe a gradual cessation of premeiotic 
proliferation between fetal weeks 12-18 (Pelliniemi, 1993);(De Felici et al., 2004).  
However it has also been noted that Ki-67 staining can be detected in gonocytes 
throughout the second and third trimesters and into postnatal life (Honecker et al., 
2004);(Berensztein et al., 2002);(Pauls et al., 2006) so further studies are required to 
resolve this issue. In rodents there is a fetal phase of proliferation during which a 
large proportion of gonocytes are proliferating. In mice this has been reported to 
occur between 13.5-16 dpc, (Culty, 2009) following which they are arrested in G1 
(Vergouwen et al., 1991), however a recent study has described mitotic arrest 
occurring slightly earlier at E14.5 (Western et al., 2008). In the rat, proliferation 
occurs between 13-18dpc (Culty, 2009);(Ferrara et al., 2006). After this period of 
proliferation there is a period of quiescence until after birth when the germ cells 
begin proliferation again. This process occurs in a synchronous manner, similar to 
that described for germ cell differentiation in rodents (Vergouwen et al., 
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1.18. Spermatogonia 
 
1.18.1. Differentiation of spermatogonia in the immature testis 
Differentiation of gonocytes to spermatogonia can be demonstrated by 
morphological changes that coincide with the loss of expression of gonocyte 
markers. For example, in the human, PLAP expression ceases first with a minimal 
proportion of germ cells positive at 19 weeks gestation (Gaskell et al., 2004), 
although occasional PLAP positive germ cells are described in early postnatal life 
(Honecker et al., 2004). NANOG expression is lost in human germ cells by 3 months 
(Hoei-Hansen et al., 2005);(Rajpert-De Meyts, 2006), whilst OCT4 (POU5F1) is 
described as being present in germ cells until 3-4 months of postnatal age (Cools et 
al., 2005);(Rajpert-De Meyts et al., 2004). An important difference in expression of 
OCT4 occurs between mice and humans. OCT4 continues to be expressed in the 
spermatogonial stem cells of the mouse into adulthood (Pesce et al., 1998);(Ohbo et 
al., 2003);(Tadokoro et al., 2002), whilst OCT4 is not expressed beyond the gonocyte 
stage in the human (Looijenga et al., 2007b). VASA (Castrillon et al., 2000), MAGE-
A4 (Aubry et al., 2001) and NANOS-1 (Jaruzelska et al., 2003) continue to be 
expressed in spermatogonia in humans. There are several subtypes of 
spermatogonia within an individual species and a variation between different 
species (Jahnukainen et al., 2006) (Fig. 1.9).  
 
Spermatogonial stem cells (SSC) undergo a process of self-renewal, which maintains 
their numbers, whilst also giving rise to the differentiating germ cells that will 
ultimately enter the process of meiosis during spermatogenesis and produce 
spermatozoa (Ehmcke et al., 2006a). In primates the (Adark) spermatogonia are 
thought to be the spermatogonial stem cell and to act as the regenerative reserve, 
while (Apale) spermatogonia are the progenitor cells acting as the functional reserve 
(Jahnukainen et al., 2006). In the rhesus monkey the Apale spermatogonia form clones 
and the subsequent differentiation and proliferation occurs in synchrony in these 
clones (Ehmcke et al., 2005). In the human the (Adark) spermatogonia are thought to 
be found in the testis from 2-3 months of postnatal age (Huff et al., 2001). In the 
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mouse A-single (As) spermatogonia are  considered to be the stem cells and it is 
suggested that the As spermatogonia act as both the stem cells and the progenitor 




Figure 1.9. Differences in spermatogonial sub-types between species. Potential number 
of cells generated are shown in brackets. As = A-single, Apr = A-paired, Aal = A-aligned. 
Taken from (Mitchell et al., 2009), adapted from (Jahnukainen et al., 2006). 
 
Spermatogonia are the only germ cell type present within the primate testis from 
infancy until the beginning of puberty, apart from the transient appearance of 
meiotic cells that ultimately degenerate (Huff et al., 2001);(Chemes, 2001).  
 
Spermatogonial stem cell survival is important for future generation of gametes. 
These SSC are thought to be located within a unique micro-environment known as 
the spermatogonial stem cell niche, which is formed by the supporting Sertoli cells, 
basement membrane, interstitial compartment and the vasculature (Hofmann, 2008). 
The importance of the niche has been shown in Drosophila, where division of stem 
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cells occurs perpendicular to the hub (Yamashita et al., 2003). The hub contains the 
somatic cells and can be considered the stem cell niche. The division results in two 
daughter cells, one of which remains in close association with the hub, whilst the 
other loses contact and hence loses the signals from the hub. This asymmetric 
division allows the distant cell to differentiate, whilst retaining a self-renewing cell 
in close contact with the niche (Yamashita et al., 2003). It is thought that a similar 
change in location results in differentiation of spermatogonial stem cells in the 
mammalian testis, with movement of cells away from the spermatogonial stem cell 
niche to a position in close association to the vasculature and interstitium (Yoshida 
et al., 2007). Supporting evidence has been provided by studies using 
transplantation of germ cells from mice into a recipient testis. It is believed that this 
requires migration of SSC to their niche on the basement membrane, adjacent to the 
interstitial compartment. Colonisation of the recipient testis following 
transplantation requires 1-integrin expression in the SSC as demonstrated by a lack 
of colonisation in 1-integrin knockout mice, whilst knocking out the gene in the 
Sertoli cells results in reduced SSC homing (Kanatsu-Shinohara et al., 2008).  
 
1.18.2. Factors implicated in regulation of SSC 
Glial derived neurotrophic factor (GDNF) is produced by Sertoli cells and studies in 
mice suggest it plays an important role in regulating self-renewal of SSC in vivo. For 
example, overexpression of Gdnf results in accumulation of undifferentiated 
spermatogonia but conversely, low Gdnf levels favour spermatogonial 
differentiation (Meng et al., 2000). The receptor for Gdnf is Gdnf family receptor 
alpha-1 (Gfra1), and is located on the cell membrane of As spermatogonia in the 
mouse testis (von Schonfeldt et al., 2004). In humans the protein is produced by the 
testis in both fetal and adult life (Davidoff et al., 2001). Isolation of Gfra1 cells from 
mouse testes has been achieved using magnetic beads and specific Gfra1 antibodies 
resulting in highly enriched As and Apr spermatogonial populations (Hofmann et al., 
2005). In addition, markers such as Oct4 and Plzf, a transcriptional repressor that 
regulates the epigenetic state of undifferentiated cells, are co-expressed in 
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undifferentiated spermatogonia (Buaas et al., 2004). These proteins are also co-
expressed with Gfra1 (He et al., 2007). Plzf is also involved in suppressing SSC 
differentiation and loss of Plzf results in the shift from SSC self renewal to 
differentiation that ultimately results in loss of germ cells (Hofmann, 2008);(Maki et 
al., 2009). Kit is expressed in the differentiating spermatogonia (A1 – B) (Filipponi et 
al., 2007), but not in As or Aal. In mice, proliferation of undifferentiated SSC is not 
affected by SCF, whilst differentiation of Kit expressing spermatogonia requires the 
stimulation of this ligand (Ohta et al., 2000). Plzf is not co-expressed with Kit and 
has been shown to repress Kit expression. Knockout of Plzf results in overexpression 
of Kit and this causes increased proliferation of undifferentiated spermatogonia and 
ultimately depletion of the SSC pool (Filipponi et al., 2007). Gfra1 positive cells 
isolated from mouse testes are enriched for Oct4+ cells, whilst the Kit+ population is 
reduced (Buageaw et al., 2005). The sorted cells demonstrated increased colony 
formation on transplantation into recipient testes, compared to the depleted Kit+ 
fraction (Buageaw et al., 2005). Overall, these results indicate that Oct4, Plzf and 
Gfra1 are all expressed in SSC in mice. Kit expression is confined to differentiating 
spermatogonia. Despite the fact that Kit positive spermatogonia are not considered 
stem cells, it has been shown that Kit positive germ cells can colonize, proliferate 
and differentiate in recipient testes in spermatogonial transplant studies (Barroca et 
al., 2009). However, the efficiency is not as high as in Kit negative cells. This is 
postulated to occur by de-differentiation of these progenitor cells into a population 
of cells that have lost their Kit expression (Barroca et al., 2009), although other 
studies have described Kit expression in a small fraction of SSC (Shinohara et al., 
2000). Of these markers for SSC, several are common to spermatogonia of rodent, 
non-human primate and human, such as GFR1 and PLZF (Dym et al., 
2009);(Hermann et al., 2009), whilst OCT4 is expressed in the SSC of the mouse, but 
not in primates (Dym et al., 2009). 
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1.18.3. Proliferation of spermatogonia in the immature testis 
The neonatal rise in gonadotrophins and testosterone in humans is accompanied by 
an increase in testis weight by two-fold (Sharpe et al., 2003b) and an increase in 
Sertoli cell (Cortes et al., 1987) and germ cell number (Sharpe et al., 2003b) during 
this period. Spermatogonial proliferation, based on Ki67 expression, is relatively 
high in humans in the first 3 months of life, with the highest rates in the first month 
(Berensztein et al., 2002). It has also been reported that gonocyte proliferation does 
not occur in this early postnatal period (Culty, 2009). Germ cell number increases 6-
fold between 0-10 years of age in humans (Muller and Skakkebaek, 1983). The Apale 
spermatogonia have a high mitotic activity producing Apale and Type B 
spermatogonia daughters (Ehmcke et al., 2006b). Type B spermatogonia are present 
from 4-5 years in the human (Culty, 2009). Spermatogonial proliferation can be 
increased in the immature rhesus monkey testis by treatment with testosterone or 
FSH (Arslan et al., 1993). There are differences between species in the theoretical 
numbers of germ cells that can result from each step of differentiation. More mitotic 
divisions of spermatogonia occur in the mouse compared to primates (Sharpe, 1994) 
and subsequently there is the potential for the production of many more 
differentiated spermatogonia (Fig. 1.9). In reality the theoretical numbers are not 
achieved because of apoptosis of a large proportion of the spermatogonial 
population (Sharpe, 1994). 
 
1.19. Spermatogenesis 
Spermatogenesis is the process by which spermatogonia proliferate and then 
differentiate into mature spermatozoa. This process is initiated by FSH during 
puberty and both FSH and testosterone appear to be required for quantitatively 
normal spermatogenesis (Sharpe, 1994);(Marshall et al., 2005);(Simorangkir et al., 
2009);(Abel et al., 2008). Testosterone acts via the androgen receptor on the Sertoli 
cells, thereby exerting indirect effects on the germ cells, as evidenced by a reduced 
germ cell number and failure to progress beyond meiosis in mice with knockout of 
the androgen receptor in Sertoli cells (Abel et al., 2008). There are three phases of 
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spermatogenesis that are common to all mammals. The first is a phase in which the 
spermatogonia are undergoing frequent cell divisions and differentiating into 
primary spermatocytes. The final mitotic division of B-spermatogonia gives rise to 
diploid preleptotene spermatocytes, which undergo meiotic division to produce 
haploid secondary spermatocytes. These cells are located in the adluminal 
compartment of the seminiferous tubule. The second meiotic division results in the 
formation of the spermatids, which will subsequently become mature spermatozoa 
following the process of spermiogenesis. The seminiferous tubule is organised with 
the spermatogonia adjacent to the basement membrane. As the germ cells 




Figure 1.10. Schematic representation of a transverse view of a human seminiferous 
tubule. Sc – spermatocyte, St – spermatid. Taken from (Mitchell et al., 2009). 
Supporting the germ cells are the Sertoli cells, which form the ‘blood testis barrier’ 
consisting of tight (occluding) junctions between adjacent Sertoli cells (Wong et al., 
2004). Each Sertoli cell provides support for numerous germ cells at different stages 
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of development and the function of the Sertoli cells at a given stage is determined by 
its germ cell complement (Sharpe, 1994). The patterns of germ cell association from 
basement membrane to the tubule lumen are classified into stages, which are based 
on the morphological development of the spermatids (Weinbauer et al., 2001). Six 
stages have been described in the human (Clermont, 1963). 
 
In human adults the proliferation rate of the spermatogonia has been calculated as 
26%, based on Ki67 staining. This is higher in type B spermatogonia (43%) 
compared to the type A spermatogonia (22%) (Steger et al., 1998). Each pachytene 
spermatocyte gives rise to four haploid spermatids and no further mitotic division 
occurs once the germ cells have reached this stage (Sharpe, 1994). 
 
Germ cell numbers can be increased by administration of FSH in adult rhesus 
monkeys (van Alphen et al., 1988) and this has been shown to be due to 
proliferation of type Apale spermatogonia (van Alphen et al., 1988), (Simorangkir 
2009). In these studies administration of hCG (van Alphen et al., 1988) or LH 
(Simorangkir et al., 2009) did not increase cell proliferation, suggesting that the 
threshold for a maximal impact of androgens has already been met, whilst FSH 
administration can augment cell function. However the importance of testosterone 
can be inferred from studies in the hpg mouse which lacks gonadotrophins and 
therefore has an immature testicular phenotype without full spermatogenesis, but in 
which replacement of testosterone induces complete spermatogenesis despite 
undetectable FSH levels (Singh et al., 1995). In men with low FSH levels, hCG can 
re-initiate spermatogenesis, although the sperm concentrations do not return to 
normal (Matsumoto and Bremner, 1985). This suggests that both FSH and LH are 
required for normal spermatogenesis although it would appear that FSH is not 
essential to the process as men with an inactivating mutation of the FSH receptor 
have varying degrees of spermatogenic impairment but are not infertile 
(Tapanainen et al., 1997).   
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1.20. Sertoli cells 
 
1.20.1. Sertoli cell differentiation 
Differentiation of Sertoli cells is associated with changes in both morphology and 
protein expression (Brehm et al., 2006). These changes result in fetal, pre-pubertal 
and adult Sertoli cell types (Fig. 1.11).  
 
Fetal Sertoli cells (SF) have an elliptical nucleus. The nuclear morphology changes 
during fetal and early postnatal life to become SA-type Sertoli cells (SA). These cells 
have a round nucleus and are the most common type of Sertoli cell during 
childhood. Also present during childhood are the SB-type cells (SB). These cells 
have an ovoid nucleus oriented perpendicular to the basement membrane. During 
fetal life the Sertoli cells express proteins such as cytokeratin 18, AMH and M2A but 
these are downregulated at different stages during subsequent development in 
parallel with Sertoli cell differentiation. Cytokeratin expression ceases by 20 weeks 
of gestation (Rogatsch et al., 1996);(Franke et al., 2004), whilst M2A persists until at 
least the 5th year of life, but is downregulated before the loss of AMH (Brehm et al., 
2006). AMH is first expressed at 8-9 weeks of gestation (Gaskell et al., 2004);(Franke 
et al., 2004) and is downregulated during puberty, reflecting terminal differentiation 
of Sertoli cells (Rajpert-De Meyts et al., 1998). 
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Figure 1.11. Temporal changes in Sertoli cell morphology and expression of 
proliferation and differentiation markers.  AMH – anti-Müllerian hormone, AR – androgen 
receptor, P – proliferation, SF – fetal Sertoli cells, SA – SA Sertoli cells, SB – SB Sertoli 
cells, SC – adult Sertoli cell. Taken from (Brehm et al., 2006). 
 
Vimentin, an intermediate filament protein, is present in Sertoli cells at all stages of 
development (Rogatsch et al., 1996) and as such is a stable and reliable marker of 
Sertoli cells throughout their differentiation (Brehm et al., 2006). 
 
Puberty signals a change in nuclear morphology to the tripartite form with 
prominent nucleolus, characteristic of the adult Sertoli cell (Sharpe et al., 2003b). 
Protein expression changes also occur during this differentiation process. The 
changes in morphology and protein expression reflect the changing role of the 
Sertoli cell (Sharpe et al., 2003b). During fetal life the Sertoli cell is involved in initial 
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testis cord formation and the regression of the Müllerian duct, hence expression of 
AMH, whilst in adult life the Sertoli cells support spermatogenesis, which is a 
process that requires androgens and expression of the androgen receptor. The 
androgen receptor is expressed before the final maturation of Sertoli cells. In 
human, non-human primates and rats AR is not expressed in fetal or early neonatal 
life (Sharpe et al., 2003b);(Williams et al., 2001);(McKinnell et al., 2001) (Murray et 
al., 2000). The protein is expressed at the end of the neonatal period in marmoset 
monkeys, but may not be expressed until close to the onset of puberty in the human 
(Sharpe et al., 2003b);(Brehm et al., 2006). Another protein that is not expressed until 
puberty is connexin 43. This gap junctional protein is described as being necessary 
for the regulation of terminal differentiation of Sertoli cells and may be involved in 
the Sertoli cell blood testis barrier (Pelletier, 1995). 
 
1.20.2. Sertoli cell proliferation 
Sertoli cells can support a finite number of germ cells during spermatogenesis (Orth 
et al., 1988). This means that proliferation of Sertoli cells is an important factor in 
determining sperm production in adult life. Sertoli cell proliferation occurs in two 
phases (Sharpe et al., 2003b);(Brehm et al., 2006). In humans, primates and rats there 
is a period of proliferation during the fetal and neonatal period (Sharpe et al., 
2003b);(Murray et al., 2000). Sertoli cell proliferation ceases during the childhood 
quiescent period in humans and non-human primates. Then, during pre-puberty 
there is a second period of proliferation. The marmoset does not exhibit a pre-
pubertal period of Sertoli cell proliferation, although this does occur in marmosets 
treated during the neonatal period with GnRHa, allowing recovery of Sertoli cell 
number to normal adult levels (Sharpe et al., 2000) Once the animal reaches 
adulthood Sertoli cells have ceased to proliferate (Bar-Shira Maymon et al., 2003). 
Rats do not have an equivalent childhood period to primates and Sertoli cell 
proliferation continues until shortly before puberty (Sharpe et al., 2003b). 
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1.21. Testicular germ cell tumours 
 
1.21.1. Germ cell tumour types 
There are several types of germ cell tumour and they can occur in gonadal or extra-
gonadal sites (Oosterhuis and Looijenga, 2005). Within the testis these tumours can 
be subdivided into three distinct groups. Each type is manifest at a different age and 
each has a different pathogenesis (Oosterhuis and Looijenga, 2005). Type I germ cell 
tumours occur in newborns and infants and are believed to originate from an early 
PGC/gonocyte. Type II testicular germ cell tumours (TGCT) are manifest in 
adolescents and young adults and arise from the pre-malignant precursor CIS cells; 
these tumours are divided into the seminomas and the non-seminomas. Finally 
there are the Type III spermatocytic seminomas that occur in elderly men (Rajpert-
De Meyts, 2006) and are believed to be derived from spermatogonia (Rajpert-De 
Meyts et al., 2003) or spermatocytes (Oosterhuis and Looijenga, 2005).  
 
1.21.2. Epidemiology of TGCT 
At least 90% of testicular tumours are TGCT and the incidence of these tumours has 
been increasing worldwide over the past 60 years (McGlynn et al., 2003);(Richiardi 
et al., 2004). These tumours account for 60% of all malignancies in men between the 
ages of 20-40 (Hersmus et al., 2008). The incidence of teratomas peaks between the 
ages of 20-29 years, whilst seminomas peak later, usually between 30-49. The five 
year survival is 95% and those surviving more than five years can be considered 
cured (Moller, 2005).  
 
Seminoma cells have the appearance of PGCs/gonocytes, whilst non-seminomas are 
capable of forming cells of all somatic, embryonic and extra-embryonic tissues 
(Hersmus et al., 2008), including germ cells (Honecker et al., 2006). Embryonal 
carcinoma is the pluripotent stem cell precursor of the non-seminomas. A summary 
of the development of TGCT can be seen in Fig. 1.12.   
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Figure 1.12. Current understanding of the pathogenesis of testicular carcinoma in situ 
(CIS). EC, embryonal carcinoma; TER, teratoma; YST, yolk sac tumour; CHC, 
choriocarcinoma. Taken from (Rajpert-De Meyts, 2006). 
 
Two models for the generation of TGCT have been proposed. CIS cells may 
transform directly into either a seminoma or a non seminoma, or alternatively these 
CIS cells may first develop into a seminoma that may subsequently become a non-
seminoma (Ulbright, 2005). Both patterns of development may also be possible 
(Oosterhuis and Looijenga, 2005). 
 
1.21.3. CIS as the precursor lesion to Type II TGCT 
The first description of CIS within the testis occurred in 1972 when it was noted that 
biopsies from the testes of two patients being investigated for infertility contained 
abnormal unidentified germ cells (Skakkebaek, 1972a). One of these patients 
subsequently developed a TGCT of the embryonal carcinoma type (Skakkebaek, 
1972b). These abnormal germ cells were described as being larger in diameter than 
spermatogonia and contained large clumps of chromatin within the nucleus. In 
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addition the DNA content was noted to be higher with frequent mitotic divisions 
(Skakkebaek, 1972b). It was hypothesised that these cells represented a precursor 
lesion for TGCT and was described as carcinoma in situ. This hypothesis is 
supported by examination of their ultrastructural, histological and protein 
expression profiles (Skakkebaek et al., 2007);(Almstrup et al., 2005). These CIS cells 
are also known by several other names, including intratubular germ cell neoplasia 
unclassified (ITGCNU), testicular intraepithelial neoplasia (TIN) or gonocytoma in 
situ (Rajpert-De Meyts, 2006). It has been reported that all patients with CIS will 
eventually develop a TGCT (Oosterhuis and Looijenga, 2005). Approximately 50% 
of patients will develop a tumour within 5 years of diagnosis of CIS and 70% will 
have developed one by 7 years of follow up (Oosterhuis and Looijenga, 2005). 
Further evidence for CIS as the precursor lesion for TGCT is indicated by 
similarities in expression of germ cell proteins and chromosomal content. All 
invasive TGCT and CIS are aneuploid (Looijenga et al., 2003b) and most of the 
chromosomal imbalances detected in the invasive tumour are also present in CIS 
lesions (Oosterhuis and Looijenga, 2005). Gain of chromosome 12p (which contains 
the NANOG gene) is a consistent feature of invasive TGCT and it is postulated that 
this chromosome abnormality is involved in malignant progression (Looijenga et al., 
2003b). 
 
1.21.4. CIS origin from fetal gonocytes 
The cell of origin for CIS has been reported to be the fetal gonocyte (Skakkebaek et 
al., 1987). These cells have phenotypic similarity to the gonocyte in terms of 
histological appearance (Skakkebaek et al., 1987) in addition to 
immunohistochemical expression of proteins common to both cell types such as 
placental alkaline phosphatase  (Jorgensen et al., 1995);(Hustin et al., 1987), OCT4 
(Jones et al., 2004);(Rajpert-De Meyts et al., 2004);(Looijenga et al., 2003a), NANOG 
(Hoei-Hansen et al., 2005), AP-2 (Hoei-Hansen et al., 2004) and KIT (Rajpert-De 
Meyts, 2006) (Table 1.3). CIS cells have a large nucleus with prominent nucleoli and 
large amounts of glycogen granules within the cytoplasm. Other hypotheses have 
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been suggested for the origin of CIS cells, including spermatogonial stem cells 
(Clark, 2007) and spermatocytes (Chaganti and Houldsworth, 2000), however the 
fact that CIS can arise in pre-pubertal gonads of patients with gonadal dysgenesis 
(i.e. prior to meiosis) makes a spermatocyte origin unlikely and the erased imprint 
status of the CIS cells suggests that a PGC/gonocyte is more likely than the SSC 
(Sonne et al., 2008);(Looijenga, 2009) 
 
1.21.5. Heterogeneity of CIS 
Although there are many proteins expressed by CIS cells, there is some variation 
between individual CIS cells in their expression pattern (Rajpert-De Meyts et al., 
1996) (Table 1.3). OCT4 has been reported to be present in all CIS cells (Oosterhuis 
and Looijenga, 2005), whilst not all CIS cells express MAGE-A4 (Aubry et al., 2001) 
(Rajpert-De Meyts et al., 2003). In addition, studies involving co-localisation of 
OCT4 and VASA have demonstrated that VASA tends to be expressed in germ cells 
that do not express OCT4 (i.e. normal germ cells), whilst most CIS cells express 
OCT4 alone. The remainder of the CIS cell population express OCT4 and VASA 
(Cools et al., 2005).  The cause of this heterogeneity is unclear but may represent CIS 
cells arising from different stages during development from gonocyte to 
spermatogonia, and this could predetermine which kind of tumour is subsequently 
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Table 1.3. Expression of germ cell proteins in normal germ cells, CIS cells and TGCT. 
Sg – spermatogonia, Sc – spermatocyte, St – spermatid, Sem – seminoma, EC – embryonal 
carcinoma, Ter – teratoma. Adapted from (Rajpert-De Meyts, 2006). 
 
1.21.6. Delay in germ cell maturation  
In patients with DSD that may be at risk of TGCT it must be noted that these 
patients often show signs of a delay in gonocyte maturation, such that the germ cells 
continue to express gonocyte markers such as OCT4 and PLAP beyond infancy 
(Cools et al., 2005). This can make diagnosis of CIS in these children difficult. 
However there are suggested criteria to differentiate between these conditions. 
These include the age of the patient, position of OCT4 cells within the tubule and 
their distribution throughout the gonad. Younger age, luminal position and 
widespread distribution indicates maturation delay, whilst older children with 
OCT4 cells on the basal lamina and located in a specific region of the testis is 
suggestive of CIS (Cools et al., 2006a). Recently it has been reported that the stem 
cell factor (SCF) is expressed in CIS cells, but is negative in fetal germ cells. This is 
the first description of a marker that can accurately distinguish between the two and 
may have a role in diagnosing CIS in pre-pubertal patients with DSD and 
distinguishing these cells from germ cells with delayed maturation (Stoop et al., 
2008).  
 
Protein PGC Gonocyte Sg Sc St CIS Sem EC Ter 
NANOG + + - - - + + + - 
OCT4 + + - - - + + + - 
AP-2 + + - - - + + + +/- 
PLAP + + - - - + + +/- - 
KIT + +/- +/- - - + + - - 
VASA +/- +/- + + + +/- +/- - - 
MAGE-A4 - +/- + +/- - +/- +/- - - 
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1.21.7. Proliferation of CIS cells 
During childhood, CIS cells divide at a slow rate. Around puberty these cells begin 
to replicate more rapidly (Brehm and Steger, 2005). The persistent expression of 
genes such as OCT4, are believed to be involved in the expansive proliferation of 
CIS cells (Cools et al., 2006b);(Rajpert-De Meyts, 2006). Proliferation of CIS cells 
results in an increase in diameter of the tubule, which is followed by invasion of the 
surrounding tissue (Donner et al., 2004). Mitotic frequency has been quantified to be 
0.65% in CIS, compared to 3.59% in seminoma (Hofken and Lauke, 1996). Once the 
CIS cells have developed into an invasive tumour they are highly proliferative. 
Studies of seminoma and embryonal carcinoma describe Ki67 staining in 70% and 
86% of cells respectively (Datta et al., 2000). The tumour suppressor gene PTEN is 
expressed in normal germ cells and Sertoli cells. It acts as an antiproliferative and 
pro-apoptotic factor through p27Kip (Di Vizio et al., 2005). PTEN is also expressed in 
CIS but is lost on transformation to invasive tumour, which may reflect increased 
proliferation in these cells on progression. Another factor that has been associated 
with differentiation and proliferation of CIS cells is Kruppel-like factor 4 (KLF4). 
This transcription factor is expressed at very low levels in human fetal gonocytes, 
but is expressed at high levels in CIS, intratubular seminoma and early seminoma. 
This suggests that it may also be involved in promotion of proliferation and 
pluripotency (Godmann et al., 2008). TSPY is also expressed in CIS cells and 
functions in mitosis. It has been hypothesised to abolish checkpoints in the cell cycle 
and result in increased growth and proliferation (Lau et al., 2009).  Cx43, expressed 
by the Sertoli cells, has also been implicated in the control of proliferation of CIS 
cells. Cx43 expressed by the Sertoli cells induces p21 (Brehm and Steger, 2005), 
which is a cyclin-dependent kinase implicated in the control of the Gl to S phase 
transition in mammals (Harper et al., 1993). This induction of p21 reduces germ cell 
proliferation and may help to maintain the long latency period of CIS during 
childhood (Brehm and Steger, 2005). As the intercellular communication between 
Sertoli cell and CIS cell breaks down the CIS cells may begin uninhibited 
proliferation (Brehm and Steger, 2005).  
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1.21.8. The relationship between Sertoli cell differentiation and testis 
pathology including CIS 
A close relationship exists between the Sertoli cell and the germ cells within the 
testis. Therefore there has been interest in the relationship between the Sertoli cells 
and the associated CIS cells in the testes of patients with TGCT. Cytokeratin 18 
(Ck18) is expressed by the Sertoli cells of the human fetal testis and downregulated 
postnatally and is not expressed in the normal adult testis (Brehm et al., 2006) 
(Stosiek et al., 1990). Expression of Ck18 has been described in adult patients with 
CIS (Stosiek et al., 1990);(Brehm and Steger, 2005), in addition to other testicular 
disorders such as SCO syndrome and spermatogenic arrest at the level of 
spermatogonia (Steger et al., 1996);(Maymon et al., 2002). It is reported that tubules 
with CIS as the only germ cell type express CK18, whilst tubules containing CIS and 
normal germ cells (including spermatocytes) may be either positive or negative. 
Tubules that contain CIS along with round or elongate spermatids are negative for 
Ck18 (Kliesch et al., 1998). This could reflect de-differentiation of Sertoli cells in 
some of the tubules resulting in the re-emergence of an immature phenotype in 
these tubules (Brehm and Steger, 2005). Alternatively this may reflect a primary 
failure of maturation. Tubules containing Ck18 in patients with various 
abnormalities of spermatogenesis also express M2A and the loss of M2A has been 
described as an irreversible marker of transition of prepubertal Sertoli cells (Steger 
et al., 1999). M2A is not found in the adult testis in either normal situations or 
spermatogenic arrest (Steger et al., 1999). AMH is expressed in Sertoli cells from 7-9 
weeks of gestation until puberty (Brehm et al., 2006);(Ostrer et al., 2007). The 
downregulation in expression of AMH coincides with the onset of androgen 
receptor expression, which can be detected in Sertoli cells from around the time of 
puberty (Brehm and Steger, 2005). In patients with AIS there is prolonged 
expression of AMH, which suggests that there is a link between AR dependent 
changes in Sertoli function and reduced expression of AMH (Rajpert-De Meyts, 
1999). This is not the case in rodents. In Tfm mice that lack the androgen receptor, 
AMH is still downregulated, albeit later than in normal mice (Al-Attar et al., 1997). 
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In addition AMH is downregulated normally in rats with knockout of the AR (Tan 
et al., 2005). In adult patients with spermatogenic arrest there is variable expression 
of AMH (Steger et al., 1999), whilst in those with Sertoli cell nodules and SCO 
tubules AMH is often present (Brehm et al., 2006). In patients with CIS there is no 
expression of AMH in either normal tubules or CIS containing tubules. Androgen 
receptor expression is present in the Sertoli cells of normal adult testes (Brehm et al., 
2006) and in CIS containing tubules (Rajpert-De Meyts and Skakkebaek, 1992). 
 
1.22. The testicular dysgenesis syndrome 
The testicular dysgenesis syndrome (TDS) is a collection of disorders that include 
testicular cancer, undescended testis, hypospadias/intersex (DSD) and male fertility 
problems with varying penetration (Skakkebaek et al., 2007). All these conditions 
are thought to be related to suboptimal testicular development during fetal life, 
which is consistent with the finding of increased rates of TGCT in patients with 
some forms of DSD (Looijenga et al., 2007b). The hypothesis proposes that abnormal 
testis development (dysgenesis), which could have numerous primary causes, leads 
secondarily to hormonal or other malfunctions of the Leydig and/or Sertoli cells 
during male sexual differentiation, leading in turn to increased risk of germ cell 
effects and reproductive disorders (Sharpe and Skakkebaek, 2008). Figure 1.13 
summarizes the relationship between the various factors that could contribute to 
development of this syndrome. 
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Figure 1.13. Schematic representation of the possible aetiology, pathogenesis and 
clinical manifestations of testicular dysgenesis syndrome. Emphasis on the key role of 
disturbed germ cell differentiation in the pathogenesis of testicular carcinoma in situ (CIS). 
Taken from (Rajpert-De Meyts, 2006). 
 
Epidemiological evidence supports the existence of a TDS. Countries with the 
highest incidence of testicular tumours also have the highest frequencies of other 
male reproductive problems and this has been demonstrated clearly in the 
Scandinavian countries (Skakkebaek et al., 2007). In addition, investigation of 
patients with one of the features of TDS, revealed the presence of dysgenetic areas 
in their testicular biopsies (Skakkebaek et al., 2003). In patients with a TGCT, 8.7% 
will have CIS and 25% of patients will have other evidence of dysgenesis in the 
contralateral testis (Hoei-Hansen et al., 2003). Patients with TGCT have poor 
spermatogenesis in their contralateral testis independent of the direct tumour effects 
and this may be due to pre-existing dysgenesis in the contralateral testis 
(Dieckmann et al., 2007). Also, men with infertility are 2.8 times more likely to 
develop TGCT (Walsh et al., 2009) and patients with TGCT have fathered 
significantly less children prior to diagnosis than men without TGCT (Norgil 
Damgaard et al., 2002). 
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The rapidity of the increase in TGCT over time suggests that TDS has an 
environmental component (Skakkebaek et al., 2001) and this has been supported by 
Scandinavian migration studies, which show that TGCT risk in the second 
generation of migrants becomes equivalent to the local population (Skakkebaek et 
al., 2007). Oestrogens, anti-androgens and other endocrine disruptors such as 
phthalates have all been suggested as potentially involved in the development of 
these disorders (Skakkebaek et al., 2001).   
 
1.22.1. Animal models of TDS  
An animal model of TDS has been described in rats treated with phthalates in utero. 
Phthalates (phthalic acid esters) are plasticizers found in most plastics and in many 
types of packaging and common household items such as soap, shampoo, cosmetics 
and hairspray (Rajpert-De Meyts et al., 1996). They form part of the polymer 
network but are not chemically coupled to it and therefore they are able to leach out 
of these products (Lucas et al., 2009). They are one of a heterogeneous group of 
chemicals known as endocrine disruptors. Treatment of rats during pregnancy with 
Di(n-butyl) phthalate (DBP) results in offspring with high rates of hypospadias, 
cryptorchidism and testicular atrophy in a dose dependent manner (Mylchreest et 
al., 1998). These effects can be achieved by treating between gestation day 12-21 
(Mylchreest et al., 2000). It was noted that these were similar effects that were seen 
with anti-androgens (Mylchreest et al., 1998). Whilst these studies demonstrated 
gross pathology of the reproductive tract, further studies identified histological and 
histochemical features that were in keeping with other features of the proposed 
human TDS, including dysgenetic seminiferous cords, SCO tubules, tubules with 
incomplete spermatogenesis, Sertoli cell immaturity, intratubular Leydig cells 
(Fisher et al., 2003) and Leydig cell aggregation (Mahood et al., 2005). These features 
were noted in addition to those described previously such as hypospadias, 
cryptorchidism and infertility. In addition, immaturity of Sertoli cells as described 
in the DBP study is also seen in patients with CIS, SCO and infertility (Stosiek et al., 
1990);(Brehm and Steger, 2005);(Steger et al., 1996);(Maymon et al., 2002). These are 
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also part of TDS in humans. The discovery of intratubular Leydig cells has also been 
described in patients with infertility and cryptorchidism (Mori et al., 1987), further 
supporting the validity of the DBP treated rat as a model of TDS. The areas of 
dysgenesis in these studies were described as being similar to areas of testicular 
dysgenesis found in the testes of patients with TGCT (Hoei-Hansen et al., 2003). 
However, although Oct4 expression persisted at e17.5 in a higher proportion of 
gonocytes in DBP treated animals compared to controls, it was no longer expressed 
in any of the germ cells at e19.5 and importantly there was no evidence of CIS or 
TGCT in the treated animals (Ferrara et al., 2006).  
 
Some of the effects of DBP in fetal rats can be explained by androgen suppression. 
There was a 90% decrease in intratesticular testosterone in DBP treated animals at 
gestational day 19, compared to controls and this could explain the hypospadias as 
inhibition of normal male external genitalia development can be induced by 
treatment with the anti-androgen flutamide (Imperato-McGinley et al., 1985). 
However the abdominal position of the cryptorchid testis is less likely to be 
explained by impaired androgen action. Although androgens are responsible for the 
latter stages of testis descent, abdominal descent of the testis is mediated by Insl3 in 
mice, as evidenced by the bilateral cryptorchidism that results from targeted 
deletion of the INSL3 gene (Zimmermann et al., 1999). Mice double mutant for AR 
and Insl3 have testes positioned adjacent to the kidneys, steadied by the cranial 
suspensory ligament, rather than free moving within the abdomen as seen in the 
INSL3 mutant (Zimmermann et al., 1999). This demonstrates that androgens play a 
role in release of the testis for descent, however in conditions with impaired 
androgen signalling in the human, such as CAIS, abdominal testis descent still 
occurs (Hughes and Acerini, 2008). Even if androgen suppression did play a role in 
the cryptorchidism, it does not play a role in the development of multinucleated 
gonocytes and Leydig cell aggregates. (Scott et al., 2008). Immaturity of Sertoli cell 
maturation in DBP treated rats was also described as being independent of 
androgen suppression, as fetal Sertoli cells of treated rats do not express the AR 
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(Sharpe et al., 2003b). However a more recent study has reported that the effects on 
Sertoli cell maturation occur in adulthood as a result of dedifferentiation of Sertoli 
cells in the absence of germ cells (Hutchison et al., 2008). 
 
1.22.2. Effects of phthalates in other species 
Although phthalates have been shown to cause a TDS-like syndrome in rats the 
effects of these chemicals in other species is variable. In particular the effect on 
androgen production that occurs in rats does not occur in mice (Gaido et al., 2007), 
although effects of phthalates are still seen in mice treated with DBP. These mice 
exhibit an increased number of multinucleated gonocytes per cord compared with 
controls, without a measurable decrease in testicular testosterone (Gaido et al., 
2007). In vitro culture of human fetal testis with MEHP (a metabolite of DEHP) 
resulted in a decrease in germ cell number despite having no effect on testosterone 
production (Lambrot et al., 2009). A lack of effect on testosterone production has 
also been shown with in vitro cultures of human fetal testes cultured with MBP 
(Hallmark et al., 2007). Despite these results there is epidemiological data to suggest 
that male reproductive disorders are correlated with levels of exposure to 
phthalates. This includes a study of phthalates in breast milk and the levels of 
reproductive hormones in the infant. Levels of MBP were inversely correlated with 
serum testosterone at 3 months of age, and positively correlated with 
LH:Testosterone and sex hormone binding globulin (SHBG) (Main et al., 2006). 
Anogenital index (AGI) in offspring has also been shown to be inversely correlated 
with the prenatal maternal urinary MBP level (Swan et al., 2005). 
 
1.22.3. Animal models of CIS and TGCT 
Despite the presence of animal models that reflect various aspects of TDS, to date 
there has been no convincing animal model of TGCT. Although many types of 
testicular tumour are described in animal models, there are fundamental differences 
between them and the human TGCTs. Testicular tumours can be induced in a 
mouse model by over-expressing Gdnf (Meng et al., 2000) and these tumours 
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demonstrate some of the features of classical seminoma (such as expression of 
alkaline phosphatase), however there remain significant differences to human 
seminoma (Sariola and Meng, 2003). The histological appearance differs between 
the two and areas of normal spermatogenesis and lymphocytic infiltration are seen 
in the testes of humans with TGCT but not in this mouse model.  Most importantly 
the precursor lesion is different between the two species. Human CIS cells and the 
mouse cluster cells have different morphology and distribution within a tubule. 
Similar clusters of cells have been described in mice expressing the HERV-K rec 
retroviral gene. These are arranged in layers and do not occur until 19 months of age 
(Galli et al., 2005), in contrast to CIS in humans, which develops in fetal life and 
consists of a ring of cells along the basement membrane. Spontaneous testicular 
tumours are also known to arise in the 129 strain of mice but once again these 
tumours are more representative of the Type 1 TGCT and do not have a pre-
invasive CIS equivalent (Anderson et al., 2009);(Walt et al., 1993). Mice have also 
been shown to develop testis tumours after diethylstilboestrol treatment, however 
these are not germ cell tumours (Newbold et al., 1987). 
 
‘CIS-like’ cells have been reported in rabbits (Veeramachaneni, 2008);(Higuchi et al., 
2003) and canines (Grieco et al., 2008). A rabbit has been described with a small 
testis and a low sperm count. Histologically this animal had tubules containing 
normal differentiating germ cells in addition to cells with the appearance of CIS 
(Veeramachaneni and Vandewoude, 1999). Cells with the appearance of CIS have 
also been described in the testes of animals treated with the anti-androgenic 
pesticide DDT during fetal and neonatal life (Veeramachaneni, 2008). ‘CIS-like’ cells 
have also been described in two rabbits after treatment with DBP (Higuchi et al., 
2003), however whilst one of the rabbits was treated in utero, the other rabbit was 
treated in adolescence. This does not fit with the concept that CIS cells have a fetal 
origin and casts doubt on whether these are truly ‘CIS’ cells. In addition, none of 
these animals develop tumours and as a result these animals cannot be considered a 
model of CIS or TGCT (Veeramachaneni, 2008).  
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It has been reported that 5-15% of all tumours in dogs are testicular (Ruttinger et al., 
2008). ‘CIS-like’ cells in association with other TDS lesions have also been described 
in 8/32 dogs receiving orchiectomy for a variety of indications (Grieco et al., 2008), 
This included impaired spermatogenesis, SCO, tubular atrophy and Leydig cell 
hyperplasia (Grieco et al., 2008). However the CIS lesions and testicular tumours 
were found in aged dogs and it has been suggested that these canine seminomas 
more likely represent the spermatocytic seminomas and that in fact they also lack 
true CIS (Oosterhuis and Looijenga, 2005).  
 
Attempts to produce an in vivo model of TGCT has also been attempted using 
intratubular transplantation of tumour cells into nude mice. The JKT seminoma cells 
are a cell line that are thought to be representative of seminoma cells. Following 
transplantation these cells demonstrated growth and proliferation and expressed 
PLAP but they did not express OCT4/TSPY or KIT (Li et al., 2008).  However there is 
some doubt as to whether the JKT cells actually represent seminoma cells (Eckert et 
al., 2008). The other problem with this approach is that it will not replicate the 
development of CIS as these cells are already transformed. 
 
1.23. The Common Marmoset monkey 
The Common Marmoset (Callithrix jacchus) is a New World primate (Fig. 1.14), 
commonly used in scientific research. It’s value as a laboratory animal is enhanced 
by its small body size, early age of sexual maturity and relatively high reproductive 
rate (Holt and Moore, 1984). They are one of the least expensive primates to 
maintain and do not harbor pathogens of concern to human health (Abbott et al., 
2003). In particular there are a number of features about the marmoset that make 















Figure 1.14. The Common Marmoset monkey. 
 
1.23.1. Reproduction in the common marmoset 
The species exhibits high reproductive efficiency with an average litter size of 2.64 
(Nubbemeyer et al., 1997). The average gestation is 144 days and adult females have 
a median interbirth interval of 154 days (Windle et al., 1999) and can therefore 
produce two sets of offspring per year. This allows for an efficient production of 
numerous offspring over a relatively short period. Multiple births are common in 
the marmoset and it is thought that they most commonly produce twins in the wild, 
although triplet births may occur at higher frequency in captive bred animals 
(Windle et al., 1999). Twins produced are dizygotic but share a chorionic cavity and 
placental circulation which makes co-twins chimeras, including germ-line 
chimerism (Ross et al., 2007). The frequent occurrence of co-twins is ideal for studies 
that investigate a treatment effect where one co-twin is treated and the other acts as 
a control. Co-twins are highly comparable and should therefore minimise the 
number of animals required for scientific studies (Sharpe et al., 2003a). 
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1.23.2. Marmoset embryology and fetal gonad development 
Relatively little is known about the development of the fetal testis in the marmoset. 
The fetal phase of gestation is relatively late in comparison with other primates and 
humans (Phillips, 1976). The embryonic phase lasts for 12/20 weeks in the 
marmoset, compared with 7-8/40 weeks in the human (Phillips, 1976). Gestation can 
be estimated from crown-rump length (CRL) (Table 1.4). Fetal sex can be 
determined histologically from a CRL of 17mm with the appearance of testicular 
cords (Hampton, 1971).  
 
CRL (cm) 0.22 0.60 1.05 2.16 3.43 4.57 5.85 6.42 7.25 7.70 
Gestation (days) 50 60 70 80 90 100 110 120 130 140 
 
Table 1.4. Comparison of crown rump length with gestational age in fetal marmosets. 
Adapted from (Chambers and Hearn, 1985);(Hampton, 1971).  
 
Gonadal formation and testicular development in the marmoset is postulated to 
take place during gestational weeks six to twelve (Li et al., 2005);(Hampton, 1971) 
(Table 1.5). During fetal gonad development the predominant cell type within the 
seminiferous tubule is reported to be the Sertoli cell with occasional germ cells 
(Hampton, 1971), as described in the human. At birth the testis has descended into 
an inguinal position (Dixson, 1993).  
 
CRL (cm) GA Testis Shape Cords/Tubules Germ Cells 
1.00 70 Oval <20m No 
2.00 80 Rounded 20-25m Rarely 
3.50 90 Round 60-70m Few 
 
Table 1.5 Features of gonadal development in the fetal marmoset. Adapted from 
(Hampton, 1971). GA – gestational age (approx.), CRL – crown rump length. 
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1.23.3. HPG axis in the marmoset 
After birth the overall pattern of circulating gonadotrophins and testosterone is the 
same in the marmoset as in the human (Fig. 1.6), with an increase in levels of 
gonadotrophins and testosterone in the marmoset during the first 15 weeks of 
postnatal life (Dixson, 1986);(Mann and Fraser, 1996). This is followed by the 
childhood period which lasts from 15-45 weeks (Kelnar et al., 2002), during which 
levels of these hormones are low. The pubertal period between 45 and 75 weeks is 
associated with an increase in the levels of these hormones, which remain high in 
adulthood (Kelnar et al., 2002);(Chandolia et al., 2006);(Wistuba et al., 2006). 
Variability in the onset of puberty has been described between different colonies 
(Kelnar et al., 2002);(Chandolia et al., 2006). 
 
A fundamental difference between the marmoset and the human surrounds the 
production of gonadotrophins. In the human, FSH and LH are produced from the 
pituitary gland. The marmoset produces FSH as in the human, but instead of LH the 
marmoset produces a chorionic gonadotrophin (CG) molecule. The marmoset does 
not possess the same LH receptor as the human due to its lack of an exon 10 (Zhang 
et al., 1997). This means that the receptor is unable to bind LH but instead will bind 
CG and cause an equivalent signal transduction to the human wild type LH 
receptor (Gromoll et al., 2000).   
 
1.23.4. Germ cell development 
In the marmoset, germ cell number varies with age. The neonatal period is 
associated with a 10-fold increase in germ cell number and a 5-fold increase in testis 
weight (Sharpe et al., 2003a). This study also described the predominant germ cell in 
the fetal testis as the gonocyte, based mainly on position in the cords and suggested 
that they undergo further differentiation and become prespermatogonia as in the 
human, based on the observation of a gradual shift from a central location within 
the seminiferous tubule to a position close to the basement membrane (Sharpe et al., 
2003a). Once a point of contact is made with the basal lamina then the cells were 
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classified as prespermatogonia. In the neonatal marmoset at birth the majority (69%) 
of cells are gonocytes with the remainder being prespermatogonia. By 18-24 weeks 
the numbers of germ cells has risen dramatically but interestingly this was reported 
to include a gonocyte population (Sharpe et al., 2003a);(Chandolia et al., 2006). 
Another study had also described gonocytes within the seminiferous tubules of the 
marmoset at 3 months of age and reported this to be the predominant germ cell type 
at this age (reviewed in (Li et al., 2005)). The presence of gonocytes within the testis 
during the childhood period would not be expected in the human, however these 
marmoset studies were based on germ cell position and morphology described for 
human germ cells (Gondos, 1993), and did not include investigation of expression of 
proteins associated with germ cell differentiation that have already been described 
(section 1.14) and which can be used to characterize differentiation from gonocyte to 
spermatogonium in the human (Gaskell et al., 2004).  
 
Based on morphological appearances spermatocytes are first observed between 21-
43 weeks, coinciding with the hormonal rise at the onset of puberty (Chandolia et 
al., 2006);(Kelnar et al., 2002);(Wistuba et al., 2006). Studies in 35 week old 
marmsosets show that tubule lumens are beginning to form (McKinnell et al., 
2001);(Kelnar et al., 2002) and occasional early spermatocytes are seen (Kelnar et al., 
2002). 
 
1.23.5. Postnatal Leydig cell development 
Three types of Leydig cell have been described in the postnatal marmoset, which 
appear at different stages in life (Li et al., 2005). 3-HSD is expressed at birth (Li et 
al., 2005), but increases during the neonatal period, with intense expression at 4 
weeks of age (Kelnar et al., 2002). Expression of this steroidogenic enzyme is weak 
during the ‘childhood’ period (22 and 35 weeks), before increasing again in puberty 
and adulthood (Kelnar et al., 2002). This pattern of 3-HSD expression mirrors the 
levels of testosterone during the neonatal, childhood, pubertal and adult periods as 
has been described (section 1.19.3). 
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1.23.6. Sertoli cell development 
Sertoli cell numbers increase from the neonatal period to 18-22 weeks (Sharpe et al., 
2003b). The timing of Sertoli cell proliferation in the neonatal period is similar to 
that seen in the human, whilst the predominant period of Sertoli cell proliferation in 
the rhesus monkey is peri-pubertal (Sharpe et al., 2003b). Androgen receptors can be  
detected by immunohistochemistry from 20 weeks onwards, and their detection 
coincides with the reduction in the intensity of AMH staining (Sharpe et al., 2003b).  
 
1.23.7. Spermatogenesis in the marmoset 
An adult pattern of spermatogenesis, with a full complement of germ cells from 
spermatogonia to fully formed elongate spermatids has been detected from 52 
weeks of age in the marmoset (Chandolia et al., 2006). There are similarities in the 
structure and organisation of the seminiferous tubules exhibiting full 
spermatogenesis in the marmoset and human (Millar et al., 2000). Nine stages of 
spermatogenesis have been described in the marmoset (Holt and Moore, 1984). It 
has also been shown that the six stages of spermatogenesis in the human can also 
easily be applied to the marmoset (Weinbauer et al., 2001). Within each tubule cross-
section in the marmoset, as in the human, there are between one and five stages 
observed (Fig. 1.15), whereas in rats and most other primates used for research, only 
a single stage of spermatogenesis will be seen in each cross section (Millar et al., 
2000);(Weinbauer et al., 2001). 
 
The spermatogonial sub-types are similar to the human with the presence of a single 
Type B spermatogonium compared to several types of spermatogonia in the rhesus 
monkey and rodent (Fig. 1.9). The efficiency of spermatogenesis can be estimated by 
the number of germ cells supported by a Sertoli cell and may also be influenced by 
the organisation of the seminiferous epithelium (Sharpe, 2003a). The germ cell to 
Sertoli cell ratio in the adult marmoset is 16:1 (Weinbauer et al., 2001) and the 
volume of germ cells supported per Sertoli cell in the marmoset is only 20% of 
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values found in the rat. This efficiency is similar to that described in the human 




Figure 1.15. Cross section of a seminiferous tubule from an adult marmoset monkey. 
Several stages of spermatogenesis (indicated by numerals, corresponding to stage number) 
can be seen within the section. 5-bromo-2-deoxyuridine (BrdU; brown) staining also 
highlights variation in germ cell proliferation between the stages. Taken from (Millar et al., 
2000). 
1.23.8. Effects of GnRH suppression on testis development in the 
immature marmoset 
 
1.23.8.1. GnRH antagonist treatment in the neonatal marmoset 
GnRH antagonists (GnRHa) are peptides that bind with high affinity to the GnRH 
receptor in the anterior pituitary. They are non-functional and compete with the 
endogenous GnRH for the binding site and provide rapid sex steroid suppression 
(Griesinger et al., 2005). The neonatal testosterone rise can be abolished in 
marmosets by the administration of a GnRH antagonist for the first 14 weeks of 
postnatal life (Lunn et al., 1994). Treatment of neonatal marmosets with GnRHa 
results in a significant reduction in testis weight and a decrease in Sertoli cell 
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number at 18-22 weeks, which recovers by adulthood (Sharpe et al., 2000). This 
observation suggests that Sertoli cell proliferation can also occur in this species 
during the peri-pubertal period, which may also be the case for the human (Cortes 
et al., 1987);(Sharpe et al., 2003b). Germ cell numbers in neonatally treated 
marmosets are also reduced at 18-24 weeks, compared with controls, although this 
was variable and not statistically significant (Sharpe et al., 2003b). In adulthood 
there was no difference between germ cell volume per Sertoli cell in neonatally 
GnRHa treated animals compared to controls (Sharpe et al., 2003a). In addition to 
effects on germ cells and Sertoli cells, there is also a regression/suppression of 
maturation of the Leydig cells with GnRHa treatment, based on the ultrastructural 
appearance of the cells (Prince et al., 1998). 
 
1.23.8.2. GnRH antagonist treatment in the juvenile marmoset 
GnRH antagonists have also been used to study the role of the HPG axis in the 
juvenile marmoset testis (Kelnar et al., 2002). Both GnRHa treated and control 
animals had low or undetectable levels of serum testosterone between 25-35 weeks 
of postnatal age. GnRH antagonists resulted in a 34% decrease in testis weight, 
compared to controls. There was also delayed Sertoli cell function in terms of lumen 
formation and reduced Leydig cell volume, however the germ cell proliferation 
index, measured by PCNA expression in spermatogonia was not affected by GnRHa 
treatment (Kelnar et al., 2002). These results suggest that germ cell proliferation in 
the juvenile marmoset is independent of gonadotrophins and testosterone, although 
it must be remembered that this is the period when levels of gonadotrophins and 
testosterone are naturally low. 
 
1.24. Testis xenografting 
Removal of testis material and xenografting into a host animal provides an in vivo 
system to study the development of germ cells and/or intact testicular tissue. The 
technique has a number of potential applications in germ/stem cell biology, fertility 
preservation and the production of transgenic sperm (Dobrinski, 2008);(Wistuba 
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and Schlatt, 2002). Material for grafting may include cell suspensions or intact testis 
tissue and these may be grafted into a number of sites within the host animal 
including the testes themselves.  
 
1.24.1. Spermatogonial transplantation 
The use of spermatogonia for intratesticular transplantation was first reported by 
Brinster and colleagues in 1994. In the original study, predominantly 
spermatogonial germ cells were isolated from immature (4-12 dpc) donor mice and 
the cell suspension was then introduced into the seminiferous tubules of recipient 
mice depleted of endogenous germ cells using a micro-injection technique (Brinster 
and Zimmermann, 1994). Full spermatogenesis was restored in the transplanted 
testes (Brinster and Zimmermann, 1994). In addition the use of this technique 
produced spermatozoa that were capable of fertilisation and production of progeny 
(Brinster and Avarbock, 1994). Despite the success of spermatogonial stem cell 
transplantation between mice, there has been less success with xenografting of 
spermatogonia between other species. Full spermatogenesis has been achieved with 
transplants of spermatogonial stem cells from rats, hamsters and goats 
(Honaramooz et al., 2003);(Clouthier et al., 1996);(Ogawa et al., 1999) into a mouse 
host and the length of the cell cycle in these transplanted cells reflects the normal 
cell cycle of the donor species (Franca et al., 1998). However attempts to graft cells 
from more distant species, including primates often results in colonisation, but 
transplanted cells fail to develop beyond the stage of spermatogonia (Dobrinski et 
al., 1999) (Dobrinski et al., 2000) (Nagano et al., 2001). Transplantation of human 
spermatogonia into mice resulted in colonisation and proliferation in the first 
month, with no differentiation (Nagano et al., 2002), however longer term grafting 
resulted in no donor germ cells surviving (Reis et al., 2000). In addition the use of a 
GnRH agonist did not enhance spermatogenic recovery in these mice (Reis et al., 
2000). It has been suggested that these spermatogonial stem cells fail to develop 
because murine Sertoli cells of the host are unable to provide appropriate factors 
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and a suitable niche to support development of the primate germ cells 
(Honaramooz et al., 2004). 
There are limitations to this technique for use as an ‘in vivo’ model of germ cell and 
testis development (Griswold et al., 2001). Firstly the system requires ablation of 
most of the endogenous germ cells in the testis of the host animal in order for the 
transplanted cells to colonise and develop. Mutant mouse strains such as the as 
W/Wv mutant that lacks Kit and hence does not have endogenous germ cells have 
been successfully tested as recipients and full restoration of spermatogenesis 
demonstrated (Lue et al., 2007). Alternatively endogenous germ cells can be 
removed from normal mice by treatment with the cytotoxic agent busulphan 
(Brinster et al., 2003) or radiotherapy (Honaramooz et al., 2005). However both these 
methods may result in alterations in the somatic compartment in the recipient 
(Zhang et al., 2007) reducing the success of the transplantation procedure since a 
compatible somatic compartment and the establishment of normal interactions 
between the spermatogonia and basement membrane appears to be necessary for 
germ cells to proliferate and differentiate (Rodriguez Sosa and Dobrinski, 
2009);(Wistuba and Schlatt, 2002). Success of this technique also relies on the 
presence of spermatogonial stem cells in the germ cell suspension that is injected, 
however SSCs account for only one in every 3-4000 cells in the testis of an adult 
mouse (Tegelenbosch and de Rooij, 1993). The spermatogonial stem cell population 
can be enriched by using immature donors or by selection with fluorescent or 
magnetic cell sorting, based on the expression profiles characteristic of 
spermatogonial stem cells (Shinohara et al., 2000);(Hofmann, 2008);(Buageaw et al., 
2005);(von Schonfeldt et al., 1999);(Hermann et al., 2009). 
 
1.24.2. Grafting of testicular cell suspensions 
In order to preserve compatability between the germ and somatic cells of the testis, 
cell suspensions can be grafted into the host animal (Arregui et al., 2008a). Cell 
suspensions containing mixed testicular cells from neonatal porcine and sheep testis 
have been used for subcutaneous xenografting and can result in the reformation of 
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cords and full differentiation of germ cells (Arregui et al., 2008a);(Honaramooz et 
al., 2007). The cell suspensions tend to develop more slowly than intact tissue grafts 
and this may be related to a reduced ability to synthesise testosterone (Arregui et 
al., 2008a). Dissociated neonatal rat testicular cells have also been used as single cell 
suspensions and cultured in 2D and 3D systems (Gassei et al., 2006). The 3D cultures 
in extracellular matrix formed regular spheres containing mixed cell types and a 
lumen. These structures contained putative germ cells and became more stable over 
time in culture. Subsequent xenografting into a nude mouse host resulted in further 
development of the tissue (Gassei et al., 2008). To date, the transplantation of 
isolated cell populations into nude mice has resulted in establishment of structures 
containing germ cells representative of full spermatogenesis in pigs, rodents and 
sheep. In rats, offspring have been produced from sperm taken from the 
transplanted material (Kita et al., 2007). 
 
1.24.3. Testis tissue xenografting 
The local environment and cell-cell relationships of the donor testis can be 
maintained by grafting whole tissue. This preserves the unique microenvironment 
for the cells within the tissue and in many species the tissue is responsive to host 
gonadotrophins and development of grafts was reported to be similar to that in 
normal testicular tissues (Rodriguez Sosa and Dobrinski, 2009). The importance of 
the niche is highlighted by the fact that transplantation of isolated germ cells from 
12.5-dpc mice into host testes resulted in no differentiation, whilst grafting of whole 
testis tissue from the same age of fetus resulted in normal spermatogenesis (Ohta et 
al., 2004). Tissue can be grafted into various sites but is most frequently grafted 
subcutaneously under the dorsal skin of the host animal (Rodriguez Sosa and 
Dobrinski, 2009).  
 
1.24.3.1. Choice of host mice for testis xenografting 
Xenografting requires the use of immunocompromised host mice such as nude or 
SCID mice. No difference has been described for the success of grafting between 
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these two strains of host (Geens et al., 2006);(Watanabe et al., 2009). SCID mice lack 
T- and B-lymphocytes and some strains also lack complement and NK cells. Nude 
mice are homozygous for the nude gene, lack a thymus and therefore do not 
produce T-lymphocytes (Geens et al., 2006). This makes SCID mice more prone to 
infection and costly than the nude mice. In addition nude mice do not have hair, 
which may provide a more optimal temperature for subcutaneous grafting of testis 
tissue than the SCID mice.  
 
1.24.3.2. Castration of host mice 
Castration of the host animal is generally recommended (Rodriguez Sosa and 
Dobrinski, 2009). This reduces negative feedback on gonadotrophin secretion and 
results in LH stimulation of the grafts to produce testosterone. In grafts from bulls it 
has been reported that castration is not necessary as spermatogenic progression is 
not significantly different between castrate and intact hosts (Huang et al., 2008). This 
is in contrast to studies in rhesus monkey grafts, which report that castration is 
essential for development of the grafts (Honaramooz et al., 2004). Castration of the 
host animal means that the serum testosterone level and seminal vesicle weight of 
the host reflect graft testosterone production (Schlatt et al., 2002). 
 
1.24.3.3. Success of xenografting of immature testis material in 
different species 
Grafting of immature testis tissue into nude mice has resulted in the development of 
full spermatogenesis in the grafted tissue of several species including newborn mice 
(Honaramooz et al., 2002);(Schlatt et al., 2002);(Shinohara et al., 2002); hamsters 
(Schlatt et al., 2002); rabbits (Shinohara et al., 2002); pigs (Honaramooz et al.);(Zeng 
et al., 2009); goats (Honaramooz et al., 2002); bulls (Oatley et al., 2004); horses (Rathi 
et al., 2006); cats (Snedaker et al., 2004) and rhesus macaques (Honaramooz et al., 
2004). In addition the spermatozoa isolated from grafts of mice, pigs, rabbits and 
rhesus macaques have all been shown to be capable of fertilisation using 
intracytoplasmic sperm injection (Honaramooz et al., 2008);(Schlatt et al., 
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2003);(Shinohara et al., 2002). In porcine grafts, 24% of spermatozoa were 
fertilisation competent and 8% resulted in the formation of blastocysts 
(Honaramooz et al., 2008), whilst in rhesus monkeys 80% of the spermatozoa 
appeared viable and ICSI resulted in 3 out of 16 injected oocytes developing to the 
blastocyst stage (Honaramooz et al., 2004). Mouse xenografts have resulted in the 
production of spermatozoa that are capable of producing progeny (Schlatt et al., 
2003). Fertilising ability of these sperm was similar to spermatozoa extracted from 
normal mice and 7 pups were produced from 312 manipulated oocytes (Schlatt et 
al., 2003). The phenomenon of accelerated spermatogenesis has been demonstrated 
in grafts from bovine and monkey (Honaramooz et al., 2004);(Schmidt et al., 2006b), 
whilst grafts from cats may exhibit normal (Snedaker et al., 2004) or even 
decelerated development (Kim et al., 2007). This is particularly important as some of 
the donor species (i.e. rhesus macaques) do not naturally reach full spermatogenesis 
until 4 years of age, which is greater than the lifespan of a potential recipient mouse 
(Honaramooz et al., 2004). Transplantation of immature testis tissue from 13 month 
old rhesus macaques, subcutaneously onto the back of ICR/SCID mice resulted in 
accelerated spermatogenesis with production of mature sperm within 7 months. 
This was in comparison with testicular development in 2 year old controls where no 
germ cell differentiation was observed (Honaramooz et al., 2004).  
 
Post-meiotic differentiation of germ cells in grafts from the horse (Rathi et al., 2006) 
and rhesus monkey are enhanced and accelerated by the administration of 
exogenous gonadotrophins to immature host mice (Rathi et al., 2008);(Honaramooz 
et al., 2004) and the somatic cell development still occurs despite the shortening of 
the childhood ‘quiescent’ period of testis development (Rathi et al., 2008). 
 
Despite the success of using grafting of testicular tissue from some species there are 
species in which the efficiency of spermatogenesis remains low. They include 
bovine (Rathi et al., 2005), equine (Rathi et al., 2006), cat (Snedaker et al., 2004) and 
monkey (Honaramooz et al., 2004) grafts. The marmoset is another species in which 
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full spermatogenesis is not induced after grafting (Schlatt et al., 2002) with a failure 
of germ cells to develop beyond the spermatocyte stage. This was associated with 
low androgen levels produced by the graft in the castrated host. In an attempt to 
overcome this problem, further experiments were performed using co-grafting of 
hamster testicular tissue, which is known to produce androgen in the host. The 
deletion of exon 10 in the LH receptor gene was also addressed by grafting with the 
addition of hCG treatment (Wistuba et al., 2004), which is known to act on the 
marmoset LH receptor to produce testosterone (Kholkute et al., 1983). Despite these 
modifications there was no effect on the outcome of the marmoset grafts. Indeed 
when testis tissue was grafted autologously into newborn marmosets the same 
meiotic arrest occurred along with a reduction in testosterone (Wistuba et al., 2006). 
The cause of the failure to induce full spermatogenesis in marmoset grafts was 
hypothesized to be related to hyperthermia, decreased testosterone levels or the 
multistage organisation of the seminiferous epithelium. Further studies have been 
performed using autologous grafts in marmosets placed either ectopically (under 
the back skin) or orthotopically (into the scrotum) (Wistuba et al., 2006);(Marc 
Luetjens et al., 2008). This resulted in complete spermatogenesis in the orthotopic 
grafts compared to the meiotic arrest in ectopic grafts as seen previously. 
Hyperthermia has therefore been suggested as the reason for lack of success of 
ectopic grafting but further studies are required to validate this hypothesis. 
 
1.24.3.4. Xenografting of immature human testis tissue 
Grafting of human testicular tissue was first reported over thirty years ago (Povlsen 
et al., 1974);(Skakkebaek et al., 1974) with the grafting of fetal human tissue 
subcutaneously into the lateral abdominal wall of nude mice. After 4-8 weeks grafts 
had become richly vascularised and contained seminiferous tubules with 
recognisable gonocytes and undifferentiated Sertoli cells. Since these original 
studies were reported only one further study has been published (Yu et al., 2006); 
testes from two human fetuses (20 and 26 weeks gestation) were grafted for 116-135 
days. The grafts were examined histologically and the cords had formed lumina 
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with accelerated maturation of Sertoli cells and the presence of spermatogonia was 
noted (Yu et al., 2006). No data relating to proliferation or differentiation of germ 
cells within human fetal testis xenografts has been reported to date 
 
Human testis xenografts have also been performed using pre-pubertal testis tissue 
(Goossens et al., 2008);(Wyns et al., 2008);(Wyns et al., 2007). In the study from 
Gossens et al, testis biopsy material from pre-pubertal patients with sickle cell 
anaemia was grafted into nude mice and allowed to develop for 4 or 9 months. The 
authors reported survival of tubules and were able to detect Sertoli cells by staining 
with vimentin as well as occasional tubules containing germ cells that expressed the 
spermatogonial protein MAGE-A4 (Goossens et al., 2008). Survival and proliferation 
of spermatogonia has also been demonstrated in short term grafts taken from 
cryptorchid testes in boys aged 2-12 years. Longer term germ cell survival was 
demonstrated in testis tissue from 5 boys aged 7-14 years, grafted for 6 months by 
investigating MAGE-A4 expression in the grafts (Wyns et al., 2008). Cells within 
these grafts were also proliferating, as demonstrated by Ki67 expression. In 
addition, this study reported the presence of primary spermatocytes, some of which 
were entering meiosis. There were no spermatids, although in one graft from a 14 
year old boy there were cells resembling spermatozoa with abnormal appearance 
(Wyns et al., 2008). 
 
1.24.3.5. Effect of donor age on xenografting success 
Donor age has been shown to affect the success of cell survival in grafted material in 
several species (Schmidt et al., 2006b) and the presence of mature germ cell types 
has been shown to result in generally poorer graft development (Rathi et al., 
2006);(Huang et al., 2008). Grafting of prepubertal mouse testis tissue is successful 
and full spermatogenesis has been reported, but when adult testis tissue was grafted 
success rates fell (Geens et al., 2006). Attempts to graft testes from adult pigs, goats, 
cattle and rhesus monkey resulted in degeneration of tubules in the surviving grafts 
(Arregui et al., 2008b). This has also been demonstrated in autologous grafts from 
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adult marmosets in which grafts did not survive (Marc Luetjens et al., 2008). 
Attempts to graft human adult testis has also been unsuccessful (Schlatt et al., 2006) 
and although occasional surviving spermatogonia have been described in 21-23% of 
the 74 grafts, no meiotic progression occurred. Most of the grafts had either 
sclerosed or were Sertoli cell only (SCO) (Geens et al., 2006). Spermatogonial stem 
cell survival was occasionally seen in human adult grafts when spermatogenesis 
had been suppressed prior to grafting with GnRH (Schlatt et al., 2006). The 
maximum practical age for successful xenografting appears to be just before puberty 
(Kim et al., 2007) and the success of differentiation in the xenografts from many 
species appears to depend upon the intensity/efficiency of spermatogenesis at the 
time of grafting (Arregui et al., 2008b), with improved survival and differentiation 
when the intensity/efficiency of spermatogenesis is lower (Arregui et al., 2008b).  
 
The failure of adult grafts to re-establish spermatogenesis has been attributed to 
several possible factors including cessation of Sertoli cell proliferation, ischaemia 
and failure of angiogenesis (Rodriguez Sosa and Dobrinski, 2009). Angiogenesis has 
been shown to be important because blood vessel numbers are significantly 
increased in grafts containing functional tubules compared to those with non-
functional tubules (Schmidt et al., 2006a). Vascular endothelial growth factor 
(VEGF) has been shown to increase the size of bovine xenografts in addition to 
increasing the numbers of elongate spermatids (Schmidt et al., 2006a). However the 
number of blood vessels was not increased by this treatment, suggesting that VEGF 
was not exerting this effect by increasing angiogenesis. 
 
1.25. Aims of the thesis 
The reproductive potential of the male depends on the normal development of the 
testis. This process continues throughout life from the fetal period into adulthood. 
Normal development of the germ cells is crucial to this process as these cells will 
ultimately become the male gametes. The development of the germ cells is 
dependent on their relationship with the supporting Sertoli cells and Leydig cells 
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that provide hormonal factors required for normal development. The term TDS has 
been used to describe a group of conditions that appear to have a common origin in 
fetal life and affect the cellular interactions that occur during testis development. 
These conditions include TGCT and infertility.  
 
This thesis aimed to investigate the origins of TGCT by characterizing the 
phenotypes of the pre-neoplastic CIS cells and comparing them to the associated 
supporting Sertoli cells and also to the germ cells of the normal human fetal testis. 
These phenotypes were also investigated in relation to the proliferation status of 
germ cells/CIS in order to identify whether certain phenotypes may influence the 
invasive potential of the CIS cells (chapter 3). The second aim was to investigate the 
Common Marmoset monkey as a potential animal model of germ cell development 
that could be relevant to conditions such as CIS and TGCT. This concept was based 
on its known similarity to the human in many other aspects of reproductive biology 
and testis development (chapter 4). Having established the animal model the next 
aim was to develop an in vivo xenografting system that could be applied to the 
human and marmoset to recapitulate normal testis development (chapter 5). Finally, 
manipulation of normal development of the testis in these model systems was 
attempted using substances known to suppress normal hormonal activity (GnRH 
antagonists) or to induce features of the TDS in a rodent model (phthalates) to 
provide insight into clinical disorders of testis development, in particular TGCT. 
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2 General materials and methods 
 
2.1. Human tissue 
 
2.1.1. Human fetal testis tissue 
Human fetal testis tissue was obtained from elective terminations of pregnancy 
during the first and second trimesters. Women gave consent in accordance with 
national guidelines (Polkinghorne) and the terminations were carried out by 
medical and nursing staff at the Simpson’s Centre for Reproductive Health, within 
the Royal Infirmary of Edinburgh. Termination of pregnancy was induced with 
mifepristone (200 mg, orally), followed by misopristone (Pharmacia, Surrey,UK. 200 
mg every 3 hours per vaginam). No terminations were due to fetal abnormalities. 
Gestational age was determined initially by ultrasound examination, followed by 
direct measurement of foot length for 2nd trimester samples.  Ethical approval was 
obtained for the use of fetal human tissue from the Lothian Research Ethics 
Committee (REC reference number: 08/S1101/1).  
 
2.1.2. Human testicular germ cell tumours 
Human testicular germ cell tumour samples were obtained from the archive in the 
pathology departments of the Western General Hospital and the Royal Infirmary of 
Edinburgh with ethical approval from the Lothian Research Ethics Committee (REC 
reference number: 07/S1101/8) and NHS R&D approval (R&D number: 
2006/R/RM/20). Slides stained for diagnostic purposes with haematoxylin and eosin 
were examined by myself, under light microscopy for evidence of the pre-neoplastic 
lesion carcinoma in-situ. Archived paraffin embedded blocks corresponding to these 
slides were located and sectioned (2.8.2) for immunohistochemical analysis. 
 
Sections of testis material from pre-pubertal patients containing pre-invasive 
carcinoma in-situ were kindly supplied by the Department of Pathology, Erasmus 
MC – University Medical Center, Rotterdam, Netherlands courtesy of Professor 
Leendert Looijenga. 
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2.2. Animal work 
All animal work was performed in accordance with the UK Home Office Animal 
Scientific Procedures (UK) Act (1986) under project licences 60/3544 and 60/219. Day 
to day husbandry duties for work with nude mice was carried out by University of 
Edinburgh animal technicians. Surgical procedures and treatments of nude mice 
were carried out by myself under Home Office personal licence 60/11139. 
Husbandry duties for the Wistar rats were carried out by Mark Fisken in the HRSU 
animal facility. Work with common marmoset monkeys was performed by the staff 
at the Medical Research Council primate facility, in particular Keith Morris and Jim 
Macdonald. This included general husbandry, treatments and tissue retrieval. 
 
2.3. Animal welfare 
All animals used were maintained in our own animal facilities according to UK 
Home Office guidelines. Common marmoset monkeys (Callithrix jacchus) used in 
this study came from a closed colony that has been self-sustaining since 1973. Wistar 
rats were bred within our own animal facility and were housed in solid bottomed 
cages, typically in groups of six with stud males housed individually. Water and 
food was available ad libitum. Light was provided from 07:00 – 19:00 and the 
temperature was maintained at 20-25oC, with humidity of 55%. Male CD1 Nude 
(Crl:CD-1 -Foxn1nu) mice were obtained from Charles River UK (Margate, England). 
These mice are immunodeficient, lacking a thymus and T-cells, making them a 
suitable animal host for xenografting as they do not reject the grafts. Mice were 
housed in individually ventilated cages (IVCs; Tecniplast, Varese, Italy).  Bottled 
sterile water and sterile food was available ad libitum. Light was provided from 
07:00 – 19:00 and the temperature was maintained at 20-25oC, with humidity of 41%. 
The animals were housed in groups of three initially, but were individually housed 
following xenografting surgery. Neonatal mice from a mixed background were used 
for initial allografting studies. These mice were kindly provided by Dr Lee Smith, 
HRSU.  
 
Chapter 2 Materials and methods 74 
2.4. Tissue collection 
 
2.4.1. Marmoset testes 
Testes were obtained from the fetuses of elderly pregnant marmosets in the colony 
breeding stock that were being euthanised to make way for younger breeding animals. 
Gestation in the marmoset lasts for approximately 20 weeks (144 days) (Windle et al., 
1999). Regular, systematic palpation and/or ultrasound were used to diagnose pregnancy 
and estimate gestational age and this was performed by Keith Morris in the MRC primate 
facility. Experience has shown this to be accurate to within one week and confirmed by 
reference to published crown rump length (CRL) data (Chambers and Hearn, 1985) as 
seen in Table 1.4. Mothers and fetuses, or postnatal animals were euthanised by injection 
of an overdose of sodium pentobarbitone (Euthatal; Rhone Merieux Ltd, Harlow, Essex, 
UK). The fetuses were delivered by hysterotomy. Fetuses were fixed in Bouins for 6 hours 
(larger fetuses were partially dissected prior to fixing) and then transferred to 70% 
ethanol. Sections of postnatal testes were obtained from tissue remaining from previous 
studies (Kelnar et al., 2002) (Sharpe et al., 2003a) in order to reduce the animal numbers 
required. In addition, testes were also obtained from newborn animals euthanized for 
colony management purposes (triplet births). All testes were fixed as described above, 
prior to processing. For xenografting experiments a small piece of testis tissue was fixed 
in Bouins as described above and the remainder was placed into media and kept on ice 
until grafting. 
 
2.4.2. Human testes 
 
2.4.2.1. First and second trimester human fetal testes  
Human fetal testes were obtained from 1st (8-10 weeks) or 2nd (14-19 weeks) trimester 
human fetal testes. The sex of first trimester samples was determined by PCR for the SRY 
gene as previously described (Gaskell et al., 2004). Testes were fixed for 2h in Bouins and 
then transferred into 70% ethanol prior to processing. For xenografting experiments a 
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small piece of testis tissue was fixed in Bouins as described above and the remainder was 
placed into media and kept on ice until grafting. 
 
2.4.2.2. Third trimester and postnatal human testes 
Third trimester and post-natal human testes were obtained at autopsy with consent of the 
legal guardian (courtesy of Dr Katherin McKenzie, Consultant Pathologist, Pathology 
Department, Royal Infirmary of Edinburgh). Testes were from boys who died from 
various causes (excluding reproductive and endocrine abnormalities). Testes were fixed 
in 10% Neutral Buffered Formalin for at least 24h and processed as below. 
 
2.4.3. Rat testis tissue collection 
Pregnant dams were killed by inhalation of carbon dioxide when their fetuses had 
reached embryonic day 15.5 (e15.5, n=5) or embryonic day 19.5 (e19.5, n=5). Fetuses were 
removed, decapitated and placed in ice-cold phosphate buffered saline (PBS; Sigma, 
Poole, Dorset, UK). Testes were removed via microdissection and fixed for 1h in Bouins 
followed by transfer into 70% ethanol. I am grateful to Matthew Jobling for providing me 
with the dissected rat testis tissue. 
 
2.4.4. Mouse testis tissue collection 
Newborn mice were killed by decapitation and the testes were removed. A small piece 
was fixed for 2h in Bouins and then transferred into 70% ethanol prior to processing. 
Testes for use in xenografting studies were placed directly into media and kept on ice 
until grafting. 
2.5. Animal treatments 
 
2.5.1. GnRH antagonist treatment 
Newborn marmosets were treated by subcutaneous injection with 10mg/kg of a 
potent long-acting GnRH antagonist (GnRHa; Antarelix; Europeptides, Argentueil, 
France) weekly for four weeks to suppress the neonatal testosterone surge (Sharpe 
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et al., 2003b);(Lunn et al., 1994). Each animal had a co-twin acting as a direct control. 
These co-twins were treated with vehicle instead of GnRHa.  
 
2.5.2. Monobutyl phthalate (MBP) treatment 
Nine pregnant females were administered 500 mg/kg/day MBP (TCI Europe, 
Zwijndrecht, Belgium) by oral gavage from 7–15 weeks of gestation. MBP was made 
up by mixing with corn oil. A total of 11 male offspring originated from these 
treated mothers and 6 of these were killed at birth (1–5 days), whilst 5 were allowed 
to grow into adulthood. 
 
2.6. Animal Surgical Procedures  
 
2.6.1. Preparation of surgical area and anaesthetic equipment 
Nude mice (Charles River Laboratories, Margate, UK) were used as hosts for all 
xenografting experiments. A sterile surgical field was prepared inside a laminar 
flow cabinet. The cabinet and all equipment were cleaned with antiseptic wipes 
(Trigene, Medichem International Ltd, Sevenoaks, UK) and a warming mat covered 
in a plastic disposable sterile drape was placed inside the cabinet. An anaesthetic rig 
(Vet Tech Solutions Ltd, Congleton, UK) was set up to direct anaesthetic to a 
chamber for induction of anaesthesia and the anaesthetic chamber was filled with 
Isoflurane. The anaesthetic was then switched to tubing ending in a nosepiece, 
which was attached to the sterile field with a clamp; for maintenance of anaesthesia 
during surgery. 
 
2.6.2. Castration of nude mice 
Isoflurane (5%) and oxygen (2L/min) were directed into an anaesthetic box, which 
had been placed into the laminar flow cabinet. Mice were put into the box until 
anaesthetised. They were then transferred onto the sterile field and placed supine 
with their noses directed into the nosepiece of the tubing for maintenance of 
anaesthesia and the gases were directed into this tubing with the concentration of 
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Isoflurane reduced to 2%. The perineum was sprayed with 70% ethanol to clean the 
surgical area. A longitudinal scrotal incision was made using surgical scissors 
followed by an incision in the underlying tunica. The testis, spermatic cord and 
testicular fat pad were exteriorised and the spermatic cord was tied off using 
Mersilk 3.0 silk sutures (Ethicon, Livingston, UK) and severed distal to the suture. 
The skin was sutured closed using 3.0 sutures. The process was then repeated for 




Figure 2.1. Castration of a nude mouse host prior to xenografting. Note the set up of the 
anaesthetic delivery and sterile field. 
 
2.6.3. Preparation of donor testis material for xenografting 
Donor testes were placed immediately into ice cold media containing Liebowitz L-
15 with glutamine, 10% fetal bovine serum, 1% penicillin/streptomycin and 1% non-
essential amino acids (all obtained from Sigma, Poole, UK). Prior to grafting the 
testes were placed into a petri dish and cut into small (1mm3 approx.) pieces using 
sterile scissors (Fig. 2.2).  




Figure 2.2. Preparation of the donor testis for xenografting. The testis has been cut into 
small pieces with sterile scissors (1mm
3
 approx.).  
 
2.6.4. Genotyping for SRY in first trimester human fetal gonads  
It was not possible to determine the sex of the first trimester fetuses for xenografting 
by microscopy and therefore tissue was taken from the fetus and genotyping for the 
SRY gene was performed. A small piece of fetal tissue (e.g. hand/foot) was digested 
in 100l 25mM NaCl/0.2mM EDTA (Digest buffer 1) at 95oC for 20min, followed by 
neutralisation in 100l 40mM Tris.HCl, pH 7.5 (Digest buffer 2). The samples were 
vortexed for 30s and the reaction mixture (total volume of 25l) was made up as 
follows: 
 
5l DNA (from samples) 
1l PCR buffer  (Qiagen, Crawley, UK) 
1l dNTP’s (Qiagen) 
0.5l SRY forward primer  
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0.5l SRY reverse primer  
15.375l dH2O (Qiagen) 
0.125l Taq polymerase (Qiagen) 
 




Samples were placed in a Perkin Elmer PTC-100 (Perkin Elmer, Massachusetts, 
USA) programmable thermal cycler PCR machine and incubated according to the 
following conditions: 
 
95oC for 15 min 
95oC for 30s  
58oC for 30s     
72oC for 45s   
72oC for 10 min 
 
Loading dye (10X, Promega, Southampton, UK) was added to the samples. A 2% 
agarose gel in TE buffer was prepared containing 1:10000 GelRed DNA stain 
(Biotium, California, US).  The gel was placed into an electrophoresis tank (Bio-Rad, 
Hemel Hempstead, UK) containing TE buffer and 10l samples were loaded into the 
wells. A 100bp ladder (5l; Biolabs, Hitchin, UK) was placed in the wells either side 
of the samples. Samples were run at 85V for 1 hour and visualised under UV light 
using a Geneflash Syngene bioimaging UV light box (Syngene, Cambridge, UK) and 
photographed. A 300bp product indicated the presence of the SRY gene and 
identified the samples as male. Some of the genotyping was carried out by Dr 
Andrew Childs, HRSU, who was using tissue from these samples, and I am grateful 
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2.6.5. Xenografting of testis material into nude mouse hosts 
Anaesthetised mice were placed prone and their dorsal skin sprayed with 70% 
ethanol. Pieces of donor testis material were placed into the tip of a 13G cancer 
implant needle (Popper and Sons, New York, USA) with the trochar withdrawn. 
The needle was inserted 1-2cm under the back skin and the trochar pushed through 
the needle to implant the tissue. The needle was withdrawn and the puncture site 
was held closed for 1-2 seconds. Up to six grafts (three either side of the midline) 
were inserted into each recipient (Fig. 2.3). A subcutaneous injection of 4mg/kg 
(0.015mls of 5mg/ml) carprofen diluted in sterile water for injection (Rimadyl SA; 
Pfizer, New York, USA), was given into the lower right flank of each mouse for 
analgesia. The mice were returned to IVCs and housed individually. Rimadyl LA 
(0.5mls per 250mls sterile water) was added to the drinking water for 5 days post 
surgery and, if antibiotics were required, Baytril (Enrofloxacin; Bayer, Germany 1ml 
per 250mls sterile water) was also added to the drinking water. I am grateful to Dr 
Stefan Schlatt, Institute of Reproductive and Regenerative Biology, Munster, 
Germany, for providing training in how to undertake the testis xenografting 
technique. 
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Figure 2.3. Subcutaneous xenografting procedure. Testis tissue pieces were placed into 
the bevel of the needle and injected under the skin (upper panel). Positions of graft 
placement can be seen in the lower panel. 
 
2.6.6. Treatments for xenografted mice 
 
2.6.6.1. hCG treatment 
hCG treatment was used to stimulate the production of testosterone from the testis 
grafts. A vial of 5000IU hCG (Pregnyl, Organon Laboratories, Cambridge, UK) was 
diluted to 1 ml with 0.9% saline. 1% Fetal calf serum (Sigma) was added to allow 
storage of hCG aliquots. Aliquots of 25 IU (5l) were stored at -20oC. Vehicle 
treatments consisting of 5l aliquots of 0.9% saline with 1% fetal calf serum were 
also stored at -20oC. Animals were randomly assigned to receive hCG or vehicle. 
Immediately prior to use, aliquots were diluted in 0.25mls sterile 0.9% saline in 1ml 
plastic syringes and 0.20mls (20IU) was injected subcutaneously into the scruff of 
the neck using a 25G injection needle. Injections were given within a laminar flow 
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unit. Treatment began one week after grafting and continued three times a week for 
the duration of the grafting period. 
 
2.6.6.2. Di (n-butyl) phthalate (DBP) treatment 
Some of the grafted mice received DBP treatment. In addition, some of these mice 
also received hCG as described in the previous section. DBP was made up by 
mixing DBP (Sigma) with corn oil. To make up the DBP, 0.5mls DBP was added to 
9.5mls corn oil to give a concentration of 50mg/ml. Two regimens were used. In the 
first regimen, host mice received 350l (500mg/kg) DBP by oral gavage 6 hours prior 
to retrieval of the grafts. In the second regimen the mice received the same dose on 
the four consecutive days prior to graft retrieval. For both regimens, vehicle treated 
controls were used. These control hosts received the same volume of corn oil 
without DBP. 
 
2.6.7. Retrieval of testicular xenografts 
Grafts were retrieved after the specified grafting period. The mice were killed by 
cervical dislocation under Schedule 1 of the Animal (Scientific Procedures) Act 1986. 
Body weight was recorded using an electronic analytical balance (Handy H110, 
Sartorius) and blood was obtained by cardiac puncture for measurement of serum 
testosterone levels. The seminal vesicles were dissected out and weighed as a 
surrogate marker of graft testosterone production. The back skin was then peeled 
back to reveal the subcutaneous tissue. The grafts were easily identified as discrete 
masses with a loose adherence to the underside of the skin (Fig. 2.4). These grafts 
were dissected and weighed before being placed into Bouins fluid for further 
analysis.  
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Figure 2.4. Retrieval of testicular xenografts. Testicular xenografts (arrows) on the 
undersurface of the back skin of a nude mouse host.  
 
2.7. Serum testosterone radioimmunoassay  
A competitive radioimmunoassay (RIA) was performed using a known 
concentration of radiolabelled antigen (testosterone labelled with I125, MP 
Biomedicals, UK) against unlabelled endogenous testosterone present in the sample. 
The radiolabelled testosterone and the testosterone within the sample compete for 
antibody binding sites. The free (unbound) radiolabelled testosterone is inversely 
proportional to the amount of testosterone in the sample. Measuring free 
radiolabelled testosterone can then be used to calculate the level of testosterone in 
the sample. Radiolabelled testosterone was added to each sample prior to the 
addition of primary antibody (AMS Biotech, Abingdon, UK), used at 1:600,000. The 
primary antibody was incubated for 3 hours at room temperature. The samples 
were then incubated overnight at 4C with a secondary donkey-anti-rabbit 
antibody. The secondary antibody binds to the testosterone/antibody complex to 
form a stable precipitate. Then 1ml of wash buffer was added and the tubes 
centrifuged for 30 minutes at 3000rpm. The supernatant was then decanted and the 
amount of radiation in the precipitate was measured and compared to a standard 
curve of known testosterone concentrations. A gamma counter (WIZARD 1470, 
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Perkin Elmer, Turku, Finland) was used to measure residual I125. This assay has a 
sensitivity of 0.1ng/ml. The Intra assay coefficients of variation (%) are 6.0, 5.5 and 
6.6, whilst Inter assay variation (%) is 14.2, 8.7 and 7.9. In each run, method blanks, 
quality control samples (MP Biomedicals, Solon, Ohio, USA), and standards were 
analysed alongside the unknown samples. Results were analysed with AssayZap 
(Biosoft, Cambridge, UK) and data expressed as ng testosterone per 1ml. I would 
like to thank Nancy Evans, from the Assay lab, HRSU, Edinburgh for performing 
the testosterone assays. 
 
2.8. Tissue preparation for staining procedures 
 
2.8.1. Fixed tissue processing  
After fixing in Bouins, testis tissue was transferred to 70% ethanol and subsequently 
processed by staff in the MRC HRSU histology department. The tissue was 
processed through a series of graded alcohols using a Leica TP-1050 processor 
(Leica UK Limited, UK), before being embedded into molten paraffin wax and 
loaded onto plastic cassettes. Once processed, blocks were stored at room 
temperature. 
 
2.8.2. Tissue sectioning 
Blocks of paraffin embedded tissue were chilled on ice prior to sectioning. Sections 
(5m thickness) were cut using a hand operated microtome (RM 2135, Leica) and 
floated onto warm water (45-50oC) in a water bath. Individual sections were then 
mounted onto charged glass slides (SuperFrost, Menzel GmbH & Co.) and dried 
overnight at 50 oC. 
 
2.8.3. Dewaxing and re-hydration 
Slides were de-waxed sequentially in xylene for 5 minutes (x2), followed by graded 
alcohols: absolute (x2), 95%, 80% and 70% for 20 seconds each. The slides were then 
washed in tap water. 
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2.9. Haematoxylin and eosin staining 
Following dewaxing and rehydrating, sections were submerged in haematoxylin 
(Triangle Biomedical Sciences, Durham, USA) for 6 minutes. Sections were rinsed in 
tap water and briefly placed into 1% acid alcohol for between 1 and 5 seconds until 
the desired staining was achieved. Sections were then washed in tap water and 
placed in Scott’s tap water for 30 seconds to stain the nuclei blue, followed by a 
rinse in tap water. The sections were then immersed in eosin Y (1% aqueous 
solution mixed with 1% alcohol solution at a ratio of 3:1; Triangle Biomedical 
Sciences) for 20 seconds and washed again in tap water. The sections were then 
dehydrated in a series of alcohols 70%, 85%, 95%, absolute, absolute for 20 seconds 
each and then placed in xylene for 5 minutes. The sections were then mounted 
under glass coverslips (VWR International, Lutterworth, UK) with Pertex mounting 




2.10.1. Immunohistochemistry method 
Immunohistochemistry was performed by the indirect immunoenzyme method 
(Fig. 2.5). This technique involves the application of an unlabelled primary antibody 
that reacts specifically to the antigen within the tissue. A biotin labelled secondary 
antibody directed against IgG of the species that the primary antibody was raised 
against is then applied. A streptavidin conjugated enzyme layer is then added, 
which binds to the biotin from the secondary layer and finally the substrate for the 
enzyme is added. The streptavidin is derived from streptococcus avidini and is 
uncharged, which means that unlike avidin there is no non-specific electrostatic 
binding to the tissue. This means that the method is more sensitive than the Avidin-
Biotin Complex (ABC) method. 
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Figure 2.5. Indirect immunohistochemistry. Sequential primary and secondary antibodies 
are applied. Peroxidase labelled Streptavidin binds to biotin on the secondary antibody and 
the peroxidise enzyme catalyses the substrate reaction to produce a visible colour.  
 
2.10.2. Single staining 
Sections were prepared as described (2.8.1 – 2.8.3) 
 
2.10.2.1. Antigen retrieval 
Antigen retrieval was required to unmask some of the antigens (Table 2.1) because 
the fixation process may result in protein cross-links within the tissue, which would 
otherwise prevent binding of the antibody to the antigen (Norton et al., 1994). 
Dewaxed and rehydrated slides were immersed in 2L of boiling citrate buffer (made 
up 1:10 with distilled water) within a Tefal Clipso pressure cooker (Tefal, Slough, 
UK) and set to the highest pressure setting. The slides were left for 5 minutes on full 
pressure, as indicated by the continuous release of steam from the valve. The 
pressure was then released and the pressure cooker taken of the heat and slides left 
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Endogenous peroxidise activity was blocked by immersing slides in 3% (v/v) 
hydrogen peroxide (VWR), followed by rinsing in water. The slides were then 
washed in TBS for two 5 minute periods. Slides were wiped dry and a circle drawn 
around the tissue with an ImmEdge hydrophobic pen (Vector Laboratories, Inc. 
Burlingame, CA) to allow good coverage of the tissue with the subsequent reagents. 
For human and primate tissue, which may contain endogenous biotin, streptavidin 
and biotin blocks were applied using a blocking kit (Vector Laboratories Inc.). Each 
block was applied (1 drop per slide) for 15 minutes with brief TBS washes in 
between. The final blocking step was with normal serum for 30 minutes, diluted 1:5 
with TBS and containing 5% (w/v) bovine serum albumin (BSA; Sigma). Choice of 
serum (normal serum/TBS/BSA) depended on the species in which the secondary 
antibody was raised.  
 
2.10.2.3. Primary antibodies 
Primary antibody diluted in normal serum/TBS/BSA was then applied to the 
sections and incubated overnight at 4oC. Details of primary antibodies used for 
single immunohistochemistry are detailed in Table 2.1.  
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Table 2.1. Primary antibodies used for single immunohistochemistry. 
 
a
 Prof. Ian Mason, The Queen's Medical Research Institute, Edinburgh, UK 
b
 Dr. Guilio Spagoli, University Hospital, Basel, Switzerland  
 
2.10.2.4. Secondary antibodies 
The slides were washed twice more (5 minutes each) in TBS and incubated with a 
biotin conjugated secondary antibody (1:500), diluted in normal serum/TBS/BSA for 
30 minutes at room temperature. Sections were washed again in TBS (5 minutes x2), 
followed by streptavidin-HRP (DAKO) diluted 1:1000 in TBS for 30 minutes. A 
summary of secondary antibodies used can be seen in Table 2.2. 
 
Antigen Source Species Dilution Retrieval 
3-HSD Gifta Rabbit 1:1000 No 
AP-2 Santa Cruz  Mouse 1:20 Yes 
AMH Santa Cruz Goat 1:500 No 
AR Santa Cruz Rabbit 1:200 Yes 
c-KIT Santa Cruz Rabbit 1:50 No 
HH3 Upstate Biotech Rabbit 1:3000 Yes 
Ki67(a) DAKO Mouse 1:40 Yes 
Ki67(b) Abcam Rabbit 1:200 Yes 
MAGE-A4 Giftb Mouse 1:500 No 
NANOG R+D Systems Goat 1:50 Yes 
NANOS1 Abcam Rabbit 1:500 Yes 
OCT4(a) Santa Cruz  Goat 1:50 Yes 
OCT4(b) Santa Cruz Goat 1:200 Yes 
Pan-cytokeratin Sigma Mouse 1:500 Yes 
PCNA DAKO Mouse 1:100 Yes 
PLAP Abcam Rabbit 1:100 Yes 
SMA Sigma Mouse 1:5000 Yes 
SOX9 Chemicon Rabbit 1:80 Yes 
VASA Abcam  Rabbit 1:200 Yes 
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2.10.2.5. Visualisation 
3,3 Diaminobenzidine (DAB) was used as a substrate for the brown colour reaction 
to visualise the areas of the section to which the primary antibody had attached to 
the target protein. The DAB (DAKO) was diluted in DAB substrate buffer (1 
drop/ml) and immediately applied to the sections for between 1 and 5 minutes, until 
the desired staining was achieved. Once adequate staining had occurred, the 
reaction was stopped by immersing the slides in tap water. 
 
2.10.2.6. Haematoxylin counterstaining, dehydration and mounting 
Sections were immersed in haematoxylin for between 4 and 6 minutes in order to 
lightly counterstain the nuclei of the cells. The sections were then immersed in tap 
water and placed into 1% acid alcohol for between 1 and 5 seconds and then rinsed 
again in tap water. The sections were then placed in Scott’s tap water for 30 seconds 
to turn the nuclei blue and then rinsed again in tap water. The sections were then 
immersed for 20 seconds each in graded alcohols of increasing concentration (70%, 
80%, 95%, absolute and absolute). The sections were then placed in xylene for 5 
minutes and mounted under glass coverslips (VWR International) with Pertex 
mounting medium (CellPath Ltd, Hemel Hempstead, UK). 
 
2.10.2.7. Imaging 
Images were obtained using a Provis microscope (Olympus, London, UK) and 
photographed using a DCS3310 digital camera (Eastman Kodak, Rochester, NY). 
Images were assembled using Adobe Photoshop 7.0 (Adobe Systems Inc, Mountain 
View, CA, USA). 
 
2.10.3. Double staining 
In order to detect two different proteins in the same section, double staining was 
performed. This technique could be used for two primary antibodies that were 
raised in different species, thus allowing two different secondary antibodies to be 
used. Visualisation was performed with two different substrates producing 
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different coloured staining for each protein. The first steps were identical to those 
described for single staining (2.10.2.1 – 2.10.2.5). Once the sections were visualised 
with DAB the sections were washed twice (5 minutes each) in TBS and blocked in 
the appropriate normal serum/TBS/BSA for 30 minutes. The second primary 
antibody diluted in normal serum/TBS/BSA was then applied overnight at 4oC. The 
next day two 5 minute washes in TBS were followed by incubation with a biotin 
conjugated secondary antibody (1:500) diluted in normal serum/TBS/BSA for 30 
minutes (Table 2.2). The sections were washed twice in TBS (5 minutes each) and 
incubated with streptavidin-alkaline phosphatase (DAKO) diluted 1:400 in TBS for 
30 minutes. Two further TBS washes (5 minutes each) were followed by visualistion 
using fast blue as the substrate to produce a blue colour. The fast blue was prepared 
by adding 1mg of fast blue salt (Sigma) to 1ml of fast blue buffer. This solution was 
filtered through a 0.2m filter (Millipore, Massachusetts, USA) to remove the 
undissolved salt. This solution was applied to the sections and kept in the dark for 
approximately 20 minutes until the desired staining was achieved. Counterstaining 
was not performed for double stained slides as the blue colour of the fast blue 
would be difficult to distinguish from the blue staining of the haematoxylin. The 
slides were mounted under glass coverslips with Permafluor (Beckman Coulter, 
High Wycombe, UK) mounting medium and images were obtained as for single 
staining (2.10.2.7). Details of double staining antibodies and detection methods are 
shown in Table 2.2. 
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Table 2.2. Antibodies and detection used for double immunohistochemistry 
 
Abbreviations: 
SAR-b – Swine anti-rabbit biotinylated (DAKO)  
RAG-b – Rabbit anti-goat biotinylated (Vector Labs.) 
RAM-b – Rabbit anti-mouse biotinylated (DAKO) 
GAM-b – Goat anti-mouse biotinylated (DAKO) 
GAR-b – Goat anti-rabbit biotinylated (DAKO) 
DAG-b – Donkey anti-goat biotinylated (Abcam) 
 
2.11. Immunofluorescence 
Sections were prepared as described (2.8.1 – 2.8.3) and subjected to antigen retrieval 
and blocking as described for immunohistochemistry (2.10.2.1 – 2.10.2.3) TBS 
washes were replaced with phosphate buffered saline (PBS; Sigma). 
 
2.11.1. Double immunofluorescence 
This technique was used to visualise antibodies binding to two different proteins, 
particularly when these proteins are localised to the same regions of a particular cell 
type. The method used combinations of indirect immunofluorescence (section 
2.10.1, using a fluorescent label) and the tyramide signal amplification (TSA) system 
(Fig. 2.6). TSATM Plus (Perkin Elmer) involves addition of horseradish peroxidase 
(HRP) labelled secondary antibody. The HRP is used to catalyze the deposition and 
binding of a labeled tyramide adjacent to the immobilised HRP enzyme. This 
binding is covalent because the reaction intermediate dimerizes with tyrosine 








OCT4(a) 1:50 RAG-b DAB MAGE-A4 1:20 RAM-b Fast blue 
VASA 1:200 SAR-b Fast blue OCT4(a) 1:50 RAG-b DAB 
Ki67(b) 1:200 SAR-b DAB MAGE-A4 1:10 RAM-b Fast blue 
Pan-cytokeratin 1:500 GAM-b Fast blue AR 1:200 GAR-b DAB 
Pan-cytokeratin 1:500 RAM-b DAB OCT4(b) 1:200 RAG-b Fast blue 
VASA 1:200 SAR-b Fast blue Ki67(a) 1:40 GAM-b DAB 
SOX9 1:80 SAR-b Fast blue OCT4(a) 1:20 RAG-b DAB 
OCT4(a) 1:50 DAG-b Fast blue c-KIT 1:20 GAR-b DAB 
c-KIT 1:20 GAR-b DAB MAGE-A4 1:20 RAM-b Fast blue 
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residues on the surface-bound endogenous proteins. Since the added labels are only 
deposited proximal to the enzyme site, there is minimal, if any, loss of resolution. 
 
Figure 2.6. Tyramide signal amplification. HRP conjugated to the secondary antibody 
catalyses the activation of the tyramide. The activated tyramide bonds to the tyrosine 
residues on the tissue surface and the fluorescent label on the tyramide can be detected. 
 
2.11.1.1. First primary antibody 
Sections were incubated overnight with the first primary antibody diluted in normal 
serum/PBS/BSA (Table 2.3).  
 
2.11.1.2. Secondary antibodies 
The slides were washed twice more (5 minutes each) in PBS and incubated with a 
biotin or peroxidase conjugated secondary antibody (1:500), diluted in normal 
serum/PBS/BSA for 30 minutes at room temperature (Table 2.3). Sections were 
washed again in PBS (5 minutes x2). 
 
Chapter 2 Materials and methods 93 
2.11.1.3. Detection reagent for first primary antibody 
The slides were kept in the dark for the remainder of the experiment to prevent loss of 
the fluorescent signal. For biotin conjugated secondary antibodies, slides were incubated 
with streptavidin conjugated to a fluorescent label that emits signal at a wavelength of 
488 nm (Molecular Probes, Leiden, Netherlands), diluted 1:200 in PBS, for 60 minutes. For 
peroxidise conjugated secondary antibodies, slides were incubated with Tyramide Cy3 or 
Cy5, diluted 1:50 in the supplied buffer, for 10 minutes. 
 
2.11.1.4. Blocking 
The slides were then blocked with normal serum/PBS/BSA for 30 minutes, the 
choice of which depended on the source of the second primary antibody (Table 2.3) 
 
2.11.1.5. Second primary antibody 
Sections were incubated overnight with the second primary antibody in normal 
serum/PBS/BSA (Table 2.3).  
 
2.11.1.6. Secondary antibodies 
The slides were washed twice more (5 minutes each) in PBS and incubated with a 
biotin or peroxidise conjugated secondary antibody at a dilution of 1:500, diluted in 
normal serum/PBS/BSA for 30 minutes at room temperature (Table 2.3). Sections 
were washed again in PBS (5 minutes x3).  
 
2.11.1.7. Detection reagents for second primary antibody 
Slides that had been incubated with a biotinylated secondary antibody were incubated 
with streptavidin conjugated to a fluorescent label that emits signal at a wavelength of 
546 nm and diluted 1:200 with PBS for 60 minutes. Alternatively for primary antibodies 
that required increased signal amplification a peroxidise labelled secondary antibody was 
used instead of the biotinylated secondary and a Tyramide labelled detection system was 
used. Slides were incubated for 10 minutes with Tyramide-Cy3 or Cy5 diluted 1:50 with 
the supplied buffer (Table 2.3). 
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2.11.1.8. Variation for detection of two primary antibodies raised in the 
same species 
A variation was required for double staining involving primary antibodies that 
were raised in the same species (Brown et al., 2004). The secondary antibodies were 
both biotinylated FAb fragments (both 1:500, diluted in normal serum/PBS/BSA), 
which prevented cross-reaction between the two detection reagents. In addition a 
second streptavidin and biotin block (2.10.2.2) was required after the first detection. 
Detection reagents were strepatavidin-488 and streptavidin-546 (as described above) 
for first and second detection reagents respectively. Details of the antibodies used 
and the detection methods are shown in Table 2.3. 
 
Table 2.3. Antibodies and detection used for double immunofluorescence 
Abbreviations: 
RAG-p – Rabbit anti-goat peroxidase (Sigma)  
GAM-p – Goat anti-mouse peroxidase (Santa Cruz) 
CAR-p – Chicken anti-rabbit peroxidase (Santa Cruz) 
CAR-b – Chicken anti-rabbit biotinylated (Santa Cruz) 
CAG-p – Chicken anti-goat peroxidase (Santa Cruz)  
GAR-b – Goat anti-rabbit biotinylated (Vector) 
Tyr Cy3 – Tyramide Cy3 (Perkin Elmer)   
Tyr Cy5 – Tyramide Cy5 (Perkin Elmer) 
Strept 488 – Streptavidin 488 (Molecular probes) 
Strept 546 – Streptavidin 488 (Molecular probes) 
 
2.11.1.9. Counterstaining, mounting and imaging 
TO-PRO-3 (Molecular Probes, Leiden, Netherlands) was applied at 1:1000 in PBS for 
5 min as a nuclear counterstain and the slides were mounted using Permafluor. 








OCT4(a) 1:100 RAG-p Tyr Cy3 AP-2 1:60 GAM-p Tyr Cy5 
PLAP 1:20 CAR-b Strept 488 OCT4(a) 1:200 CAG-p Tyr Cy3 
NANOG 1:150 CAG-p Tyr Cy5 OCT4(a) 1:150 CAG-p Tyr Cy3 
VASA 1:200 GAR-b Strept 488 AP-2 1:60 GAM-p Tyr Cy3 
AP-2 1:60 GAM-p Tyr Cy3 NANOS1 1:60 GAR-b Strept 488 
VASA 1:200 GAR-b Strept 488 OCT4(a) 1:100 RAG-p Tyr Cy3 
VASA 1:200 GAR(fab)-b Strept 488 NANOS1 1:60 GAR(fab)-b Strept 546 
AP-2 1:60 GAM-p Tyr Cy3 Ki67(b) 1:100 GAR-b Strept 488 
NANOG 1:150 CAG-p Tyr Cy5 VASA 1:100 CAR-p Tyr Cy3 
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Images were captured using an LSM 510 Confocal microscope (Carl Zeiss, 
Hertfordshire, UK). 
 
2.11.2. Triple immunofluorescence 
For triple immunofluorescence, further periods in boiling citrate between each 
primary antibody was required to prevent cross reaction. TSATM, plus enhanced 
detection systems were required for each primary antibody as the streptavidin 
based fluorescent antibodies were unable to withstand repeated boiling in citrate. 
Sections were prepared as described (2.8.1 – 2.8.3) and subjected to antigen retrieval 
and blocking as described for immunohistochemistry (2.10.2.1 – 2.10.2.3) with PBS 
washes replacing TBS. 
 
2.11.2.1. First primary antibody 
After blocking with normal serum/PBS/BSA for 30 minutes, sections were incubated 
overnight with the first primary antibody in normal serum/PBS/BSA.  
 
2.11.2.2. Secondary antibodies 
The slides were washed twice more (5 minutes each) in PBS and incubated with a 
peroxidase conjugated secondary antibody (Table 2.4), diluted in normal 
serum/PBS/BSA for 30 minutes at room temperature. Sections were washed again in 
PBS (5 minutes x2). 
 
2.11.2.3. Detection reagent for first primary antibody 
The slides were kept in the dark for the remainder of the experiment to prevent loss of 
the fluorescent signal. Slides were incubated with labelled Tyramide diluted in buffer at 
1:50 for 10 minutes. 
 
2.11.2.4. Blocking cross reactivity 
Sections were placed in a plastic rack and into a glass trough containing citrate 
buffer and covered in pierced cling film. The slides were then microwaved on full 
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power for 2.5 minutes using a conventional microwave oven and then left in the hot 
citrate for 30 minutes. The slides were then washed in PBS for 5 minutes. 
 
2.11.2.5. Second and third primary antibodies 
The two remaining primary antibodies were incubated sequentially by repeating 
steps described in section 2.11.2.1 – 2.11.2.4 for the second antibody and 2.11.2.1 – 
2.11.2.3 for the final antibody, using detection with Tyramide  conjugated to 
different fluorescent labels. 
 
2.11.2.6. Counterstaining, mounting and imaging 
DAPI (Sigma) was applied at 1:1000 in PBS for 10 min as a nuclear counterstain and 
the slides were mounted using Permafluor. Images were captured using an LSM 510 
Meta Confocal microscope (Carl Zeiss). Details of the antibodies used and the 











Table 2.4. Antibodies and detection used for triple immunofluorescence. 
 
Abbreviations: 
GAR-(fab)-p – Goat anti-rabbit-FAB-peroxidise (Abcam) 
CAM-p – Chicken anti-mouse peroxidase (Sigma)  
CAR-p – Chicken anti-rabbit peroxidase(Sigma) 
CAG-p – Chicken anti-goat peroxidase (Sigma) 
Tyr Cy3 – Tyramide Cy3 (Perkin Elmer)   
Tyr Cy5 – Tyramide Cy5 (Perkin Elmer) 












Antigen 1 VASA MAGE-A4 OCT4(a) 
Dilution 1:1000 1:100 1:150 
Secondary antibody GAR-(fab)-p CAM-p CAG-p 
Detection Tyr Cy5 Tyr Cy5 Tyr Cy3 
Antigen 2 PLAP OCT4(a) MAGE-A4 
Dilution 1:200 1:150 1:100 
Secondary antibody GAR-(fab)-p CAG-p CAM-p 
Detection Tyr Fluorescein Tyr Cy3 Tyr Cy5 
Antigen 3 OCT4(a) PLAP Ki67(a) 
Dilution 1:150 1:200 1:150 
Secondary antibody CAG-p CAR-p CAM-p 
Detection Tyr Cy3 Tyr Fluorescein Tyr Fluorescein 
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2.12. Image analysis 
 
2.12.1. Image analysis - immunohistochemistry  
Quantification of germ cells and proliferation counts on sections obtained from 
immunohistochemistry were performed using Image-pro Plus 4.5 software (Media 
Cybernetics, Wokingham, Berkshire, UK). Live images were obtained using a Zeiss 
microscope (Carl Zeiss) fitted with an automatic stage (Prior Scientific Instruments 
Ltd, Cambridge, UK). Sections were tiled using a 40x objective and an area of 
interest (AOI) was drawn around the entire section. Random fields were generated 
and the total number of germ cells was calculated for each field based either on 
morphology and position or alternatively following staining with a germ cell 
marker. The total number of proliferating germ cells was also calculated. 
 
2.12.2. Image analysis – immunofluorescence 
 
2.12.2.1. Double immunofluorescence  
In order to investigate whether GnRHa treatment of neonatal marmosets resulted in 
persistence of gonocytes (section 2.5.1) in 6 week old animals, the proportion of 
germ cells expressing NANOG was compared to the proportion in control co-twins. 
Quantification was performed using Image-pro Plus 4.5 software (Media 
Cybernetics, Wokingham, Berkshire, UK). Live images were obtained using a Zeiss 
microscope fitted with fluorescent filters (Zeiss) and an automatic stage (Prior 
Scientific Instruments Ltd, Cambridge, UK). Sections were double stained with a 
general germ cell marker (VASA) in addition to the gonocyte maker of interest 
(Table 2.3). Sections were tiled using a 40x objective and an area of interest (AOI) 
was drawn around the section. The stage was moved around the entire section and 
the total number of germ cells (VASA positive) in the entire section was counted 
using the red filter. Once all the germ cells had been counted the stage was again 
moved across the whole section using the green filter and the total number of cells 
expressing the gonocyte marker (NANOG positive) was calculated. The number of 
cells expressing the gonocyte marker was then divided by the total number of germ 
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cells to give the proportion of germ cells expressing the gonocyte marker. Data from 
each treated animal was compared to its co-twin and statistical analysis was 
performed with a students paired t-test using Graphpad Prism 5 software (La Jolla, 
California USA). A p-value of <0.05 was considered significant. 
 
2.12.2.2. Triple immunofluorescence  
Quantification of germ cell subpopulations and proliferation indices were 
performed using Axiovision 4.6 software (Carl Zeiss) and images obtained using an 
Axiovert 200M microscope with attached Axiocam HRc camera and an MCU2P 
automatic stage (all Carl Zeiss). Fluorescent filters were attached to detect green, 
blue and red fluorescence. The multidimensional acquisition function was used and 
the appropriate channels selected. The exposure of each of the fluorochromes was 
measured individually. The ‘mark and find’ function was then used to acquire a 
background image. Using the MosaiX function at a magnification of 5x a tiled image 
was created with the DAPI filter on. This allowed the observer to identify the 
boundaries of the sample and identify the areas of interest without being able to see 
the individual staining. Points within the desired area were randomly chosen (Fig. 
2.7) and the focus (including z co-ordinate) for each position adjusted manually. 
 
For each field, an image was captured for every individual channel, in addition to a 
merged image. These images were then exported as JPEG files for quantitative 
analysis. Quantitative analysis was performed using Adobe Photoshop 7.0 (Adobe, 
San Jose, USA). All of the images for an individual field were opened (Fig. 2.8).  
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Figure 2.7. Generating random points for quantification of cell types within triple 





Figure 2.8. Opening images in Photoshop for counting cells from triple staining 
experiments. 
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The images were kept at a constant size and the cells within the first image marked 





Figure 2.9. Marking the first layer of stained cells. Cells labelled with the green tyramide 
signal were marked in white (arrow) using the paint function. 
 
This layer was then duplicated onto the next image (Figure 2.10). A new layer was 
then created and the co-stained cells were marked with the paint function using a 
different colour to the first mark. The remaining single stained cells could then be 
marked on a further layer. In order to visualise the cells beneath the superimposed 
layers, the hide layers function could be turned on and off as the cells were counted. 
The cells were counted manually. This process could be repeated to duplicate marks 
onto a third layer. 
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Figure 2.10. Duplication of the paint marks from one image onto the subsequent layer. 
The white paint marks (arrow) are duplicated from the green image to the red image. 
 
Using this technique it was possible to count all the combinations of single, double 
and triple stained cells. In addition, the presence of nuclei could be established by 
superimposing layers onto the DAPI image in order to confirm the presence of a 
nucleus in situations where a cell was negative for staining with a nuclear marker 
and thus rule out ‘false negatives’. Statistical analysis was performed with a 
students t-test using Graphpad Prism 5 software. A p-value of <0.05 was considered 
significant. 
 
2.13. Western immunoblotting 
 
2.13.1. Protein extraction and quantification 
Frozen testis tissue from human fetuses and marmoset (neonatal to adult), were 
used for protein extraction. Fat and ductal tissues were removed from the testis and 
the tissue was cut into small pieces and placed into Eppendorf tubes containing 
200l RIPA buffer. Samples were then homogenised and incubated on ice for 1 hour 
before being centrifuged (2500rpm) for 10 minutes at 4 oC. The supernatant was 
removed. 
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Protein quantification was performed using the Biorad assay (Bio-Rad, California, 
US) to compare the protein content of the samples to those of known concentrations 
of BSA. Standards of BSA in RIPA buffer were prepared in concentrations ranging 
from 0.125mg/ml to 1.5mg/ml. 20l of Solution S was added to 1ml Buffer A. 
Aliquots of 25l of this solution were then added to the wells of a clear 96 well plate. 
To these wells, 5l aliquots of the protein/standard were added in duplicate. Finally 
200l of Reagent B was added to the wells. The samples were left to incubate for 15 
minutes at room temperature. A blue colour was produced by the reduction of the 
folin reagent by the protein, which had initially reacted with copper. The intensity 
of the colour was determined using a Labsystems Multiskan EX plate reader (VWR) 
at 698nm. A standard curve was generated from the readings for the standards 
using Microsoft Excel and the volume required to obtain 10g protein was 
calculated. 
 
2.13.2. Gel Electrophoresis and Transfer 
Samples were prepared by adding 2.5l 4x NuPAGE LDS Sample Buffer to 1l of 
10x NuPAGE Reducing Agent (both Invitrogen, California, US). The appropriate 
volume of sample for 10l protein was then added and each vial was made up to a 
total of 10l with deionised water. The samples were then heated at 70oC for 10 
minutes before being transferred to ice. A 10% NuPAGE Bis-Tris gel (Invitrogen) 
was loaded into a Novex Mini-cell gel tank (Invitrogen) containing 1x NuPAGE 
MOPS SDS running buffer (Invitrogen)  and samples were loaded along with 5l 
SeeBlue Plus2 pre-stained standard (Invitrogen), in a parallel lane. The gel was run 
at 200V for 50 minutes. The gel was removed from the tank and transferred to a 
nitrocellulose imobilin FP membrane (Millipore) pre-soaked in methanol. Successive 
layers of scourers x2, Whatman 3MM paper x3 (Whatman, Brentford, UK), gel, 
membrane, Whatman paper x3, scourers x2 were loaded into a cassette and placed 
into a Hoefer TE-22 transfer tank (Amersham Biosciences, San Fransisco, US) filled 
with 1x transfer buffer (Invitrogen) and run at 20V overnight. 
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2.13.3. Immunoblotting 
The membrane was removed and washed twice in PBS for 5 minutes each. The 
membrane was then blocked in Odyssey blocking buffer (LI-COR Biosciences, 
Cambridge, UK): PBS (1:1), for 1 hour. The membrane was incubated with the 
primary antibody (Table 2.5) and a loading control (-tubulin) diluted in blocking 
buffer/PBS containing 0.1% Tween, for 1 hour. This was followed by four washes in 
PBS Tween (0.1%) for 5 minutes each. The membranes were then incubated with 
secondary antibodies diluted 1:10000 in Odyssey blocking buffer/PBS containing 
0.1% Tween, for 1 hour. Details of the secondary antibodies can be seen in Table 2.5. 
A further 4 washes in PBS Tween (0.1%) for five minutes each followed before 
fluorescent images were obtained. Images were scanned using the Licor Odyssey 
system and software (LI-COR Biosciences).   
 










VASA Rabbit Abcam 1:500 Goat anti-rabbit Rockland 
USA 
800nm 






PLAP Rabbit Abcam 1:500 Goat anti-rabbit Rockland 
USA 
800nm 
-tubulin Mouse Sigma 1:1000 Goat anti-mouse Molecular 
Probes 
680nm 
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2.14. Commonly Used solutions 
 
Citrate buffer 
 42.02g Citric acid monohydrate 
 1900ml Distilled H2O 
 Adjust pH to 6.0 with NaOH 
 
Fast Blue Buffer 
 12.1g Tris 
 950ml Distilled H2O 
 Make up to 1L at pH 8.2 with HCl  
 Take 98ml of solution from above, add 
 20mg Napthol AS-MX phosphate 
 2ml Dimethyl formamide 
 
Scott’s Tap water    
 10g Potassium chloride  
 100g Magnesium sulphate  
 Tap water 5L 
 
RIPA buffer 
 25mM tris 
 1% triton 
 0.05% sodium deoxycholate 
 0.1% SDS 
 150mM NaCl 
 
Tris-Acetate (TE) Buffer 
 242g Tris base 
 57.1ml Acetic acid 
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 100ml 0.5M EDTA 
 Adjust pH to 8.5 
 
Tris-buffered Saline (TBS) 
 60.5g Tris base 
 87.6g NaCl 
 300mls HCl 
 Adjust pH to 7.4 with HCl 
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3.1.1. Carcinoma in situ as the precursor lesion for TGCT 
It has been known for some years that the precursor cells that ultimately lead to a 
TGCT are the CIS cells (Skakkebaek, 1972b). This hypothesis is supported by the 
temporal relationship between CIS and TGCT in addition to the shared features 
between the two (1.21.3). CIS is present in biopsies of the testis of patients who 
subsequently develop a TGCT and eventually all patients with CIS will develop a 
TGCT (Oosterhuis and Looijenga, 2005). 
 
3.1.2. The origin of CIS cells from fetal germ cells 
CIS cells are thought to be present in the testis from fetal life and have been 
hypothesised to arise from abnormally differentiated gonocytes (Skakkebaek et al., 
1987). This is supported by the fact that CIS cells have a similar morphological 
appearance to fetal gonocytes. Both cells are relatively large compared to 
spermatogonia and have abundant clear cytoplasm. CIS cells also express of a 
variety of proteins that are involved in pluripotency and early germ cell fate, such as 
PLAP (Jorgensen et al., 1995);(Hustin et al., 1987) and OCT4 (Jones et al., 
2004);(Rajpert-De Meyts et al., 2004);(Looijenga et al., 2003a). Germ cell specific 
proteins that are expressed in germ cells during fetal life, such as VASA are also 
expressed in CIS cells (Castrillon et al., 2000);(Zeeman et al., 2002). The precise 
period for germ cells to transform into CIS cells remains uncertain and indeed may 
occur at different stages of fetal germ cell development (Rajpert-De Meyts et al., 
1998). 
 
3.1.3. Heterogeneity of CIS cells 
It is reported that all CIS cells express OCT4 (Looijenga et al., 2003a). Expression 
persists in seminoma and embryonal carcinoma before being downregulated upon 
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differentiation of embryonal carcinoma to a non-seminoma (Oosterhuis and 
Looijenga, 2005). Other proteins are expressed in CIS cells, however it has been 
noted that there exists a heterogeneity of expression of many of these proteins. 
Whilst PLAP is described as being present in 83-99% of CIS cells, other proteins 
(TRA-1-60, VASA and MAGE-A4) are expressed in a more heterogeneous manner 
(Rajpert-De Meyts, 2006). Despite the knowledge that this heterogeneity exists, the 
relationship between cells of different phenotypes and their malignant and 
proliferative potential has not been extensively investigated. 
 
3.1.4. Proliferation in CIS cells 
CIS cells have a high rate of mitotic divisions (Skakkebaek, 1972b). The majority of 
sections from patients with TGCT contain CIS cells that express Ki67 and this is the 
case for both seminoma and non-seminoma (Datta et al., 2000), however no 
indication of other phenotypic characteristics of the Ki67 positive CIS cells have 
been described.  
 
3.1.5. Sertoli cell development and relationship to CIS development 
A close relationship exists between the Sertoli cell and the germ cells within the 
normal testis (1.19). Studies have investigated the relationship between CIS cells and 
their associated Sertoli cells within the testes of patients with TGCT (Brehm and 
Steger, 2005);(Brehm et al., 2006);(Rajpert-De Meyts and Skakkebaek, 1992). 
Cytokeratin 18 (Ck18) is expressed by the Sertoli cells of the human fetal testis and 
downregulated in early postnatal life and is not expressed in the normal adult testis 
(Brehm et al., 2006);(Stosiek et al., 1990). In adults, expression of Ck18 has been 
described in the tubules containing CIS (Brehm and Steger, 2005). AMH is expressed 
in the seminiferous tubules of the testis from fetal life until puberty, when it is 
downregulated (Brehm et al., 2006). Androgen receptor expression is present in the 
Sertoli cells in the tubules  of normal adult testes (Brehm et al., 2006) and CIS 
containing tubules (Rajpert-De Meyts and Skakkebaek, 1992). The relationship 
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between the differentiation status of the Sertoli cells and the phenotype of the 
associated CIS cells remains to be established. 
3.2. Chapter aims 
This chapter aimed to further characterise the CIS cell in terms of expression of 
common markers of fetal germ cells, and to identify subpopulations of CIS cells that 
may provide insight into the cell of origin. An additional aim was to investigate the 
relationship between these CIS subpopulations and their proliferation status, as well 
as the functional development of their associated Sertoli cells. 
 
3.3. Materials and methods 
 
3.3.1. Human testicular germ cell tumour tissue 
Tissue from patients with testicular germ cell tumours was obtained as described in 
section 2.1.2.  A minimum of three pre-invasive CIS, seminoma and teratoma 
samples were investigated for each experiment. 
 
3.3.2. Human fetal testis tissue collection 
Human fetal testis tissue for use in immunohistochemical studies and Western blots 
were obtained as described in Section 2.4.2. The sections used were from 14 - 19 
week gestation fetuses. 
 
3.3.3. Haematoxylin and eosin staining 
The method for haematoxylin and eosin staining is described in section 2.9 
 
3.3.4. Immunohistochemistry 
Single immunohistochemistry was performed with DAB detection as described in 
section 2.10.2. The primary antibodies used for these experiments are listed in Table 
2.1. Double staining was performed with DAB and fast blue detection as outlined in 
section 2.10.3. Details of conditions for double staining experiments can be found in 
Table 2.2. 
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3.3.5. Immunofluorescence 
Double immunofluorescence was performed as described in section 2.11.1. The 
primary and secondary antibodies, and detection labels used for these experiments 
are listed in Table 2.3. Triple immunofluorescence was performed as described in 
section 2.11.2. The primary and secondary antibodies, and detection labels used for 
these experiments are listed in Table 2.4. 
 
3.3.6. Quantification of CIS subpopulations and proliferation  
Quantification of subpopulations of CIS cells in double stained cells is described in 
section 2.12.1. Sections of pre-invasive CIS, seminoma and teratoma were randomly 
chosen (n=3). The proportion of germ cells expressing the various combinations of 
markers was calculated by dividing the number of CIS cells with an individual 
expression profile by the total CIS cells, for a minimum of 40 random fields. 
Statistical analysis was performed using a one-way analysis of variance (ANOVA).  
 
Quantification of triple stained immunofluorescent sections was performed as 
described in section 2.12.2.2. Sections of pre-invasive CIS, seminoma and teratoma 
were randomly chosen (n=3). The proportion of germ cells expressing the different 
combinations of markers was calculated as described above and a proliferation 
index for each subpopulation was calculated by dividing the number of 
proliferating (Ki67 positive) cells by the total number of cells within that 
subpopulation. Statistical analysis was performed using the unpaired students t test.  
 
3.3.7. Western blotting 
Fetal testis tissue was obtained for Western analysis as described in section 2.13.1. 
Details of the protein extraction, quantification and Western blotting procedure can 
be found in section 2.13. Details of the primary antibodies used are found in Table 
2.5. 
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3.4. Results 
 
3.4.1. Histology of seminiferous tubules containing CIS and normal 
spermatogenesis in adults with TGCT 
Patients with TGCT display a variety of tubule types within the testis (Fig. 3.1). 
Some areas of the affected testis may contain tubules that have active 
spermatogenesis and appear histologically normal, whilst other tubules will contain 
the tumour precursor CIS cells. These cells have a characteristic appearance and line 
the basement membrane of the tubules. They contain a large amount of clear 
glycogen rich cytoplasm. These CIS cells can develop into either a seminoma or a 
non-seminoma (including teratoma) and some are mixed tumours containing both 
types within the same testis of an individual patient. 
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Figure 3.1. H+E. Sections taken from adult patients with TGCT. The affected testis may 
contain tubules with normal appearance of spermatogenesis and tubules with CIS (upper 
panels). CIS cells may develop into malignant tumours of either the seminoma (lower left) or 
non-seminoma (e.g. teratoma, lower right) types. Scale bar - 50m. 
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3.4.2. Expression of pluripotency and PGC proteins in CIS and human 
fetal testis 
Consistent with reports in the literature, we were able to confirm expression of 
proteins associated with pluripotency and undifferentiated germ cells in fetal germ 
cells are also expressed in CIS cells. These include OCT4, NANOG, AP-2 and PLAP 
(Fig. 3.2).  
 
 
Figure 3.2. Expression of OCT4, NANOG, AP-2 and PLAP in tubules containing CIS, 
from adult patients with TGCT. The same proteins can be identified in sections from TGCT 
(left panels) as are found in human fetal testes (right panels). In tubules with normal 
spermatogenesis there is no expression of these proteins (*). Scale bar - 50m.   
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3.4.3. Expression of differentiating germ cell proteins in CIS and normal 
testis 
In patients with a TGCT, VASA, MAGE-A4 and NANOS-1 are expressed in a 
proportion of cells within a CIS containing tubule. However there are cells within 
these tubules that have the phenotypic appearance of CIS cells, which are negative 
for these markers (Fig. 3.3). These proteins are also expressed in germ cells of 
tubules that contain active spermatogenesis in patients with a TGCT (Fig. 3.3).  
 
 
Figure 3.3. Expression of VASA, MAGE-A4 and NANOS-1 in CIS containing tubules 
from adult patients with TGCT. Cells resembling CIS cells can be identified that are 
positive (arrows) or negative (arrowheads) for these proteins. In tubules with active 
spermatogenesis there is expression of these proteins in normal germ cells (*). Scale bar - 
50m.    
 
The antibodies for VASA and PLAP were tested on tissue from fetal human testes in 
order to show their specificity for the protein of interest. For VASA a single band of 
67 KDa was obtained. PLAP was detected as a band at 58 KDa (Fig. 3.4). 
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Figure 3.4. Western blots for VASA and PLAP in human fetal testes. -tubulin (51 KDa) 
was used as a loading control. Black arrows represent bands at the expected MW for the 
expected proteins. M = molecular weight marker, N = negative, w = weeks. 
3.4.4. Co-expression of early germ cell markers in tubules containing 
CIS cells 
Fluorescent immunohistochemistry revealed that OCT4 and AP-2 were co-
expressed in the nuclei of the majority of germ cells in CIS containing tubules (Fig. 
3.5a). NANOG and OCT4 were also expressed in the nucleus of the majority of 
germ cells within CIS containing tubules (Fig. 3.5b), although a few germ cells were 
OCT4+/NANOG-, whilst there were also occasional cells that were OCT4-/NANOG+. 
A similar pattern of expression was demonstrated by double staining of OCT4 and 
PLAP (Fig. 3.5c). In the CIS containing tubules most of the germ cells co-expressed 
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OCT4 and PLAP. There were also some germ cells that were OCT4+/PLAP-. These 
two populations can also be identified in the germ cells of the human fetal testis 
(Fig. 3.5d). However there were germ cells that were OCT4-/PLAP+ (Fig. 3.5c) in the 




Figure 3.5. Co-expression of classical markers of CIS cells and gonocytes. OCT4 (red), 
AP-2 (a; green), NANOG (b; green) and PLAP (c; green) in CIS containing tubules from 









 (c; arrowhead). (d) Co-expression of OCT4 and 




 cells are not present.  
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3.4.5. Identification of CIS cells based on the expression of germ cell 
proteins 
In an attempt to distinguish CIS cells from normal germ cells, double staining for 
‘classical’ CIS proteins (OCT4, AP-2, PLAP and NANOG) with proteins considered 
characteristic of differentiating germ cells (VASA, MAGE-A4 and NANOS-1) was 
undertaken. Tubules containing CIS cells had germ cells with variable phenotypes 
(Fig. 3.6). The majority of the germ cells expressed markers such as OCT4, which 
would be consistent with a CIS phenotype. Some of the cells co-expressed OCT4 
with either VASA or MAGE-A4. The fact that they expressed OCT4 suggests that 
these are also CIS cells. However the majority of the cells that expressed VASA or 
MAGE-A4 were immunonegative for OCT4, which suggests that they may not be 
CIS cells but may be ‘normal’ germ cells within CIS containing tubules. 
 
 
Figure 3.6. Co-expression of OCT4 and the germ cell specific proteins VASA and 
MAGE-A4 in sections from adult patients with TGCT. OCT4 (brown) and VASA or 
MAGE-A4 (both blue) were expressed in germ cells within CIS containing tubules. Cells 
resembling CIS cells can be identified that are positive for OCT4 alone (arrowheads) or both 
markers (arrows). Note the variation in expression patterns between tubules. Magnification 
x20 (upper panels) and x40 (lower panels). Scale bar - 50m.   
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A similar expression pattern could be seen with double fluorescent staining of AP-
2 and VASA (Fig. 3.7). In tubules with a complement of normal germ cells,  
expression of VASA was detected but no AP-2 positive cells were present (Fig. 
3.7a). In tubules containing a mixture of germ cells with either CIS or normal 
phenotypes, the putative CIS cells (located on the basement membrane) expressed 
AP-2 and a small proportion of these cells also co-expressed VASA (Fig. 3.7b). 
Putative ‘normal’ germ cells (located nearer the lumen) expressed VASA only and 
were immunonegative for AP-2. Different populations of germ cells as determined 
by their patterns of expression of AP-2, OCT4 and VASA were also identified 
within the tubules of the normal human fetal testis. 
 
 
Figure 3.7. Expression of AP-2 and VASA in CIS containing tubules from adult 
patients with TGCT. a) Tubule with normal spermatogenesis contains cells expressing 
VASA (green) only. b) Tubule with a mixture of cells expressing AP-2 (red), AP-2/VASA 
(arrow, putative CIS cells) or VASA (arrowhead, putative ‘normal’ germ cells). c) Tubule with 
typical appearance of CIS with AP-2, (putative CIS cells) or VASA (putative ‘normal’ germ 
cells) located along the basement membrane. Sections counterstained with TO-PRO-3 
(blue).  
 
In the current study, NANOS-1 was detected in germ cells in tubules with active 
spermatogenesis, whilst AP-2 was not present in these cells (Fig. 3.8a). In tubules 
containing CIS cells, NANOS-1 and AP-2 were expressed in separate populations 
of germ cells with no co-localisation (Fig. 3.8b,c). This is in contrast to the results 
obtained when sections were co-stained for AP-2 and VASA when both markers 
were co-localised in some germ cells (Fig. 3.7). 
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Figure 3.8. Expression of AP-2  and NANOS-1 in CIS containing tubules from adult 
patients with TGCT. a) Tubule with normal spermatogenesis contains cells expressing 
NANOS-1 (green) only. b) Tubule with a mixture of cells expressing AP-2 (red; putative CIS 
cells) or NANOS-1 (putative ‘normal’ germ cells). c) Tubule with typical appearance of CIS 
with AP-2, (putative CIS cells) located on the basement membrane or NANOS-1 (putative 
‘normal’ germ cells) located on the luminal side of the AP-2. Note that co-localised cells are 
not identified in CIS tubules. Sections counterstained with TO-PRO-3 (blue).  
 
3.4.6. The expression of germ cell proteins in putative CIS cells that do 
not express classical CIS markers 
In order to further characterise cells those germ cells within CIS tubules that express 
VASA, but do not express OCT4, triple fluorescent staining was performed for 
VASA, OCT4 and PLAP (Fig. 3.9). In tubules containing CIS cells the majority of 
cells expressed OCT4 and most of these were co-stained with PLAP. A small 
proportion of germ cells expressed VASA only. However there was also a 
population of germ cells that expressed VASA and PLAP, but did not express 
OCT4, suggesting that some of the VASA+/OCT- cells may also represent CIS cells 
(VASA+/OCT-/PLAP+). Cells with a VASA+/OCT-/PLAP- phenotype are likely to be 
‘normal’ germ cells within these tubules. The expression profiles described for 
tubules from adults with TGCT are similar to those seen in normal human fetal 
germ cells (Fig. 3.10). During the second trimester the majority of the germ cells 
express OCT4. Some of these germ cells co-express OCT4 with PLAP. However 
there is not a population of cells that express PLAP with VASA, as described for a 
subpopulation of cells within CIS tubules (Fig. 3.9), consistent with the impression 
that these VASA+/OCT-/PLAP+ cells are not ‘normal’ germ cells. 




Figure 3.9. Expression of OCT4, PLAP and VASA  in CIS containing tubules from a 
patient with a TGCT. Most of the cells co-express OCT4 (red) and PLAP (green). Some of 
the cells express VASA (blue; arrow) or VASA/PLAP (arrowhead), but remain negative for 
OCT4. Sections counterstained with DAPI (cyan).  




Figure 3.10. Expression of OCT4, PLAP and VASA in a 14 week human fetal testis. 
Most of the germ cells express OCT4 (red). Some of the cells express OCT4 and PLAP 
(green; arrow). None of the VASA positive cells (blue; arrowhead) expressed PLAP. 
Sections counterstained with DAPI (cyan).  
 
3.4.7. Distinguishing between CIS cells and normal germ cells based on 
expression of a single marker 
In order to distinguish between CIS cells and normal germ cells within CIS 
containing tubules, OCT4, PLAP and MAGE-A4 co-localisation was performed (Fig. 
3.11). The majority of germ cells within CIS containing tubules expressed PLAP and 
OCT4. Germ cells that contained either or both of these markers were negative for 
MAGE-A4. MAGE-A4 was expressed in a small proportion of germ cells within 
these tubules and these could be regarded as normal germ cells retained within these 
CIS containing tubules.  
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Figure 3.11. Expression of OCT4, PLAP and MAGE-A4 in tubules containing CIS from 
a patient with a TGCT. Most of the cells co-express OCT4 (red) and PLAP (green). Some of 
the cells express MAGE-A4 (blue; arrow) but remain negative for OCT4 and PLAP. Sections 
counterstained with DAPI (cyan).  
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Some rare germ cells expressed MAGE-A4 in combination with either PLAP or 
OCT4 (Fig. 3.12). Therefore although MAGE-A4 is mainly restricted to cells that do 





3.4.8. Subpopulations of CIS cells according to the expression of germ 
cell proteins and relationship with tumour type 
The proportions of CIS cells with different phenotypes were quantified based on the 
expression of OCT4/PLAP/MAGE-A4 (Fig. 3.13). Only cells that expressed OCT4 or 
PLAP with typical morphological appearance of CIS cells were included to avoid 
counting normal germ cells within the CIS containing tubules. There was a 
significantly larger population of OCT4/PLAP CIS cells compared to CIS cells 
positive for either OCT4 or PLAP alone. These single stained cells were also 
significantly more frequent than any of the populations that expressed MAGE-A4. 
 
 
Figure 3.12. Co-expression of OCT4, 
PLAP and MAGE-A4 in CIS containing 
tubules from a patient with a TGCT. 
OCT4 (red) and MAGE-A4 (blue) are co-
expressed (arrow) in some of the germ 
cells that do not express PLAP (green). 
Chapter 3 The origins of CIS and TGCT in the human testis 123 
 
OCT4 + - + + + - 
PLAP - + + + - + 
MAGE-A4 - - - + + + 
 
Figure 3.13. Quantification of subpopulations of CIS cells based on the expression of 
OCT4, PLAP and MAGE-A4. Groups without letters in common are significantly different 
from each other. Mean ± sem for n=9 (3 seminoma, 3 non-seminoma, 3 pre-invasive CIS), 
p<0.05. 
 
We quantified the frequency of CIS subpopulations in the different tumour types 
(pre-invasive CIS, seminoma and non-seminoma). In all tumour types the most 
common phenotype was OCT4+/PLAP+/MAGE-A4-. This profile was present in 
between 65 and 71% of CIS cells, whilst cells stained with either OCT4 or PLAP 
alone accounted for less than 25% of CIS cells in each group. CIS cells expressing 
MAGE-A4 were rare, accounting for less than 3% of cells in the pre-invasive and 
teratoma testis. Seminomas demonstrated a higher proportion of MAGE-A4 
expressing cells than the other two groups with 14% of cells positive (Fig. 3.14). No 
statistically significant differences were observed for the expression of any of the 
subpopulations between the different tumour types. 
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OCT4 + - + + - + 
PLAP - + + - + + 
MAGE-A4 - - - + + + 
 
 
Figure 3.14. Quantification of CIS subpopulations based on expression of 
differentiation markers. a) Overview of quantification of subpopulations of CIS cells and 
comparison between tumour types. No significant differences are seen between tumour 
types for all subpopulations. Mean ± sem for n=3, p>0.05. b) quantification of subpopulations 
of CIS cells and comparison between tumour types. No significant differences are seen 
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Overall, the proportion of CIS cells expressing MAGE-A4 was highest in the 
seminoma samples with a lower proportion in the teratoma samples (Fig. 3.15). 
Interestingly, the pre-invasive samples had almost no expression of MAGE-A4. 
 
Figure 3.15. Quantification of MAGE-A4 expression in CIS cells and comparison 
between tumour types. No significant differences were seen between tumour types. Mean 
± sem for n=3, p>0.05. 
 
3.4.9. Comparison of differentiation status in CIS cells using two 
different methods 
In order to compare the effectiveness of the different techniques employed in these 
studies, quantification of OCT4+/MAGE-A4- and OCT4+/MAGE-A4+ CIS cells was 
performed on sections stained by either immunohistochemistry (IHC) or 
immunofluorescence (IF). The quantification of the two subpopulations was 
comparable using both techniques. MAGE-A4 expressing cells represented a mean 
of 4% of CIS cells for IHC compared to 12% of total CIS cells for IF (Fig. 3.16). 
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Figure 3.16. Comparison of immunohistochemistry and immunofluorescence for 
OCT4 v OCT4/MAGE-A4 expression in CIS cells. n=6 (3 seminoma, 3 teratoma) for each 
method. Mean sem. ***p<0.0001 
 
3.4.10. Expression of proliferation markers in tubules containing CIS  
We investigated the expression of proliferation markers Ki67, HH3 and PCNA in 
CIS tubules (Fig. 3.17). HH3 was expressed in a minority of germ cells within the 
CIS containing tubules, including cells that had the morphological appearance of 
CIS. A similar frequency of expression was also identified in tubules that had active 
spermatogenesis. PCNA was immunolocalised to the majority of the germ cells 
within CIS containing tubules and a large proportion of germ cells in tubules with 
active spermatogenesis, but was not detected in elongate spermatids. Ki67 staining 
was detected in more of the germ cells than HH3 but less than PCNA in both CIS 
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Figure 3.17. Expression of HH3, PCNA and Ki67 in CIS containing tubules and tubules 
exhibiting spermatogenesis with grossly ‘normal’ appearance. Occasional cells are 
positive for HH3 (top panels; black arrows). PCNA (middle panels) negative CIS cells were 
rare (arrowhead). A Ki67 (lower panels) positive germ cell without typical CIS appearance, 
which may represent a differentiating germ cell can also be identified (blue arrow). Original 
magnification x20 (upper panels) and x40 (middle and lower panels). Scale bar - 50m. 
 
3.4.11. Proliferation within subpopulations of CIS cells 
To obtain quantitative data for proliferation in the various subpopulations of CIS 
cells, Ki67 was chosen as the proliferation marker because it is expressed in all cells 
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that are not resting and therefore represented a suitable marker of germ cell 
proliferation (1.15). HH3 only stained a very small number of cells, whilst Ki67 
stained enough cells to allow quantification studies.  PCNA stained almost all the 
cells, which made it unsuitable for quantification studies. Co-staining of MAGE-A4 
and Ki67 in CIS tubules revealed that both MAGE-A4 positive and MAGE-A4 
negative cells may be proliferating. In addition there were also cells that were not 




Figure 3.18. Co-expression of Ki67 and MAGE-A4 in CIS containing tubules. 
Proliferating (KI67, brown) cells may be MAGE-A4 (blue) positive (arrowhead) or MAGE-A4 
negative (arrow). Note that there are also non-proliferating cells that may be either positive 
or negative for MAGE-A4 and that all four types of cell can be identified in the same tubule. 
Scale bar - 50m. 
 
Proliferative activity of CIS cells may reflect their capacity to develop into an 
invasive tumour. Therefore the proliferative activity of the various subpopulations 
of CIS cells was evaluated. Using triple staining for OCT4/MAGE/Ki67, CIS cells 
could be identified by the expression of OCT4 (Fig. 3.19). Within the OCT4 
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expressing cell population there were MAGE-A4 positive and MAGE-A4 negative 
cells. A proportion of both OCT4+/MAGE-A4- and OCT4+/MAGE-A4+ cells were Ki67 




Figure 3.19. Co-expression of Ki67, MAGE-A4 and OCT4 in CIS containing tubules. 
OCT4 (red) positive cells can be considered CIS cells, whilst MAGE-A4 (blue) may represent 




cells can be 








(arrow) cells can be seen in the same tubule. 
 
3.4.12. Variation in proliferation of CIS cells depending on tumour type 
The proportion of CIS cells that were proliferating was calculated for the different 
tumour types, based on the co-expression of OCT4 and Ki67. The proliferation index 
was highest in CIS cells from patients with pre-invasive disease (15%). CIS cells 
within testes from patients with seminoma had a lower proliferation index (12%), 
whilst those patients with teratomas had the lowest proportion of proliferating CIS 
cells (9%). There was no significant difference in proliferation rate between the 
different tumour types (Fig. 3.20). 
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Figure 3.20. Proliferation index for CIS cells in pre-invasive CIS, seminoma and 
teratoma. n=3.  Mean ± sem for n=3, p>0.05. 
 
The proliferation index in the different subpopulations of CIS was also calculated. 
MAGE-A4 expressing CIS cells (OCT4+/MAGE-A4+) had a significantly lower 
proliferation index than the CIS cells that did not express MAGE-A4 
(OCT4+/MAGE-A4-) (Fig. 3.21).  
 
Figure 3.21. Proliferation index for MAGE-A4 expressing CIS cells. Quantification of 
MAGE-A4  expressing CIS cells (OCT4+MAGE-A4) and comparison with CIS cells that do 
not express MAGE-A4 (OCT4). Mean ± sem for n=9. **p<0.01. 
 
When the individual tumour types were analysed the same trend could be seen for 
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proliferation index of the CIS subpopulations only in samples from patients with 




Figure 3.22. Proliferation index for MAGE-A4 expressing CIS cells in individual tumour 









), in individual 
tumour types. Mean ± sem for n=3. **p<0.01. 
 
3.4.13. Sertoli cells within CIS tubules express markers of 
undifferentiated cells  
Sertoli cells in the normal fetal testis are immunopositive when stained with a pan-
cytokeratin antibody. The expression of protein(s) detected by this antibody is lower 
in postnatal testes and Sertoli cells in the adult testis are immunonegative. Therefore 
immunostaning can be used as a marker of undifferentiated Sertoli cells (Fig. 3.23). 
Androgen receptor is immunolocalised to the peritubular myoid and some 
interstitial cells in the fetal testis and this continues into adulthood. Androgen 
receptor was not expressed in the Sertoli cells of the human fetal testis, but it was 
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Figure 3.23. Expression of pan-cytokeratin  and androgen receptor  in fetal and adult 
human testis. Pan-cytokeratin (top panels) is expressed in fetal Sertoli cells, but not those 
of the adult. Androgen receptor (lower panels) is expressed in Sertoli cells of the adult, but 
fetal Sertoli cells are negative for androgen receptor. Scale bar - 50m. 
 
The differentiation status of Sertoli cells was investigated within CIS containing 
tubules, using co-staining for androgen receptor and pan-cytokeratin (Fig. 3.24). 
Androgen receptor was immunolocalised to all the Sertoli cells of CIS tubules, 
however pan-cytokeratin was only detected in a subpopulation of these Sertoli cells. 
The tubules expressing cytokeratin tended to be in regions adjacent to the tumour 
itself, whilst cytokeratin was often not detected in regions distant from the tumour. 
A similar expression pattern was seen for both seminomas and teratomas. 
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Figure 3.24. Co-expression using pan-cytokeratin and androgen receptor antibodies 
on sections of seminiferous tubules from a patient with a TGCT. Strong cytokeratin 
(blue) expression is shown in Sertoli cells in tubules (*) adjacent to the tumour (near), but not 
in those further away the tumour (distant), whilst androgen receptor (brown) is expressed in 
all Sertoli cells. Scale bar - 50m. 
 
3.4.14. The relationship between CIS cells and their associated 
Sertoli cells 
In order to investigate the relationship between the CIS cells and the differentiation 
status of their associated Sertoli cells sections were co-stained for OCT4 and 
cytokeratin (Fig. 3.25). OCT4 expression was seen in most of the cells within tubules 
of both seminoma and teratoma patients, regardless of the distance from the 
tumour. Immunoexpression of Pan-cytokeratin was more frequent in the Sertoli 
cells of CIS tubules adjacent to the tumour. However there was no apparent 
association between the differentiation status of the CIS cells and the Sertoli cells 
that surrounded them, based on detection with the pan-cytokeratin antibody (Fig. 
3.25). 
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Figure 3.25. Co-expression of pan-cytokeratin and OCT4 in CIS tubules from patients 
with TGCT. OCT4 (brown) is expressed in CIS cells regardless of the pan-cytokeratin (blue) 
status of its associated Sertoli cell. Scale bar - 50m. 
 
Immunolocalisation of VASA and pan-cytokeratin also demonstrated that the 
differentiation status of the CIS cells was not associated with the differentiation 
status of the Sertoli cells within a CIS tubule. VASA positive cells were located in 
CIS containing tubules regardless of whether those tubules expressed pan-
cytokeratin (Fig. 3.26) 
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Figure 3.26. Co-expression of pan-cytokeratin and VASA in CIS tubules from a patient 
with a TGCT. Tubules containing VASA positive germ cells (blue) are present (arrowhead), 
as are tubules with pan-cytokeratin only (brown; arrow). Tubules expressing both markers (*) 




3.5.1. Heterogeneous expression of germ cell proteins in CIS 
 
3.5.1.1. CIS cells do not always express classical markers 
OCT4 and PLAP are described as ‘classical’ markers of CIS cells and are routinely 
used for diagnostic purposes for patients at risk of, or with suspected, TGCT 
(Oosterhuis and Looijenga, 2005). PLAP has been reported to be detectable in 83-
99% of CIS specimens, whilst OCT4 is reported to be a sensitive and specific marker 
(Jones et al., 2004), and present in all CIS cells (Oosterhuis and Looijenga, 2005);(van 
Casteren et al., 2008). In addition the expression of NANOG has been reported as 
present in an identical population of germ cells to that of OCT4 (Oosterhuis and 
Looijenga, 2005). The present co-localisation studies demonstrate that most of the 
cells expressing either NANOG or PLAP, also express OCT4. Moreover OCT4 and 
PLAP were co-localised in 68% of CIS cells.  However, surprisingly there was also a 
population of cells with a CIS phenotype that expressed either PLAP or NANOG, 
but were immunonegative OCT4 expression. In the case of the PLAP+/OCT4- 
population this was quantified as representing 18% of the total CIS cells. NANOG 
positive cells that did not express OCT4 were much less frequent. Occasional 
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gonocytes have also been described in the normal human fetal testis that are 
NANOG+/OCT4- (Kerr et al., 2008). In the literature there has been some debate 
about the choice of OCT4 antibody and the specificity of antibodies from different 
sources (Looijenga, 2009). OCT4 expression has been reported in spermatogonia of 
the mouse (Pesce et al., 1998). OCT4 has also been reported to be present in the adult 
stem cell spermatogonia of the human, however these reports may be explained by 
the use of non-specific antibodies (Looijenga, 2009). For example the OCT4 
antibodies used in the present studies were polyclonal goat antibodies directed 
against either the N-terminus or C-terminus of the OCT4 protein and produced the 
same results, with no staining found in normal adult tissues or negative controls. 
The present results demonstrate heterogeneity in expression of markers that are 
considered highly sensitive and specific for CIS cells. This highlights the fact that a 
single marker cannot be used to definitively determine whether an individual cell is 
a CIS cell. This is particularly important for interpretation of studies that rely on 
immunostaining for OCT4 as an indication that a cell is not a CIS cell. In a study of 
non-seminomas a population of cells that are VASA+/OCT4- was described. The 
authors suggested that this population could have arisen as a result of 
differentiation of non-seminoma into germ cells (Honecker et al., 2006). However 
results obtained during the present study would imply that these cells could 
actually be OCT4 negative CIS cells.  
 
3.5.1.2. CIS cells do not always display a differentiation phenotype 
characteristic of fetal germ cells 
CIS cells have been postulated to arise from embryonic germ cells and this is based 
on evidence from a combination of morphological, immunohistochemical and 
genetic studies (Rajpert-De Meyts, 2006);(Looijenga et al., 2007a);(Almstrup et al., 
2004). Expression of proteins implicated in maintenance of pluripotency such as 
NANOG and OCT4, can be demonstrated in human fetal gonocytes (Gaskell et al., 
2004);(Rajpert-De Meyts et al., 2004);(Hart et al., 2005). In addition proteins 
associated with migrating and early fetal germ cells such as AP2 (Hoei-Hansen et 
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al., 2004) and PLAP (Jorgensen et al., 1995);(Gaskell et al., 2004) have also been 
demonstrated in the same cell population. The proportions of germ cells expressing 
these proteins is reduced as gestation progresses and the germ cells differentiate 
(Hoei-Hansen et al., 2005);(Mitchell et al., 2008);(Rajpert-De Meyts, 2006) (Cools et 
al., 2005);(Rajpert-De Meyts et al., 2004).  
 
The same proteins have been described as being frequent markers of CIS cells (Hoei-
Hansen et al., 2004);(Looijenga et al., 2007a);(Jorgensen et al., 1995);(Hart et al., 
2005). However, co-localisation of combinations of these proteins have revealed 
populations of CIS cells that do not express a phenotype that correlates to a 
particular stage of normal fetal germ cell development. For example, PLAP can be 
detected in most of the germ cells in a first trimester fetal testis, but is rare by the 
start of the second trimester (Honecker et al., 2004). OCT4 is also present in most of 
the germ cells of the first trimester, but is downregulated later in gestation in 
comparison to PLAP (Gaskell et al., 2004). The present study has identified OCT4-
/PLAP+ cells with a phenotype characteristic of CIS, which contrasts with reports of 
expression in human fetal testis where PLAP is always co-expressed with OCT4 
(Honecker et al., 2004).   
 
The fact that the majority of CIS cells are immunopositive for proteins that are 
found to be expressed in germ cells in normal human fetal gonads, would support 
the hypothesis that CIS cells originate from human fetal germ cells, however the 
finding of phenotypes that do not occur in the normal human fetal testis suggests 
that some changes in expression occur after transformation has taken place. 
 
3.5.1.3. Distinguishing between normal germ cells and CIS cells within 
the same tubule 
In addition to the proteins that can be detected in PGCs and gonocytes, CIS cells 
have also been reported to express proteins characteristic of more differentiated 
germ cell types such as VASA (Rajpert-De Meyts et al., 2003) and MAGE-A4 (Aubry 
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et al., 2001). These proteins are first expressed in germ cells during fetal life and can 
be detected in an increasing proportion of germ cells within the individual testis 
cords as the cells differentiate (Aubry et al., 2001);(Castrillon et al., 2000);(Gaskell et 
al., 2004). Both proteins are readily detected in postnatal germ cells where MAGE-
A4 expression is present in pre-meiotic cells (Aubry et al., 2001) and VASA is 
detected in both pre and post-meiotic germ cells (Castrillon et al., 2000). 
 
MAGE-A4 (Aubry et al., 2001) and VASA are have also been reported as present in 
a proportion of CIS cells (Rajpert-De Meyts et al., 2003). Because CIS tubules, also 
contain Sertoli cells and may contain germ cells that are not strictly CIS cells, it is not 
possible to say with certainty whether the MAGE-A4 and VASA population 
represent the CIS, non-CIS or both populations. The present study has provided 
novel information of the phenotype of CIS cells based on the use of double and 
triple immunohistochemistry and fluorescence. Co-expression of ‘classical’ CIS 
markers such as OCT4, PLAP and AP2 with markers of differentiated germ cells 
(VASA and MAGE-A4) revealed that there are a proportion of cells that express 
both markers. These are likely to be CIS cells because OCT4, PLAP and AP2 are not 
normally expressed in the adult human testis (Looijenga, 2009);(Hoei-Hansen et al., 
2004);(Giwercman et al., 1991);(Skakkebaek et al., 1987). However MAGE-A4 and 
VASA are only expressed in a small proportion of CIS cells. We have quantified the 
expression of these differentiated germ cell markers in CIS for the first time. MAGE-
A4 is only expressed in 6% of CIS cells and is therefore not a common phenotype for 
CIS cells. Heterogeneous expression of MAGE-A4 in CIS has been described 
previously, however VASA was reported to be expressed in all CIS cells (Rajpert-De 
Meyts, 2006). Our findings appear at odds with this conclusion as VASA expression 
was not found in all CIS cells in the present study and was expressed 
heterogeneously in a similar fashion to MAGE-A4.  
 
In a previous study, co-staining for OCT4 and VASA identified cells that had an 
OCT4- /VASA+ phenotype (Cools et al., 2005). Based on this pattern of staining these 
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cells might have been identified as differentiated germ cells rather than CIS cells, 
however the use of triple co-localisation has revealed that some cells that do not 
express OCT4 may express PLAP and therefore these OCT4-/VASA+ cells can still be 
considered as CIS cells. The present results suggest that only those germ cells that 
are OCT4-/PLAP- represent a ‘differentiated’ germ cell population that have not 
undergone malignant transformation. 
 
3.5.1.4. The frequency of CIS subpopulations varies between pre-
invasive disease, seminoma and teratoma 
The use of tissue from patients who have already developed a TGCT make it 
impossible to determine whether CIS cells arise from different subpopulations of 
fetal germ cells, or alternatively whether there is a common fetal cell of origin and 
subsequent changes in expression occur with CIS cell progression. One approach to 
addressing some of these questions is to use tissue from patients with pre-invasive 
disease. CIS cells are believed to lie dormant within the testis for years during 
childhood before they develop into an invasive tumour (Skakkebaek, 1972b). From 
puberty onwards these cells may transform into either a seminoma or a non-
seminoma. It is unclear as to whether there is a specific difference between the CIS 
cell phenotype in seminoma or non-seminoma. Because seminoma cells have also 
been described as the malignant equivalent of the fetal germ cell, it may be 
hypothesised that MAGE-A4 expression would be higher in the CIS cells that are 
associated with these tumours than in the non-seminomas, in which the malignant 
cells are differentiated somatic and extra-embryonic tissues. A trend towards 
increased MAGE-A4 expression was found in CIS cells from the seminoma patients, 
however the expression was variable between individual patients and the difference 
was not statistically significant. The fact that the CIS cells within the non-seminomas 
all expressed very low levels of MAGE-A4 may point to a requirement of MAGE-A4 
for the formation of a seminoma and this would be supported by the fact that 
seminoma cells variably express MAGE-A4, whilst non-seminomas and the 
preceding embryonal carcinoma stage do not (Rajpert-De Meyts, 2006) (Aubry et al., 
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2001). MAGE-A4 is not expressed in the gonocyte and therefore if seminoma is the 
malignant counterpart of the gonocyte, then MAGE-A4 positive cells within these 
tumours could represent subsequent differentiation of CIS cells, de-differentiation 
of MAGE-A4 expressing spermatogonia, or alternatively the presence of 
‘differentiated’ MAGE-A4 positive germ cells within the tumour. Pre-invasive CIS 
cells also rarely expressed MAGE-A4 in a similar proportion of cells to the non-
seminomas. This again could suggest that the expression of MAGE-A4 could direct 
the CIS cells towards a seminoma. The concept of heterogeneous cell populations 
having a different developmental potential has been suggested for SSC in the mouse 
testis, where a fraction of these cells express OCT4 (Buageaw et al., 2005). However, 
the fact that we have only investigated small numbers of samples and that we 
cannot predict which of the tumour types will result from the pre-invasive samples 
analysed, make it difficult to reach firm conclusions. 
 
3.5.2. Proliferation rate varies between the different CIS subpopulations 
Proliferation is one of the characteristic features of malignant cells. The switch from 
pre-invasive CIS to invasive tumour is thought to result from an increase in 
seminiferous tubule diameter by proliferation of CIS cells (Donner et al., 2004). 
Proliferation in the various stages of TGCT development has been investigated by 
quantifying mitotic frequency. CIS cells are reported to have a mitotic frequency of 
0.65% which increases through intratubular seminoma (0.84%) to seminoma with a 
mitotic frequency of 3.59% (Hofken and Lauke, 1996), suggesting that the cells with 
the highest malignant potential are more proliferative. Interestingly when 
proliferation was investigated in the different tumour types in the present studies, 
the highest rate was found in the CIS cells from the pre-invasive samples. This was 
not entirely expected as the CIS cells are described as being relatively inactive 
during this period.  It was also demonstrated that OCT4+/MAGE-A4- CIS cells had a 
significantly higher expression of Ki67 than the OCT4+/MAGE-A4+ CIS cells, 
suggesting that the MAGE- population of CIS cells are more proliferative. The 
persistent expression of genes such as OCT4, TSPY and CCND2 have previously 
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been implicated in the survival and expansive proliferation of CIS cells (Cools et al., 
2006b);(Rajpert-De Meyts, 2006). This result is also in keeping with a previous report 
that describes increased malignant potential and aggressiveness in OCT4 expressing 
cells in tumours derived from ES cells (Gidekel et al., 2003). In these tumours, co-
localisation of OCT4 with Ki67 showed high proliferative activity in the OCT4 
expressing cells, with no proliferation demonstrated in the OCT4 negative areas 
(Gidekel et al., 2003). Therefore reduced proliferation may be a feature of cells that 
are further down the differentiation pathway from OCT4+/MAGE-A4- cells. This 
concept is supported by the fact that in the normal human fetal testis a significantly 
increased proportion of OCT4+/MAGE-A4- cells express Ki67, compared to the 
MAGE-A4+ population. These results are consistent with a previous study in normal 
human fetal testis that described Ki67 expression in most KIT positive cells, but only 
some of the MAGE-A4 expressing cells (Pauls et al., 2006). These results will be 
discussed in more detail in chapter 5 (Fig. 5.23).  
 
3.5.3. Sertoli cell differentiation status varies within CIS tubules 
 
3.5.3.1. Differentiation status of Sertoli cells is associated with tumour 
proximity  
Sertoli cells located within CIS tubules displayed variable expression of AR and 
cytokeratin proteins used as markers of Sertoli cell maturity. Immunopositive 
staining for cytokeratin was found in some tubules; Sertoli cells expressing this 
marker were often located close to the tumour itself, whilst Sertoli cells in tubules 
further away were frequently immunonegative for this marker. The pan-cytokeratin 
antibody used in this study recognises cytokeratins 1,4,5,6,8,10,13,18, and 19. A 
similar gradient has been described for cytokeratins 8, 18 and 19, with expression 
being more abundant in atrophic tubules adjacent to tumours (Nistal et al., 2006). 
The current study has also discovered tubules with Sertoli cells that are 
immunopositive for cytokeratin and androgen receptor. This would support the 
concept of either a partial differentiation or a partial de-differentiation of Sertoli 
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cells, because cytokeratin 18 expression ceases in late gestation, whilst androgen 
receptor is not expressed until late childhood (Brehm et al., 2006). Partial 
differentiation may have occurred such that androgen receptor is expressed as 
normal, but cytokeratin has been retained from fetal life. Alternatively partial de-
differentiation may have occurred in Sertoli cells that had previously undergone 
differentiation and ceased to express cytokeratin, only to re-express cytokeratin later 
(Fig. 3.27).  Evidence exists to support the concept of de-differentiation of Sertoli 
cells. In rhesus monkeys, cytokeratin 18 expression can be induced in the testis by 
making the adult animal cryptorchid (Zhang et al., 2004) and a similar result is 
obtained by local heating of the testis (Zhang et al., 2006). The re-expression of 
cytokeratin 18 is reversible and expression is gradually reduced with time and 
eventually ceases. Sertoli cells in prepubertal dysgenetic testes, express AMH but 
barely any CK18 (Schreiber et al., 2003). These patients are at high risk of CIS and 
TGCT and therefore the appearance of cytokeratin in CIS containing tubules in these 
patients would indicate that these cells have undergone initial differentiation and 
subsequent de-differentiation to re-express cytokeratin. The finding that cytokeratin 
can still occasionally be found in CIS tubules distant to the tumour itself supports 
the hypothesis that it is a primary event within the Sertoli cells, rather than a 
reactive event (Nistal et al., 2006). It is unclear whether the CIS cells themselves are 
the trigger for this primary failure. 
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Figure 3.27. Expression of cytokeratin and androgen receptor in the normal testis and 
in models of partial differentiation or de-differentiation. In partial differentiation  
androgen receptor (AR) is expressed in a normal fashion but cytokeratin (CK) expression is 
retained. In the partial de-differentiation model loss of CK and expression of AR occurs as in 
the normal testis, but CK is subsequently re-expressed while AR is retained. 
 
3.5.3.2. Differentiation status of Sertoli cells is not associated with that 
of the neighbouring CIS cell 
Sertoli cells play a crucial role in supporting germ cell maturation during 
spermatogenesis. The relationship between the differentiation status of the Sertoli 
cell and that of the associated CIS cell is unclear. This study hypothesised that the 
Sertoli cells expressing markers of de-differentiation are associated with tubules that 
contain CIS cells only, whilst those Sertoli cells that are negative for these markers 
are associated with tubules that contain a mixture of CIS and differentiating germ 
cells. Previous studies have suggested that the presence of differentiating germ cells 
within the CIS tubules prevents the expression of cytokeratin within CIS containing 
tubules (Kliesch et al., 1998) and that cytokeratin 18 expression is only present in 
CIS tubules that do not contain normal germ cells (Brehm and Steger, 2005). 
Chapter 3 The origins of CIS and TGCT in the human testis 144 
However in the present studies no relationship was found between the Sertoli cell 
differentiation status and the CIS/germ cell complement within a tubule. 
Cytokeratin was expressed in CIS tubules containing OCT4 positive, OCT4 negative 
or VASA positive cells. This suggests that the differentiation status of the Sertoli 
cells is not directly related to the differentiation status of the associated CIS/germ 
cells and that this is unlikely to explain the variation in differentiation status of 
Sertoli cells in different regions of the testis. However it was not determined 
whether the VASA positive cells within the tubules are CIS cells or differentiated 
germ cells, given that the present studies have shown that no single marker 
(including OCT4) is expressed by every CIS cell. Communication between Sertoli 
cells and CIS cells has been proposed to have a role in maintaining the latency 
period in CIS cells during childhood and that loss of communication between the 
Sertoli cells or between Sertoli cells and CIS cells may be important for subsequent 
proliferation and invasion of CIS cells in adulthood (Brehm et al., 2002). De-
differentiation of Sertoli cells may be the cause of the loss of intercellular 
communication (Brehm et al., 2002). A loss of intercellular communication has also 
been described in CIS cells (Gondos et al., 1983) and this may also play a role in 
invasive progression.  
 
3.5.4. Conclusion 
This chapter has provided new insight into the phenotype of CIS cells and 
demonstrated that some germ cells with the histological characteristics of CIS cells 
do not appear to express ‘classical’ markers such as OCT4, whilst others do, 
resulting in various subpopulations of CIS cells. Using a panel of antibodies no 
single marker was found to be expressed in all CIS cells. Because of this 
heterogeneity of protein expression, distinguishing between CIS cells and 
differentiated germ cells within a tubule is difficult and requires determination of 
multiple markers. Proliferation occurs at a variable rate in the different CIS 
subpopulations, suggesting that some subpopulations may have an increased 
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tendency to invasive progression. No clear association was seen between the 
differentiation status of the Sertoli cells and their associated CIS cells. This chapter 
has emphasised the importance of correctly establishing the identity of cells within a 
CIS tubule to avoid inaccurate interpretation. The heterogeneity of protein 
expression in CIS cells in patients with TGCT could result from a variable cell of 
origin, or alternatively from subsequent differentiation of CIS cells. A comparable 
animal model of fetal testicular development may provide more insight into the 
origins and progression of CIS. The next chapter will examine the Common 
Marmoset monkey as such a model.  
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4.1.1. The importance of testicular germ cell differentiation 
Male fertility depends on the daily production of millions of sperm, and this is 
dependent upon the continuous, controlled proliferation of spermatogonia.  The 
latter develop from relatively undifferentiated fetal germ cells (gonocytes), a process 
that is initiated in fetal life (Fukuda et al., 1975). If differentiation from a gonocyte to 
a spermatogonium and subsequent progression through meiosis does not occur, 
then this cell cannot contribute to spermatogenesis in adulthood. Failure of normal 
germ cell differentiation results in reduced fertility and may predispose to the 
development of TGCT (Rajpert-De Meyts, 2006). Studies relating to these conditions 
require an understanding of normal reproductive development and this 
understanding can be enhanced by identifying relevant animal models. 
 
4.1.2. Current animal models of early germ cell development 
Rodent studies have provided some insight into the maturation of the germ cell 
lineage in fetal/neonatal life (Wilhelm et al., 2007), but their usefulness is limited as 
there are some fundamental differences in the ‘set-up’ of spermatogenesis between 
rodents and humans. For example, the profile of gonadotrophin secretion is 
different in rodents when compared to humans. In humans there is a neonatal 
period of reproductive hormonal activity (neonatal testosterone rise or ‘mini-
puberty’) (Mann and Fraser, 1996), followed by a period of ‘childhood’ quiescence 
(Kelnar et al., 2002) prior to the onset of puberty. This quiescent period does not 
occur in rodents (Plant, 2006). In addition, compared to the human, rodents exhibit a 
high efficiency of spermatogenesis compared to some primates (Millar et al., 2000) 
and humans (Clermont, 1963). The ‘segmental’ arrangement of spermatogenic 
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stages in the seminiferous tubules of rodents may be associated with more efficient 
spermatogenesis than the ‘mixed’ arrangement in the human. Differentiation of 
gonocytes into spermatogonia occurs during fetal life in both humans and rodents, 
however the process appears less synchronised in the human, with gonocytes still 
detectable in early postnatal life (Hoei-Hansen et al., 2005);(Hoei-Hansen et al., 
2004). The persistence of gonocytes in the postnatal testis in humans may be 
important in the pathogenesis of TGCT (Rajpert-De Meyts et al., 2003) and this may 
partially explain why TGCT have never been observed in rodents. There are also 
differences in the organisation of germ cell proliferation between human and 
rodents. For example, rodents exhibit synchronised cessation of proliferation during 
the perinatal period (Ferrara et al., 2006), which is not apparent in the human 
(Honecker et al., 2004). 
 
4.1.3. The marmoset as a potential animal model of germ cell 
development 
Based on previous studies the Common Marmoset (Callithrix jacchus), a small New 
World primate, could potentially provide a better animal model for human germ 
cell development than rodents. The marmoset has many similarities to the human in 
terms of timing of testis development and function, in addition to the subsequent 
organisation and efficiency of spermatogenesis. This includes the neonatal period of 
reproductive hormonal activity (Kelnar et al., 2002). In adulthood, similar to the 
human, there is a ‘mixed’ organisation of spermatogenic stages within the tubule, in 
contrast to rodents and other primate models in which there is a ‘segmental’ 
organisation of the spermatogenic stages (Sharpe, 1994);(Weinbauer et al., 
2001);(Millar et al., 2000). Additionally, the germ cell to Sertoli cell ratio is low in the 
marmoset, as in the human (Sharpe et al., 2000), indicating low efficiency of 
spermatogenesis when compared with rodents. These similarities led us to consider 
if the marmoset might also be a better model than rodents in terms of perinatal testis 
development and in particular germ cell differentiation and proliferation. 
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4.2. Chapter aims 
This chapter aimed to investigate testicular germ cell development in the fetal and 
postnatal marmoset, with particular emphasis on differentiation and proliferation in 
the fetal and early postnatal period. The chapter also aimed to compare and contrast 
the findings with the human and rodent. 
 
4.3. Materials and Methods 
 
4.3.1. Marmoset tissue collection 
Marmoset testes from fetal (11 weeks, n=1; 14 weeks, n=2; 15 weeks, n=1; 16 weeks, 
n=2; 17 weeks, n=2; 20 weeks, n=2) and postnatal (aged 1 day, 2, 6, 22, 35 or 48 
weeks, adult; n=3 for each age) animals were obtained as described in 2.4.1.  
 
4.3.2. Human fetal testis tissue collection 
Human fetal testis tissue was obtained as described in Section 2.1.1. First trimester 
testes (8-10 weeks, n=4), 2nd trimester (14-19 weeks, n=9), third trimester (27-31 
weeks, n=2) and postnatal (4 weeks – 11 months, n=4) testes were used for these 
experiments. 
 
4.3.3. Rat testis tissue collection 
Testes were obtained from e15.5 and e19.5 rat fetuses as described in 2.4.3. 
 
4.3.4. Haematoxylin and eosin staining 
The method for haematoxylin and eosin staining is described in section 2.9. 
 
4.3.5. Immunohistochemistry 
Single immunohistochemistry was performed with DAB detection as described in 
section 2.10. The primary antibodies used for these experiments are listed in Table 
2.1. Double staining was performed with DAB and fast blue detection as outlined in 
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Double immunofluorescence was performed as described in section 2.11.1. The 
primary and secondary antibodies, and detection labels used for these experiments 
are listed in Table 2.3. 
 
4.3.7. Quantification of germ cell subpopulations and proliferation  
Quantification of proliferating germ cells was calculated for marmoset and human 
testes as described in section 2.12.1. For quantification in fetal samples 
immunohistochemistry for Ki67 was performed as described in section 2.10. The 
fetal germ cells were identified based on morphology and position within the 
seminiferous cords, whilst postnatal germ cells were identified using VASA/Ki67 
co-staining as described in 2.10.3. Sections were counted independently by two 
observers (Myself and Dr Gillian Cowan) to ensure accuracy of germ cell 
identification. Excellent agreement between the two observers was found. The 
proliferation index was calculated by dividing the number of Ki67-positive germ 
cells by the total number of germ cells assessed in thirty randomly selected fields. 
 
4.3.8. Western blotting 
Fetal testis tissue was obtained for Western analysis as described in section 2.13.1. 
Details of the protein extraction, quantification and Western blotting procedure can 
be found in section 2.13. Details of the primary antibodies used are found in Table 
2.5. 
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4.4.1. The reproductive tract of the fetal male marmoset monkey 
The general appearance of the marmoset male fetal reproductive tract can be seen in 
Figure 4.1. During fetal life the testes are intra-abdominal and are situated inferior 
to the kidney. The adrenal glands in the fetal marmoset are large relative to the size 
of the kidney.  
 
 
Figure 4.1. General structure of the 98 day male fetal marmoset reproductive tract. Left 
panel shows the testis (T) position within the abdomen, with the bladder (B) moved laterally 
to expose the testes. Note the large size of the fetal adrenal gland (A) relative to the kidney 
(K). The right panel shows the gross structure and size of the testis (T) and its associated 
mesonephros (M). Note that the markings on the ruler in the right hand panel are 1mm apart. 
 
4.4.2. Localisation of cell types within the fetal marmoset testis  
Testes obtained from fetal marmosets between 11 weeks gestation and term all 
contained well defined testicular cords surrounded by an interstitial compartment 
(Fig. 4.2). The seminiferous cords were composed mostly of Sertoli cells with a few 
germ cells identified within each cord. 
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Figure 4.2. General structure and organisation of the fetal testis in the human and 
marmoset. Germ cells (arrows) are identified within the cords. Scale bar 50m. w=weeks. 
 
Sertoli cells were identified both histologically (small, irregular shaped nuclei) and 
by the cytoplasmic localisation of anti-müllerian hormone (AMH), which was 
expressed in all the testes examined (Fig. 4.3). Germ cells were identified within the 
cords, because the nuclei had a larger diameter than the Sertoli cells, they expressed 
one or more germ cell markers (see below) and they lacked expression of AMH (Fig. 
4.3). Within the interstitium, steroidogenically active Leydig cells were identified by 
expression of 3-HSD (Fig. 4.3).  
 
Figure 4.3. Localisation of cell types within the fetal and early postnatal marmoset 
testis. Immunoexpression of AMH in Sertoli cells within seminiferous cords (upper panels) 
and 3-HSD in Leydig cells in the interstitium (lower panels). In the top panels, the clear, 
unstained cytoplasm surrounds the nuclei of germ cells within seminiferous cords (inset). 
Scale bar 50m. wks=weeks, d=days. 
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Cytokeratins detected with a pan-cytokeratin antibody were detected in the 
cytoplasm of Sertoli cells in fetal testes of both marmoset and human (Fig. 4.4). The 
peritubular myoid cells of both species were immunopositive for nuclear androgen 
receptor (Fig. 4.4). In addition there is expression of androgen receptor in a 
proportion of the interstitial cells, whilst Sertoli cells were immunonegative.  
 
 
Figure 4.4. Immunoexpression of pan-cytokeratin and androgen receptor in fetal 
marmoset and fetal human testis. Pan-cytokeratin (left panels) is expressed in Sertoli cells 
and androgen receptor (right panels) is expressed in peritubular myoid and some interstitial 
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4.4.3. Germ cell differentiation in the marmoset and human 
 
4.4.3.1. Expression of markers of pluripotency and early germ cell 
differentiation in fetal life 
In the marmoset expression of AP-2, NANOG and OCT4 was germ cell specific and 
was detected in a decreasing proportion of the total germ cell population during 
progression through fetal life into the early postnatal period (Fig. 4.5). All three 
proteins were expressed in the majority of germ cells at 14 weeks’ gestation, but by 
the end of pregnancy the proteins were only immunolocalised to a small subset of 
germ cells. For NANOG, germ cell expression ceased between 2 and 6 weeks of 
postnatal age, whilst OCT4 and AP-2 expression persisted in a few, scattered germ 
cells at 6 weeks postnatally (Fig. 4.5).  
 
A similar expression pattern was demonstrated in fetal human testes. OCT4 (Fig. 
4.5), NANOG and AP-2 were detected in most testicular germ cells of first trimester 
fetuses (9 weeks) but the proportion of immunopositive germ cells decreased as 
gestation progressed. A few OCT4 positive germ cells were still present at 4 weeks 
postnatally (Fig. 4.5) and occasionally at 6 months after birth (Fig. 4.6) and similar 
results were obtained for AP-2. NANOG was detected in occasional germ cells at 4 
weeks of postnatal age but not in tissue from older individuals (Fig. 4.5). 
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Figure 4.5. Immunoexpression of gonocyte markers (AP-2, NANOG, OCT4) in the 
marmoset testis and comparison with the human. Note that the proportion of germ cells 
expressing these markers decreases with increasing age and the similar pattern of OCT4 
expression in the marmoset compared to the human. Scale bar 50m. wks=weeks.  
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Figure 4.6. Persistence of OCT4 expression in occasional germ cells in a 6 month 
infant human testes. Note OCT4 (arrow) expression in the 6 month testis, but no 
expression in an 11 month old infant. Scale bar 50m. m=months. 
 
4.4.3.2. Expression of proteins associated with germ cell 
differentiation in perinatal life 
In the marmoset during fetal life there was an increase in the proportion of germ 
cells that were immunopositive for MAGE-A4 and VASA as gestation progressed 
(Fig. 4.7). VASA or MAGE-A4 were expressed within the cytoplasm of a small 
proportion of germ cells by 15 weeks. By birth the majority of germ cells were 
positive for VASA and similar results were obtained for MAGE-A4. By 6 weeks of 
postnatal age only the occasional germ cell remained immunonegative for these 
proteins (Fig. 4.7).  
 
In the human, VASA immunopositive germ cells were first detected in second 
trimester testes, with an increasing proportion of germ cells expressing VASA in the 
third trimester (Fig. 4.7). In the early postnatal period almost every germ cell 
expressed VASA. A similar pattern of expression was also found for MAGE-A4 (Fig. 
4.7). 
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Figure 4.7. Immunoexpression of MAGE-A4 and VASA in the marmoset testis and 
comparison with the human. Note the increasing proportion of germ cells expressing these 
markers in the marmoset and human. wks=weeks Scale bar 50m.  
 
The specificity of the antibody for VASA was tested by Western blotting of fetal 
human and postnatal marmoset testes. For VASA a single band at the expected 
molecular weight of 67 KDa was obtained in fetal human and newborn marmoset 
testes (Fig. 4.8). 
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Figure 4.8. Western blot for VASA in fetal human and neonatal marmoset testes. -
tubulin (51 KDa) was used as a loading control. Arrows indicate the band corresponding to 
the VASA (green) protein at 67KDa. M = molecular weight marker, N = negative control, 
w=weeks, d=days.  
 
4.4.3.3. Co-localisation of germ cell markers in the fetal marmoset, 
human, and rat 
Co-localisation studies were used to investigate the relationship between germ cells 
expressing proteins previously localised to human gonocytes (OCT4, NANOG, AP-
2) and those expressing VASA, MAGE-A4 or NANOS-1. These investigations 
revealed a distinct and only partially overlapping pattern of expression in germ cell 
subpopulations in both the marmoset and human. For example, co-localisation of 
AP-2 with VASA confirmed our earlier findings of a decreasing proportion of AP-
2 positive cells and an increasing proportion of VASA positive cells with increasing 
age (Fig. 4.9). In addition a small proportion of cells were positive for both proteins 
at the same time. Notably, within a single testicular cross section mixed populations 
of germ cells were detected within individual cords, such that a single cord could 
contain AP-2+/VASA-, AP-2+/VASA+ or AP-2-/VASA+ germ cells; this pattern was 
equally evident in the marmoset and human. The existence of seminiferous cords 
containing a germ cell cohort that was predominantly AP-2+/VASA- and those that 
were mostly AP-2-/VASA+ appeared to be separated by a period of several months 
from fetal into early postnatal life, in both the marmoset and the human. Germ cells 
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were not synchronised in their expression of these proteins between or within the 
seminiferous cords of an individual fetus/neonate and there was also some variation 
in the timing of expression between individuals of the same age (Fig. 4.9).  
 
Figure 4.9. Expression of AP-2 and VASA in human and marmoset testis during fetal 
and early postnatal life. Distinction between undifferentiated germ cells expressing AP-2 
(red, nuclear localisation) and differentiated germ cells expressing VASA (green, cytoplasmic 
localisation) can be seen in both human and marmoset. Note that all germ cells are 
visualised with this combination of markers. A small proportion of germ cells co-expressed 
both markers (arrows). Sections counterstained with TO-PRO-3 (blue, nuclear). wks=weeks, 
d=days, m=months. 
 
In the marmoset and human a similar expression profile was demonstrated for 
OCT4 and VASA (Fig. 4.10), with co-localisation of both proteins in a small 
proportion of germ cells, resulting in three different subpopulations, namely 
OCT4+/VASA-, OCT4+/VASA+ and OCT4-/VASA+. However in the fetal rat, there was 
no evidence for an OCT4+/VASA- population of germ cells. Co-localisation of OCT4 
and VASA was detected in all germ cells at e15.5. By e19.5, no germ cells expressed 
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OCT4, but all continued to express VASA. The loss of OCT4 immunoexpression 
appeared to be synchronous in all germ cells in every cord over this relatively 
narrow time period (Fig. 4.10). 
 
Figure 4.10. Comparison of perinatal germ cell differentiation in the marmoset, human 
and rat. Expression of protein markers of undifferentiated (OCT4: red, nuclear localisation) 
and differentiated (VASA: green, cytoplasmic localisation) germ cells. Note that in 
seminiferous cords in both the marmoset and human at each age studied, there is a mixed 
population of germ cells in the human and marmoset, including occasional cells in which the 
markers were co-localised (arrows). In the rat OCT4 is co-expressed with VASA in all germ 
cells at e15.5 but is no longer detected within any of the germ cells at e19.5. wks=weeks.  
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4.4.3.4. Expression of NANOS-1 in the fetal and postnatal marmoset 
and comparison with the human 
In the marmoset at 11 weeks’ gestation none of the germ cells expressed NANOS-1 
(Fig. 4.11). Increasing proportions of germ cells expressed NANOS-1 in the nucleus 
during the final third of gestation and by early postnatal life most of the germ cells 
contained NANOS-1, with localisation of the protein to both the nucleus and peri-
nuclear cytoplasm (Fig. 4.11). Human testes were immunonegative for NANOS-1 in 
the first trimester, but this protein was expressed in the nucleus of germ cells from 
the second trimester onwards with an increasing proportion of germ cells 
expressing this protein as gestation progressed. In postnatal life, NANOS-1 was also 
detected in the peri-nuclear cytoplasm of germ cells. Germ cells immunopositive for 
NANOS-1 also expressed VASA (Fig. 4.11, a). AP-2 and NANOS-1 were not co-
localised (Fig. 4.11, b), which was in contrast to results obtained when co-staining 
for AP-2 and VASA was performed (Fig. 4.9), when a proportion of germ cells were 
found to be immunopositive for both proteins. This suggests that within an 
individual cell, expression of NANOS-1 begins shortly after VASA expression 
begins. 
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Figure 4.11.  Expression of NANOS-1 with VASA and AP-2 in human and marmoset 
testes during fetal and early postnatal life. a) Comparison of the immunoexpression of 
NANOS-1 (red, nuclear and cytoplasmic localisation) and VASA (green, cytoplasmic 
localisation) in germ cells in the testis during fetal and postnatal life in the marmoset (upper 
panels) and human (lower panels) testis. The proteins are expressed in the final third of 
gestation in the marmoset and in the second trimester in the human testis. In postnatal life 
co-localisation in the peri-nuclear region is seen (yellow) in most germ cells. b) 
Immunoexpression of NANOS-1 (green, nuclear localisation) and AP-2 (red, nuclear 
localisation) in the marmoset and human testis for comparison with VASA/AP-2 expression 
(Fig. 4.9). NANOS-1 is expressed in most of the germ cells in the neonatal marmoset (left 
panel) and 31 week gestation human testis (right panel), with the remainder expressing AP-
2. However, in contrast to VASA/AP-2 (Fig. 4.9), no germ cells co-localised NANOS-1 and 
AP-2. All sections counterstained with TO-PRO-3 (blue). wks=weeks, d=days. 
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4.4.3.5. Expression of KIT in the germ cells of the marmoset testis 
from fetal to adult life 
KIT is expressed in gonocytes of the fetal marmoset testis (Fig. 4.12). The proportion 
of cells expressing KIT decreases as the cells differentiate from gonocyte to 
spermatogonia as described for OCT4, AP-2 and NANOG (Fig. 4.5). Co-staining of 
MAGE-A4 and KIT demonstrated that the KIT stained gonocytes were distinct from 
the MAGE-A4 population. The KIT positive gonocytes are located throughout the 
tubules and many are found in a central position within these tubules. In the 
neonatal and early postnatal testis rare KIT+/MAGE-A4- gonocytes persist but these 
cells are absent after 6 weeks of postnatal age. In the juvenile testis after the 
gonocytes have differentiated, KIT expression occurs again in a subset of 
spermatogonia (Fig. 4.12). These spermatogonia are located on the basement 
membrane and in contrast to the gonocytes these cells also express the 
spermatogonial marker MAGE-A4 (Fig. 4.12). 
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Figure 4.12. Expression of KIT and MAGE-A4 in fetal and postnatal germ cells of the 
marmoset testis. KIT (brown) is localised on the membrane of gonocytes (arrows), whilst 
later in postnatal life and into adulthood KIT can be detected in a subset of spermatogonia. 
MAGE-A4 is expressed in spermatogonia that are also immunopositive for KIT (arrowheads), 
but is not expressed in the gonocytes. w=weeks Scale bar = 50m. 
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4.4.3.6. Germ cell differentiation in the pre-pubertal and adult 
marmoset testis 
Following the neonatal period the marmoset enters infancy, then progresses 
through pre-puberty, puberty and adulthood. By the end of infancy the remaining 
gonocytes have differentiated into spermatogonia, which line the basement 
membrane. Sertoli cells separate these germ cells from the luminal surface of the 
tubule. As described previously, these spermatogonia are not immunopositive for 
pluripotency markers such as OCT4 and NANOG. Puberty commences at 
approximately one year in the marmoset, when the process of spermatogenesis 
begins. Expression of proteins such as VASA, MAGE-A4 and NANOS-1 within the 
germ cell population continues throughout this period (Fig. 4.13). VASA is 
expressed in all germ cell types from the end of the neonatal period and into 
puberty and adulthood. Immunoexpression of VASA is intense in the 
spermatogonia, late spermatocytes and spermatids, but is weak in the early 
spermatocytes. VASA can be detected in the cytoplasm of these cells. The pattern of 
expression of NANOS-1 is similar to that of VASA but there is less staining in the 
spermatogonia than with VASA, and NANOS-1 tends to be present in the nucleus 
and perinuclear cytoplasm. MAGE-A4 is expressed of spermatogonia and early 
spermatocytes with less intense staining in the later spermatocytes and spermatids. 
This staining may be detected in either the cytoplasm or nucleus (Fig. 4.13) 
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Figure 4.13. MAGE-A4, VASA and NANOS-1 expression in postnatal germ cells of the 
marmoset. Expression in pre-pubertal (22,35 weeks), pubertal (48 weeks) and adult 
marmoset. MAGE-A4 is mainly expressed in spermatogonia and early spermatocytes, whilst 
VASA and NANOS-1 are expressed in the majority of germ. w=weeks Scale bar = 50m. 
 
4.4.4. Germ cell proliferation in the marmoset and human 
 
4.4.4.1. Germ cell proliferation in the perinatal marmoset, human and 
rat testis 
Immunoexpression of Ki67 was detected in the marmoset testis at all fetal ages 
investigated from 11 weeks’ gestation until birth, with a significant reduction in the 
number of Ki67 positive germ cells during weeks 15-16 (Fig. 4.14). Ki67 positive 
germ cells were also found in postnatal life, although they were less frequent than 
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during the majority of fetal life (Fig. 4.14). In the human fetal testis, germ cell 
proliferation occurred in a relatively high proportion of germ cells in the first and 
second trimester, similar to that seen in the fetal marmoset (Fig. 4.14). The 
proportion of germ cells proliferating in the first trimester was significantly higher 
than in the second trimester (p<0.01). Unfortunately poor preservation of third 
trimester tissue prevented us from accurate determination of the proliferation index. 
  
 
Figure 4.14. Germ cell proliferation in the human and marmoset testis in fetal and 
early postnatal life. a) Germ cell proliferation in the marmoset testis in fetal and early 
postnatal life determined by immunoexpression of Ki67 (brown). Germ cell proliferation 
(arrows) occurs in a proportion of germ cells throughout fetal and postnatal life in the 
marmoset. At all ages a variable proportion of germ cells are not proliferating (arrowheads). 
Note that some Sertoli cells are also proliferating in the sections. Scale bar = 50m. b) 
Proliferation index for germ cells in fetal and postnatal marmoset (left panel) and first and 
second trimester human fetal testes (right panel). Groups labelled with an ‘a’ are significantly 
different from those marked with a ‘b’. ** p<0.01, compared with 1
st
 trimester values. Means 
± sem (n3 for each age). w=weeks, d=days. 
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In both the marmoset and human, proliferation occurred in a proportion of both 
undifferentiated (AP-2 positive, gonocytes) and differentiated (VASA positive 




Figure 4.15. Proliferation of gonocytes in the human and marmoset fetal testis. 
Immunoexpression of Ki67 (green) and AP-2 (red) in fetal marmoset (left panel) and fetal 
human (right panel) testis. Germ cell proliferation occurs in a proportion of undifferentiated 
germ cells (arrows). Note that there are also proliferating germ cells that do not express AP-
2 (arrowhead), which would be expected to express VASA. w=weeks. 
 
In contrast to the situation in the human and marmoset, germ cell proliferation in 
the fetal rat testis ceases completely in late gestation (Fig. 4.16). A large proportion 
of germ cells are proliferating at e15.5, but by e19.5 the germ cells have ceased 
proliferation and remain quiescent until postnatal life. 
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Figure 4.16. Germ cell proliferation in the fetal rat testis. Germ cell proliferation (Ki67; 
arrows) occurs in the majority of germ cells at e15.5 but has ceased completely by e19.5 
when all germ cells are negative for Ki67 (arrowhead). Note that at both ages, some Sertoli 
cells (peripherally located) are immunopositive for Ki67. Scale bar 50m. 
 
4.4.4.2. Germ cell proliferation in the pre-pubertal and adult marmoset 
testis 
In the marmoset, proliferation was noted in a proportion of germ cells at all ages 
studied when sections were co-stained with Ki67 and VASA (Fig. 4.17). Proliferating 
germ cells were more frequent in infancy (2,6 weeks) and puberty/post puberty (48 
weeks, adult), whilst there were fewer co-stained cells during the childhood phase 
(22, 35 weeks). 
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Figure 4.17. Proliferation of germ cells in the postnatal marmoset testis. VASA (blue; 
cytoplasmic) and Ki67 (brown; nuclear) co-staining in postnatal marmoset testes from birth to 
adulthood for use in quantification studies below. Co-stained cells (arrows) represent 
proliferating germ cells. w=weeks. Scale bar = 50m. 
 
The variation in the proliferation index at different ages was quantified (Fig. 4.18) 
and it demonstrated a significant decrease in germ cell proliferation during the 
childhood phase (22,35 weeks), compared to the majority of neonatal and pubertal 
life. 
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Figure 4.18. Quantification of germ cell proliferation in the marmoset testis from birth 
to adulthood. Mean  sem (n3 for each age). Bars with letters in common are not 




4.5.1. The structure and morphology of the fetal marmoset testis is 
similar to the human 
Despite the similarities that exist between the marmoset and the human in terms of 
reproductive biology, little is known about germ cell differentiation and 
proliferation in the marmoset. In particular the development of fetal germ cells in 
the marmoset testis has not been described in detail. In fetal life the testes in both 
the human (Heyns and Hutson, 1995) and marmoset are intra-abdominal. We have 
demonstrated that seminiferous cords are present in the testes of the marmoset at 11 
weeks’ gestation and that there is a similar organisation of the cords compared to 
the human. The general organisation of the cell types within the fetal marmoset 
testis was comparable to that described in the human fetal testis (Wartenberg, 
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1981);(Gaskell et al., 2004). Identification of the particular cell types within the testis 
was possible and this was confirmed by expression of cell specific markers for germ 
cells (VASA), Sertoli cells (AMH), Leydig cells (3-HSD) and peritubular myoid 
cells (SMA).    
 
4.5.2. Differentiation from gonocyte to spermatogonia occurs during 
fetal and early postnatal life in the human and marmoset 
Using a battery of germ cell-specific protein markers the present studies 
demonstrated sequential germ cell differentiation in the marmoset testis, similar to 
that described for the human (Hoei-Hansen et al., 2005{Rajpert-De Meyts, 2004 
#46);(Honecker et al., 2004);(Gaskell et al., 2004);(Anderson et al., 2007). Expression 
of proteins required for pluripotency, such as OCT4 and NANOG (Loh et al., 2006), 
and undifferentiated germ cell (AP-2) proteins were demonstrated in the fetal testis 
of both the human and marmoset. This is consistent with previous reports for the 
fetal human (Gaskell et al., 2004);(Honecker et al., 2004),(Kerr et al., 2008);(Looijenga 
et al., 2003a);(Pauls et al., 2006);(Rajpert-De Meyts et al., 2004), with a decreasing 
proportion of immunopositive germ cells identified as gestation progressed.  
 
Our results, together with previous reports (Rajpert-De Meyts et al., 2004), show 
that OCT4 is still detected in occasional germ cells in the human at 4-6 months 
postnatally, whilst NANOG was no longer detected after 4 weeks. In the marmoset 
the timing of loss of expression of OCT4 occurred between 6 and 14 weeks 
postnatally, whilst NANOG expression ceased by 6 weeks. This is in keeping with 
previous suggestions of down-regulation of NANOG occurring earlier in 
development than OCT4 in human testes (Hoei-Hansen et al., 2005). AP-2 was 
expressed until 4-6 months of age in the human testis, in agreement with previous 
findings (Hoei-Hansen et al., 2004), whilst in the marmoset only occasional germ 
cells expressed this protein by 6 weeks postnatally.  
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Previous studies have described gonocytes being present in the marmoset testis well 
into the juvenile period (Sharpe et al., 2003a);(Chandolia et al., 2006). In these 
studies cells were characterised based on their position and morphology. The 
present studies have demonstrated that expression of proteins considered as 
classical markers of gonocytes are downregulated much earlier in postnatal life than 
previously suspected. This suggests that the germ cells in previous studies are not in 
fact gonocytes but are differentiating germ cells that were located in the centre of 
the tubules rather than adjacent to the basement membrane. In the human it has 
been reported that spermatogonia do not migrate to the basement membrane until 
puberty (Yu et al., 2006) and this may also be the case for the marmoset. 
Identification of central germ cells during the juvenile period as gonocytes is 
therefore probably misleading.  
 
Proteins associated with differentiating germ cells (VASA, MAGE-A4 and NANOS-
1) showed the opposite pattern of expression to those considered characteristic of 
undifferentiated germ cells in both marmoset and human, consistent with previous 
studies in the human fetal testis (Anderson et al., 2007);(Aubry et al., 2001). In the 
human, VASA and MAGE-A4 immunopositive germ cells were detected in second 
trimester testes, with one report of rare MAGE-A4 positive germ cells in the first 
trimester (Gaskell et al., 2004).  An increasing proportion of the germ cells were 
immunopositive for these proteins in the third trimester. In the early postnatal 
period almost every testicular germ cell expressed VASA and MAGE-A4. In the 
marmoset, MAGE-A4 and VASA were initially detected at 14-15 weeks gestation 
and the proportion of positive cells increased as gestation progressed. By 6 weeks of 
postnatal age the majority of germ cells expressed these markers. The increasing 
proportion of germ cells expressing VASA has also been described in the human 
(Anderson et al., 2007).  Other studies have described the frequency of cells 
expressing VASA during fetal life as being constant from the second trimester 
onwards in the human (Honecker et al., 2004), or even reduced from high levels in 
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the second trimester to a stable level around birth (Cools et al., 2006b). However, 
these studies involved counting the total number of positive cells rather than the 
proportion of positive germ cells at each age as in our study. 
 
Based on previous data the OCT4/NANOG/AP-2 expressing germ cells can be 
considered to represent gonocytes, whilst the VASA and MAGE-A4 expressing 
germ cells can be classified as spermatogonia (Gaskell et al., 2004), maturation of the 
latter involves loss of stem cell/embryonic cell characteristics (Honecker et al., 
2004);(Gaskell et al., 2004). The co-stained cells in the marmoset may represent an 
‘intermediate’ population that has been described in the human (Gaskell et al., 
2004);(Fukuda et al., 1975). 
 
VASA and NANOS-1 were mostly co-expressed in the same germ cells. Whilst 
expression of VASA was localised exclusively within the cytoplasm at all ages 
studied, localisation of NANOS-1 expression changed from the nuclear 
compartment in fetal life to being present in both nuclear and peri-nuclear 
cytoplasmic compartments postnatally. This pattern of expression was consistently 
observed in sections taken from both the human and the marmoset. Peri-nuclear 
expression of NANOS-1 has been described previously in adult germ cells of the 
human (Jaruzelska et al., 2003) and mouse (Haraguchi et al., 2003). A similar change 
in localisation within germ cells has been reported for DAZL, this protein was 
detected in the nucleus of first trimester germ cells, but was present in both the 
nucleus and cytoplasm of second trimester germ cells (Anderson et al., 2007). The 
change in cellular localisation of NANOS-1 suggests that this protein may also have 
more than one function during germ cell development.  
 
Chapter 4 The common marmoset as a model for germ cell  
 differentiation and proliferation 
  
174 
4.5.3. The difference in timing of appearance of the germ cell phenotypes 
in the human and marmoset reflects the timing of the stages of fetal 
development 
The timing of expression of the germ cell specific proteins during fetal life in the 
marmoset and human can be considered in relation to the differences in embryology 
between these two species. Although the pattern of expression is similar in the 
marmoset, the decrease in expression of gonocyte markers tends to occur 
comparatively late in gestation compared to the human. VASA immunopositive 
germ cells were detected from 14/20 weeks’ gestation in the marmoset as opposed to 
9-14/40 weeks gestation in the human. Similarly the proportion of germ cells 
expressing OCT4 remained high in the marmoset compared to the human during 
late gestation. A comparison of the timing of perinatal germ cell differentiation in 




Figure 4.19. Comparison of the timing of expression of germ cell proteins during 
perinatal life in the human and marmoset. The width of the bars represent proportions of 
germ cells expressing the protein. F=fetal, w=weeks, m=months. 
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The reason for the differences in timing of the transition from gonocyte to 
spermatogonia is likely to be related to the fact that fetal life in the marmoset is 
characterised by a relatively late implantation and a prolonged embryonic phase 
such that the fetal phase, during which most of the linear growth occurs, begins at 
11/20 weeks gestation (Wistuba et al., 2006), compared to 7/40 weeks in the human 
(Phillips, 1976). This may explain why proteins that are first expressed in the human 
during the early part of the second trimester (e.g. VASA) are not expressed in the 
marmoset until the final third of gestation. 
 
4.5.4. Germ cell differentiation is asynchronous in the marmoset and 
human, resulting in mixed germ cell populations 
The present studies have demonstrated evidence for mixed subpopulations of fetal 
and early postnatal germ cells within individual seminiferous cords of the 
marmoset testis. Co-localisation studies revealed a mixed population of germ cells 
within individual cords, such that a single cord could contain cells expressing an 
undifferentiated germ cell marker only, a differentiating germ cell marker only or 
cells in transition that are expressing both markers. Similar subpopulations have 
also been described in the human for combinations of markers including 
OCT4/VASA (Anderson et al., 2007);(Honecker et al., 2004), OCT4/MAGE-A4 
(Gaskell et al., 2004);(Pauls et al., 2006) and AP-2/MAGE-A4 (Pauls et al., 2006) and 
these subpopulations are associated with morphological changes that occur as 
gonocytes differentiate into spermatogonia (Fukuda et al., 1975). The intra-cordal 
mix of germ cells in varying stages of differentiation in the marmoset and human is 
in marked contrast to the rat, in which all germ cells are synchronised in their 
differentiation.  
 
We would propose that in the marmoset as in the human the OCT4+/VASA- germ 
cells are gonocytes, with OCT4+/VASA+ being intermediate and OCT4-/VASA+ 
representing spermatogonia (Gaskell et al., 2004). The presence of a mixed 
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population of germ cells in the human and marmoset testis is in contrast to the rat. 
In the rat all germ cells appear to be VASA positive on arrival in the developing 
gonad and there is no evidence of an OCT4+/VASA- population even at e13.5 before 
the cords have formed (unpublished observation). This has also been demonstrated 
in the mouse, where VASA is expressed in the germ cells immediately after 
colonisation of the gonad, but not in migratory primordial germ cells (Toyooka et 
al., 2000). In the rat, by e19.5 all of the germ cells in every cord were OCT4 negative 
but continued to express VASA. Indeed, in most germ cells, cessation of OCT4 
expression is complete by as early as e17.5 (Ferrara et al., 2006). The transition from 
gonocyte to spermatogonia occurs over a very short time period in the rat, when 
compared to the human and marmoset in which it takes many months for all the 
cells to differentiate. In the human and marmoset testis this process spans much of 
fetal life and also extends into early postnatal life, as opposed to the rat in which the 
process occurs over a period of 2 days and is confined to a short period of fetal life. 
 
4.5.5. Germ cell proliferation is asynchronous in the marmoset and 
human, resulting in mixed germ cell populations 
In addition to germ cell differentiation, the present studies have also demonstrated 
for the first time that proliferation of germ cells occurs in a variable proportion of 
germ cells in the marmoset during all fetal ages investigated from 11 weeks’ 
gestation until early postnatal life and that this proliferation occurs in a proportion 
of both undifferentiated (AP-2 positive gonocytes) and differentiated (VASA 
positive spermatogonia) germ cells during this period. Proliferation of germ cells 
occurs in the human during the first and second trimester and has been reported to 
continue in the third trimester and into early postnatal life (Honecker et al., 2004), 
similar to the proportions seen in the fetal marmoset. In contrast, the rat exhibits a 
synchronised pattern of germ cell proliferation in which a high proliferation index 
occurs at e15.5 followed by a complete cessation of proliferation for the remainder 
of gestation until postnatal days 4-6 (Ferrara et al., 2006), and a similar period of 
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quiescence also occurs in the mouse (Vergouwen et al., 1991);(Culty, 2009). This 
proliferative quiescence includes the period of differentiation of germ cells from 
gonocyte to spermatogonia. A period when testicular germ cell proliferation has 
ceased has not been found in the marmoset or human and proliferation continues to 
occur during the transition of germ cells from gonocyte to spermatogonia. 
 
4.5.6. Asynchronous development of germ cells may predispose to CIS 
and TGCT 
The apparently gradual and asynchronous differentiation and proliferation of fetal 
germ cells in the marmoset and human is intriguing and may have implications 
regarding the development of CIS and TGCT. It is well recognised that CIS cells (the 
precursor lesion for TGCT), closely resemble human fetal germ cells in terms of both 
morphology (Gondos, 1993) and protein expression, including NANOG, OCT4, AP-
2, VASA and MAGE-A4 (Rajpert-De Meyts, 2006). These expression patterns 
support the hypothesis that CIS cells arise from immature fetal germ cells that fail to 
differentiate completely into normal spermatogonia (Skakkebaek et al., 1987). Germ 
cell differentiation occurs over a prolonged period in humans and this may, given 
the right circumstances, predispose to the development of CIS (Rajpert-De Meyts, 
2006). Indeed in humans with some disorders of sex development  there is evidence 
of delayed germ cell differentiation, based on persistence of OCT4 expression. These 
patients have an increased risk of CIS and TGCT in later life (Cools et al., 2006a). 
The presence of several subpopulations of germ cells at different stages of 
differentiation and proliferation, all exposed to the same local environment within 
the seminiferous cords during fetal or early postnatal life may also increase the 
likelihood of incomplete differentiation of some of the more immature germ cells 
and thus increase the risk of developing CIS. 
 
In humans the development of CIS and TGCT has been proposed to be part of a 
testicular dysgenesis syndrome (TDS) (Skakkebaek et al., 2007). A combination of 
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features similar to human TDS can be induced in the rat using phthalates (Fisher et 
al., 2003), but this does not include the development of CIS or TGCT. This failure to 
induce CIS in the rodent may be related to the way in which the fetal germ cells 
differentiate. If asynchronous and prolonged differentiation, with several 
subpopulations of germ cells co-existing in different stages of differentiation, 
predisposes to malignant transformation in the human (Rajpert-De Meyts, 2006), 
then CIS may also occur spontaneously or be inducible in the marmoset. However 
to date there are no published reports of testicular tumours in this species, which 
could suggest that other predisposing factors may be required.  These factors may 
include exposure to environmental factors such as phthalates.  
 
4.5.7. Postnatal germ cell differentiation and proliferation in the 
marmoset has similarities to the human  
The postnatal marmoset testis continues to express proteins such as VASA, MAGE-
A4 and NANOS-1. The cell types expressing these proteins are identical to those 
described in the human. Expression of VASA is weak in spermatogonia, with strong 
staining in spermatocytes and spermatids in the human adult testis (Castrillon et al., 
2000), which exactly matches the expression seen in the marmoset. Equally, MAGE-
A4 staining has been described to be strong in spermatogonia with faint staining in 
primary spermatocytes and no expression in later spermatocytes and spermatids 
(Aubry et al., 2001), as has been described in the present study for the marmoset 
testis. Importantly, in the context of CIS and TGCT, proteins associated with fetal 
germ cells and CIS (e.g. OCT4, NANOG, PLAP) in the human are not identified in 
germ cells in either normal adult human (Looijenga et al., 2007a) or marmoset testis. 
This means that identification of OCT4 expression beyond the infancy period in 
either human or marmoset testes would indicate delayed differentiation of 
gonocytes or development of CIS (Oosterhuis and Looijenga, 2005);(Cools et al., 
2006b). The cessation of expression of OCT4 that occurs on differentiation from 
gonocyte to spermatogonia in the human and marmoset contrasts with the situation 
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in the prepubertal and adult mouse in which stem cell spermatogonia retain 
expression of Oct4 (Pesce et al., 1998);(Ohbo et al., 2003);(Tadokoro et al., 2002). KIT 
expression is bimodal in germ cells of the marmoset testis. In fetal life KIT is 
expressed in the gonocytes (Robinson et al., 2001) and these cells are distinct from 
the MAGE-A4 expressing differentiating germ cells as has been described in the 
human (Gaskell et al., 2004). As the gonocytes differentiate in fetal and early 
postnatal life the proportion of KIT expressing germ cells decreases, however KIT 
begins to be expressed in the differentiating spermatogonia of the juvenile and adult 
testis. Unlike the gonocyte population these KIT expressing cells co-express MAGE-
A4. This bimodal expression of KIT also occurs in the human (Unni et al., 
2009);(Gaskell et al., 2004) and the mouse (von Schonfeldt et al., 2004);(Culty, 
2009);(Prabhu et al., 2006). The interpretation of results of KIT staining must 
therefore be considered in the context of the age and stage of development of the 
testis in these species.  
 
Germ cell proliferation continues in the marmoset from fetal into postnatal life. This 
has also been demonstrated during early postnatal development in the human fetal 
testis (Honecker et al., 2004), although another study did not detect proliferating 
germ cells during the neonatal period (Ketola et al., 2003). A relatively high germ 
cell proliferation index was found in the neonatal period in the marmoset, followed 
by a reduced index during the childhood phase. With the onset of puberty the 
proliferation index increased to levels comparable to those during the neonatal 
period. A relatively high proliferation index has also been shown to occur in the 
spermatogonia of the adult human testis, with 26% of spermatogonia expressing 
Ki67 (Steger et al., 1998). The pattern of germ cell proliferation in the marmoset 
corresponds to the level of gonadotrophins and testosterone during the three phases 
of development, although a direct association between germ cell proliferation and 
levels of these hormones has not been demonstrated. This finding led to 
investigation of experimental suppression the gonadotrophins and testosterone and 
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its effect on proliferation during the childhood phase in the marmoset (Kelnar et al., 
2002). Suppression of gonadotrophins and testosterone did not affect germ cell 
proliferation during this period, however the effect on germ cell proliferation or 
differentiation has not been investigated during the neonatal period when levels of 
both are high. Such an effect could be relevant to disorders that involve delayed or 
abnormal development of gonocytes, such as CIS and TGCT (Cools et al., 2005). The 
effects of treatment with GNRHa on neonatal germ cell development will be 
investigated in chapter 6.  
 
4.5.8. Conclusion 
This chapter has demonstrated that germ cell differentiation and proliferation in the 
marmoset is comparable to that of the human during fetal and postnatal life. This 
makes the marmoset suitable for studies that may have direct relevance to human 
testis development. During fetal life, gonocytes differentiate into spermatogonia. 
This process occurs over a relatively prolonged period of time and is asynchronous 
in the marmoset and human. This results in the presence of germ cells at several 
stages of differentiation within individual seminiferous cords. This is in marked 
contrast to the rodent in which more synchronous germ cell differentiation and 
proliferation occurs during fetal and early postnatal life, during a relatively narrow 
time window. This pattern of germ cell differentiation may explain why rodents do 
not develop CIS and TGCT and this would imply that the marmoset could be 
predisposed to develop these tumours, although no such tumours have been 
previously described. Having established the marmoset as a comparable model of 
germ cell development to the human the next chapter will investigate the 
development of an in vivo xenografting model to recapitulate germ cell development 
in perinatal marmoset and fetal human testes. 
Chapter 5 Testicular xenografting as an in vivo model of testis  
 development in the human and marmoset 
  
181 
5 Testicular xenografting as an in vivo model of testis development in 




5.1.1. Approaches for manipulation of testis development in the human 
and marmoset  
The previous chapter demonstrated that the marmoset is a relevant model for germ 
cell differentiation and proliferation in the human testis. Further study of testis 
development, including perturbation of normal development could potentially be 
achieved using one of three possible approaches. The first approach would be to 
administer interventions to the animal directly. Alternatively, tissue could be 
removed from the animal and treated under in vitro conditions. Both of these 
approaches have limitations as some treatments might not be acceptable and the in 
vitro systems may not recapitulate normal development. Therefore an in vivo system 
that can be achieved ex-situ could be useful for such studies. One such approach is 
to xenograft testis tissue fragments into a rodent host animal and study the 
functional development of the grafts. Treatments can then be administered to the 
host animal to affect development of the grafts. 
 
5.1.2. Xenografting as an in vivo system of testis development 
Testis xenografting has been shown to sustain tissue survival and promote 
differentiation of germ cells in several species (Honaramooz et al., 2002). In rodents, 
testis tissue taken from immature animals and grafted into immunodeficient hosts 
exhibits germ cell progression through meiosis and can produce functional 
spermatozoa, capable of producing progeny following intracytoplasmic sperm 
injection (Schlatt et al., 2003). Potential applications of this technique include fertility 
preservation and restoration, preservation of endangered species and production of 
transgenics (Griswold et al., 2001), however the fact that this technique can sustain 
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normal testicular architecture and recapitulate normal development of germ cells 
may also make it useful in studies of early germ development and perturbation in 
human and non human primates.  
 
5.1.3. Conditions required for testis xenografting 
The hormonal environment is important for the normal development of the testis 
and the same is true for xenografts. It is generally recommended for the host animal 
to be castrated (Rodriguez Sosa and Dobrinski, 2009), in order to reduce negative 
feedback by androgen on the pituitary and thereby stimulate the release of 
gonadotrophins, which in turn can induce testosterone production from the grafts. 
High intratesticular concentrations of testosterone are essential for normal testis 
development and studies in rhesus monkey grafts have reported that castration is 
essential for development of the grafts (Honaramooz et al., 2004). Most studies have 
described introducing grafts of 0.5-1mm3  although evidence for the optimum size of 
grafts is lacking (Rodriguez Sosa and Dobrinski, 2009). Temperature is also 
important for the success of xenografting and therefore the choice of site for grafts 
may be important. Most studies insert grafts under the back skin of a nude mouse 
and the outcome is satisfactory, however hyperthermia has been cited as a possible 
cause of less successful outcomes in some subcutaneous grafts such as those in 
primates (Wistuba et al., 2004). 
 
5.1.4. Xenografting of human and marmoset testis tissue 
Xenografting of human and non-human primate testis material has been performed 
for postnatal testes. In the rhesus monkey this can result in the completion of 
spermatogenesis (Honaramooz et al., 2004). However as discussed previously it is 
known that the rhesus monkey exhibits an organisation of spermatogenesis that 
shows closer resemblance to the rodent than the human (Millar et al., 2000). To date, 
xenografting of postnatal human and marmoset testes have not resulted in 
progression through meiosis (Schlatt et al., 2002);(Goossens et al., 2008). 
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5.1.5. Xenografting of fetal testis tissue 
There are few studies on fetal testis development using this approach (Yu et al., 
2006);(Skakkebaek et al., 1974) and it remains to be established whether this system 
is able to recapitulate normal fetal germ cell development in either the human or 
non human primate testis. 
 
5.2. Chapter aims 
This chapter aimed to investigate the potential of a testis xenografting approach to 
recapitulate normal development in the human and marmoset by grafting fetal and 
postnatal testis tissue and comparing the development with non grafted controls of 
comparable ages.  
 
5.3. Materials and methods 
 
5.3.1. Neonatal mouse testis tissue collection 
Neonatal mouse testes (n=7) were collected as described in section 2.4.4. 
 
5.3.2. Human fetal testis tissue collection 
Human fetal testis tissue for use in immunohistochmical studies was obtained as 
described in Section 2.4.2. The sections used were first trimester fetuses (9 weeks 
gestation, n=4), second trimester fetuses (14, 15, 16, 17, 18 weeks gestation; n=1 for 
each age). 
 
5.3.3. Fetal and postnatal marmoset testis collection 
Marmoset testes from fetal (15 weeks, n=1; 16 weeks, n=1; 18 weeks, n=1; and 
postnatal (1 day, n=2; 25 weeks, n=1) animals were obtained as described in section 
2.4.1.  
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Castration and xenografting of testis tissue was performed as detailed in section 2.6. 
 
5.3.5. SRY genotyping 
The sex of first trimester human fetuses was established by SRY genotyping as 
described in section 2.6.4. 
 
5.3.6. Haematoxylin and eosin staining 
The method for haematoxylin and eosin staining is described in section 2.9. 
 
5.3.7. Immunohistochemistry 
Single immunohistochemistry was performed with DAB detection as described in 
section 2.10. The primary antibodies used for these experiments are listed in Table 
2.1. Double staining was performed with DAB and fast blue detection as outlined in 




Triple immunofluorescence was performed as described in section 2.11.2. The 
primary and secondary antibodies, and detection labels used for these experiments 
are listed in Table 2.4. 
 
5.3.9. Serum testosterone radioimmunoassay 
Serum testosterone levels were measured in host mice as described in section 2.7. 
 
5.3.10. Calculation of the germ cell to Sertoli cell ratio and quantification 
of germ cell subpopulations in human fetal testis xenografts 
Sections of pre-graft controls, xenografts and post-graft controls were analysed. For 
the first trimester xenografts, pre-graft controls were obtained using tissue from the 
same testis prior to grafting. Second trimester control tissue acted as the post-graft 
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control for first trimester xenografts, as well as a pre-graft control for the second 
trimester xenografts. Post-graft controls for second trimester xenografts were 
obtained using tissue taken from 20 week gestation fetuses.  
 
The ratio of Sertoli cells per germ cell was calculated following double staining for 
OCT4 and VASA, which together stained all fetal germ cells. The total number of 
germ cells was calculated by adding together the unstained (Sertoli) cells and 
dividing them by the total number of stained (germ) cells.  Quantification of 
subpopulations of germ cells in double stained cells is described in section 2.12.1, 
The proportion of germ cells expressing the various combinations of markers were 
calculated by dividing the number of germ cells with a particular expression profile 
by the total cells, for a minimum of 40 random fields. Statistical analysis was 
performed using a one-way analysis of variance (ANOVA). Triple stained 
immunofluorescent sections were analysed as described in section 2.12.2.2. 
Quantification of sections from pre-graft controls, xenografts and post-graft controls 
was also undertaken. The proportion of germ cells expressing the different 
combinations of markers was calculated as described above and a proliferation 
index for each subpopulation was calculated by dividing the number of 
proliferating (Ki67 positive) cells by the total number of cells within that 
subpopulation. Statistical analysis was performed using the unpaired students t-test 




5.4.1. Neonatal mouse testis allografting 
In order to complement the in vivo work in the perinatal marmoset, we wished to 
use a xenografting approach for investigating germ cell development during this 
period. Firstly we needed to establish the system within our institution and to do 
this we used neonatal mouse testes as the donor tissue in order to reproduce results 
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obtained in other laboratories. Testis pieces were grafted subcutaneously for 2, 4 or 
8 weeks and the grafts showed excellent survival, comparable to recent reports (Yu 
et al.) and substantially better than early reports (Schlatt 2003), (Honaramooz 2002) 








Grafts with testis cords 
(%) 
2 12 92 67 
4 18 100 72 
8 18 100 72 
 
Table 5.1. Success rate for neonatal mouse testis allografts.  
 
Castration of the host meant that serum testosterone measurement in the host 
animal reflected testosterone production by the grafts. In addition, seminal vesicle 
weight of the host could also be used as a surrogate marker for testosterone 
production. In castrate animals with no recoverable grafts the serum testosterone 
was below the limit of detection (<0.1ng/ml) and mean seminal vesicles weight was 
31.5mg, whilst intact host animals had mean serum testosterone levels of 6.1 ng/ml 
and seminal vesicle weight of 264mg. In castrate animals with grafts the serum 
testosterone and seminal vesicle weights indicated that the grafts were producing 




Castrate/Intact Testosterone Seminal vesicle  
ng/ml range mg range 
Control Castrate <0.1 (all <0.1) 31.5 (23-40) 
Grafted (4w) Castrate 1.0 (0.6–1.3) 103 (69-120) 
Grafted (8w) Castrate 2.7 (1.8-3.7) 213 (160-151) 
Control Intact 6.1 (0.3-11.8) 264 (209-318) 
 
Table 5.2. Serum testosterone and seminal vesicle weight for hosts receiving neonatal 
mouse testis allografts. Control – animals with no recoverable testis in grafts. w=weeks. 
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The morphology of the seminiferous tubules in grafts was similar to controls of 
equivalent age at each time point analysed. In addition grafts that had been left in-
situ for 8 weeks had undergone complete spermatogenesis with the production of 
elongate spermatids and this was associated with a higher testosterone and seminal 
vesicle weight, compared with the 4 week grafts (Figure 5.1). These results validated 
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Figure 5.1. H+E. Allografting of neonatal mouse testis. Allografts retrieved after 8 weeks 
(right panels) compared with testis from an 8 week old control animal (left panels). Note that 
both control and grafted tissue exhibit complete spermatogenesis with appearance of 
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5.4.2. Marmoset testis xenografts 
 
5.4.2.1. Marmoset fetal testis xenografts  
Having established the grafting technique we then wished to investigate the 
suitability of this approach for studying early germ cell development in the fetal 
marmoset, as this species has been shown to represent a good model for human 
germ cell development (Chapter 4). Testes from 15, 16 and 18 week gestation 
marmosets were grafted for 6 weeks and a high proportion of these grafts were 
retrieved, with easily identifiable testis cords in most of these grafts. In addition 
there had been a significant growth of the grafts from the original 1mm in diameter 




Figure 5.2. Subcutaneous testis xenograft from an 18 week fetal marmoset donor 
retrieved after 6 weeks. Note that the diameter of the graft has increased to approximately 
3mm. 
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The success rate was lower in the grafts from 15-16 week fetuses, with fewer cords 













Grafts with testis 
cords 
(%) 
15 6 12 100 75 
16 6 12 67 58 
18 6 9 100 100 
 
Table 5.3. Success rate for fetal marmoset testis xenografts. 
 
Serum testosterone and seminal vesicle weights indicated that the grafts were 
producing small amounts of testosterone. The testosterone production was much 





Castrate/Intact Testosterone Seminal vesicle  
ng/ml range mg range 
Control Castrate <0.1 (all <0.1) 31.5 (23-40) 
Grafted (6w) Castrate 0.11 (0.1–0.17) 49 (37-66) 
Grafted (6w) Intact 0.99 n/a 249 n/a 
Control Intact 6.1 (0.3-11.8) 264 (209-318) 
 
Table 5.4. Serum testosterone and seminal vesicle weight for hosts receiving fetal 
marmoset testis xenografts. Control – animals with no recoverable testis in grafts. 
w=weeks. 
 
Grafts from 15 week fetal marmoset testes retained seminiferous cord structure and 
the cords contained large numbers of germ and Sertoli cells (Figure 5.3).  
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Figure 5.3. H+E. 15 week fetal marmoset testis xenografts. Xenograft of a 15 week fetal 
marmoset testis retrieved after 6 weeks (right panel) and comparison with testis from a 
neonatal control animal (left panel). Germ cells (right panel, inset) are present within the graft 
(arrows). Scale bar = 50m.  
 
Grafts from 18 week gestation testes showed excellent morphology (Figure 5.4a). 
The grafts had formed an oval capsule structure giving them a distinct border and 
making them easy to dissect from the under surface of the skin (Figure 5.4b). These 
fetal grafts expressed markers of, Sertoli (AMH, cytokeratin), Leydig (3-HSD) and 
peritubular myoid (AR) cells (Figure 5.5). 
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Figure 5.4. H+E. 18 week fetal marmoset testis xenograft. a) H+E. Xenograft of an 18 
week marmoset testis retrieved after 6 weeks (right panel) and comparison with testis from 
a 6 week postnatal control animal (left panel). Scale bar = 50m. b) H+E. Low power 
image (x4) of graft in a). Note that the cords are distributed throughout the graft and the 
graft has taken up the ovoid shape of a testis with a surrounding ‘capsule’. Scale bar = 
1mm.  
Chapter 5 Testicular xenografting as an in vivo model of testis  





Figure 5.5. Expression of 3-HSD, AR, AMH and pan-cytokeratin in 18w fetal marmoset 
xenografts. Grafts were retrieved after 6 weeks (right panels), and compared with testis 
from the pre-graft tissue (left panels). Note that both control and grafted tissue has a full 
complement of testicular somatic cell types. Scale bar = 50m.  
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The integrity of the basement membrane in grafts from fetal marmosets is 
demonstrated by the strong expression of SMA at the periphery of the cords. In 
addition the structure of the vasculature and the integrity of the endothelial cells 
can also be observed using this marker (Figure 5.6). 
 
 
Figure 5.6. SMA expression in an 18w fetal marmoset testis xenograft. Grafts were 
retrieved after 6 weeks (right panel), and compared with the pre-graft tissue (left panel). 
Expression of SMA in vascular smooth muscle cells is seen in both control and graft 
(arrows). Scale bar = 50m.  
  
Germ cell differentiation occurred in grafts from fetal marmosets (Figure 5.7). The 
expression of OCT4 and AP-2 decreased after grafting, whilst the expression of 
VASA and MAGE-A4 increases (Figure 5.7). This progression is comparable to the 
situation in the equivalent age post graft control, suggesting that the grafting 
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Figure 5.7. Expression of AP-2, MAGE-A4 and OCT4/VASA in a xenograft of an 18 
week fetal marmoset testis. Grafts were retrieved after 6 weeks. a) AP-2 expression 
decreases, whilst MAGE-A4 expression increases after grafting. b) OCT4 (brown) is also 
reduced during grafting (arrows), whilst VASA (blue) expression increases. Scale bar = 
50m. Original magnification (a) 40x, (b) 20x.  
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5.4.2.2. Neonatal marmoset testis xenografts 
Testes from neonatal marmosets were grafted for 2 or 6 weeks and demonstrated 
excellent survival with all of the grafts retrieved and most of the grafts exhibiting 








Grafts with testis cords 
(%) 
6 14 100 79 
 
Table 5.5.  Success rate for neonatal marmoset testis xenografts. 
 
Serum testosterone and seminal vesicle weights indicated that these grafts were not 
producing testosterone. Serum levels of testosterone were below the limit of 
detection and mean seminal vesicle weight was 22mg (19-28). Morphology of the 
tubules was variable with occasional grafts exhibiting marked degeneration of the 
tubules, however most of the grafts demonstrated morphology characteristic of 
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Figure 5.8. H+E. Xenograft of neonatal marmoset testis. Grafts were retrieved after 6 
weeks (right panels) and compared with testis from a 6 week postnatal control animal (left 
panels). Note that both control and grafted tissue has a full complement of cell types 
including germ cells (arrows). Scale bar = 50m.  
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Grafts were compared to pre graft testes in addition to those taken from non grafted 
animals at 6 weeks of postnatal age (post graft controls). Expression of 3-HSD, 
androgen receptor, AMH and pan cytokeratin were demonstrated in all three 
conditions, which showed the presence of Leydig, Sertoli and peritubular myoid 




Figure 5.9. Expression of 3-HSD, androgen receptor, AMH and pan cytokeratin in a 
xenograft of a neonatal marmoset testis. Grafts were retrieved after 6 weeks (middle 
panels). Comparison with testis from neonatal pre-graft tissue (left panels) and a six week 
old postnatal post graft control (right panels). Scale bar = 50m.  
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There was evidence of germ cell differentiation in the grafts when compared to the 
controls. There was a reduction in the proportion of germ cells that expressed AP-2 
and an increase in the proportion that expressed MAGE-A4 (Figure 5.10). The same 
pattern of loss of early markers (OCT4) and expression of germ cell differentiation 
proteins (VASA) was also noted in co-staining experiments (Figure 5.10). 
 
 
Figure 5.10. Expression of AP-2, MAGE-A4 and OCT4/VASA in neonatal marmoset 
testis xenografts. Grafts were retrieved after 6 weeks. Note the reduction in AP-2 
expression and increase in MAGE-A4 expression after grafting. OCT4 (brown) is also 
reduced (arrows) after grafting, whilst VASA (blue) expression increases. Scale bar = 50m.  
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5.4.2.3. Juvenile marmoset testis xenografts 
Germ cell development in the juvenile marmoset has been demonstrated to have 
similarities to the human (see Chapter 4). We grafted 25 week old marmoset testes 
for 10 weeks in order to assess the ability of these grafts to survive and 
differentiate/proliferate during this relatively quiescent ‘childhood’ period. In total, 
24 xenografts were implanted and of these 58% were retrieved. All of these grafts 
contained seminiferous tubules with a qualitatively normal appearance. Of the four 
hosts into which tissue was grafted, 2 were castrate and 2 were intact. Castrated 
animals had small seminal vesicles and low serum testosterone levels similar to 
those obtained in untreated host animals in the previously described grafting results 
(Table 5.6). For each host larger grafts (2mm) were placed down the left side of the 
back, whilst grafts of standard size (1mm) were placed down the right side of the 
back. The larger grafts were more likely to be retrieved after the grafting period 
than the smaller ones and they were on average more than twice the weight of the 















Castrate 23 0.16 6 50 3.3 
Castrate 14 <0.1 6 67 1.1 
Intact 240 8.29 6 50 1.1 
Intact 333 1.26 6 50 1.7 
 
Table 5.6. Effect of castration on seminal vesicle weight and serum testosterone of the 






Table 5.7. Effect of initial graft size on subsequent retrieval rates and graft weights in 
juvenile marmoset testis grafts. 




Mean graft weights 
(mg) 
1mm 12 33 0.88 
2mm 12 83 1.95 
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Figure 5.11. Graft weights for juvenile marmoset testis grafts. Original grafts were 
standard size (1mm) or larger size (2mm), n=12. Mean  sem. p>0.05. 
 
The seminiferous tubules of the grafts had a normal appearance with germ cells and 
Sertoli cells present. In addition the process of lumen formation was seen in some of 
the tubules (Figure 5.12) 
 
Figure 5.12. H+E. Juvenile marmoset testis xenografts. Testes from 25 week old 
postnatal marmosets were grafted for 10 weeks and compared with pre graft controls. Cord 
structure was maintained with germ cells and Sertoli cells clearly identifiable in the juvenile 
marmoset grafts (right panel) similar to pre-graft tissue (left panel). Lumen formation (*) can 
also be seen within the grafts. Scale bar = 50m.  
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Both grafts and pre-graft controls expressed 3-HSD in occasional interstitial cells. 
AMH was also expressed in both pre graft controls and grafts, with weak staining in 
both. Sertoli cells and peritubular myoid cells expressed AR (Figure 5.13) 
 
 
Figure 5.13. Expression of 3-HSD, androgen receptor and AMH in a xenograft of a 
juvenile marmoset testis. Grafts were retrieved after 10 weeks. Note occasional Leydig 
cells express 3-HSD (arrows). Comparison with testis from a 25 week pre-graft control. 
Scale bar = 50m.  
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The grafts expressed markers characteristic of both pre and post-graft controls, such 
as VASA (Figure 5.14, also see Figure 4.16) 
 
Figure 5.14. Expression of VASA in a xenograft of a 25 week old juvenile marmoset 
testis. Grafts were retrieved after 10 weeks and compared with testis from a 25 week pre-
graft control. Scale bar = 50m.  
 
Germ cells within the juvenile marmoset grafts were proliferating as are those in the 
pre-graft control tissue. Proliferation appeared to occur in a higher proportion of 
germ cells compared to the pre-graft control (Figure 5.15). 
 
Figure 5.15. Expression of Ki67 in a xenograft of a 25 week old juvenile marmoset 
testis. Grafts were retrieved after 10 weeks and compared with testis from a 25 week pre-
graft control. Scale bar = 50m. 
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5.4.3. Human fetal testis xenografts 
Having established an in vivo model of marmoset perinatal germ cell development 
we wished to investigate whether the technique would also be applicable to human 
fetal testis grafts, as this might have wide application. Testis grafts from both first 
and second trimester fetuses were grafted for 6 weeks.  
 
5.4.3.1. Genotyping of first trimester fetal gonads 
SRY genotyping was performed on tissue from each first trimester fetus in order to 
establish the sex of the fetus (Figure 5.16). 
 
   
 
Figure 5.16. SRY genotyping in tissues from first trimester human fetuses. Note that 
3/4 samples are (M) male and 1/4 are female (F). L = 100bp ladder, N = negative control, P 
= positive control. Product at 300bp. 
 
5.4.3.2. First trimester human fetal testis xenografts 
Grafts from four male first trimester (9 week gestation) fetuses were grafted for 6 
weeks.  The majority of the grafts were retrieved and all grafts had identifiable testis 
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Grafts with testis 
cords 
(%) 
9 6 3 100 100 
9 6 3 67 67 
9 6 3 67 67 
9 6 3 67 67 
  12 75 75 
 
Table 5.8. Success rate for the four first trimester fetal human testis xenografts. 
 
The grafts from the first trimester testes did not produce detectable levels of serum 
testosterone and the mean seminal vesicle weight was 22mg (15-28), which was a 
similar value to that obtained for non-grafted castrate mice. The pre-graft control 
tissue had not completed seminiferous cord formation, however over the duration 
of the grafting period the seminiferous cords had fully formed with a normal 
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Figure 5.17. H+E. 9 week human fetal testis xenograft. Control testes lack completed 
seminiferous cord formation (upper panels), whilst grafts have developed cords with normal 
appearance (lower panels). Scale bar = 50m.  
 
In the pre-graft tissue the germ cells and Sertoli cells were distributed throughout 
the developing gonad. Many of the germ cells were not yet enclosed within 
identifiable testis cords although aggregates of Sertoli cells were apparent (Figure 
5.18). However, 6 weeks after grafting seminiferous cords containing OCT4 
expressing germ cells and SOX9 expressing Sertoli cells, had become more 
organised with the germ cells and Sertoli cells enclosed within clearly identifiable 
seminiferous cords outlined by staining with SMA in peritubular myoid cells 
(Figure 5.18).  
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Figure 5.18. Expression of SOX9/OCT4 and SMA in first trimester human testis 
xenografts and controls. Isolated OCT4 (brown) germ cells can be identified (arrowhead) 
distant to the SOX9 (blue) Sertoli cells in controls, however all germ cells are enclosed within 
clearly defined seminiferous cords in grafts. The cords are outlined by the expression of 
SMA in the grafts (arrows), whilst the control tissue is negative for SMA. Scale bar = 50m. 
Original magnification x40 (upper left panel x20). 
 
The Leydig cells of the grafts were weakly immunopositive for 3-HSD (Figure 
5.19), indicating active steroidogenesis. The expression was not as strong as that of 
the equivalent post graft control, however no expression of 3-HSD was 
demonstrated in the pre graft control. This indicates functional maturation of the 
Leydig cells during the grafting period in addition to the formation of the 
seminiferous cords. Peritubular myoid cells and some interstitial cells expressed AR, 
whilst Sertoli cells expressed AMH, which was similar to post-graft controls (Figure 
5.19). Expression of these proteins was weaker in the pre graft controls than in the 
grafts. 
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Figure 5.19. Expression of 3-HSD, AR and AMH in a xenograft of a first trimester 
human testis. Grafts were retrieved after 6 weeks, and compared with testis from the pre 
and post-graft controls. The pre-graft control was negative for 3-HSD, whilst grafts and 
post-graft controls expressed this enzyme (arrows). Note that some red blood cells 
(arrowhead) are also labelled with the 3-HSD antibody in the post-graft control. Pre-graft 
controls had weak expression of AMH and AR compared to the grafts and post-graft 
controls. Scale bar = 50m.  
 
5.4.3.3. Second trimester human fetal testis xenografts 
Grafts from four second trimester (14-17 week gestation) fetuses were grafted for 6 
weeks. The majority of the grafts were retrieved and all grafts had identifiable testis 
tissue with testis cords exhibiting normal appearance in all but one of the retrieved 
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Grafts with testis 
cords 
(%) 
14 6 18 88 72 
15 6 36 67 67 
16 6 5 80 80 
17 6 6 100 100 
  65 77 72 
 
Table 5.9. Success rate for the four second trimester fetal human testis xenografts. 
 
Serum testosterone and seminal vesicle weights indicated that the grafts were 
producing small amounts of testosterone. The testosterone production was much 
reduced compared to grafted, non-castrate mice at the equivalent age (Table 5.10). 
 
Table 5.10. Serum testosterone and seminal vesicle weight for hosts receiving second 
trimester human fetal testis xenografts. 
 
The seminiferous cords had a normal structure and they contained both germ cells 
and Sertoli cells with a visible basement membrane (Figure 5.20).  
 
 Testosterone Seminal vesicle weight 
ng/ml range mg range 
Testis grafts (castrate host) 0.13 0.1-0.26 20 17-28 
Testis grafts (intact host) 3.4 n/a 225 n/a 
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Figure 5.20. H+E. Second trimester human fetal testis xenografts. Cord structure was 
maintained with germ cells (arrowheads) and Sertoli cells clearly identifiable. Scale bar = 
50m. Original magnification x20 (left panels), x40 (right panels). 
 
Some of the tissue from the 17 week human fetal testis was grafted into a nude 
mouse for an extended period of time. The grafts were left for 21 weeks, which 
would be equivalent to 38 weeks gestation (term), in order to see whether the 
capacity for germ cell survival was maintained. Of the 6 grafts, 5 (83%) were 
retrieved and all of the grafts exhibited preservation of normal cord structure 
(Figure 5.21). Germ cells were present throughout the tissue and were located in 






Chapter 5 Testicular xenografting as an in vivo model of testis  






Figure 5.21. H+E. Second trimester (17 week) human fetal testis xenograft grafted for 
21 weeks. Cord structure was maintained with basal (arrow) and central (arrowhead) germ 
cells, and Sertoli cells clearly identifiable. Scale bar = 50m. Original magnification x4 (left 
panel), x40 (right panel). 
 
AR and AMH were expressed in second trimester grafts after 6 weeks and the 
equivalent post graft controls (Figure 5.22). This expression was similar to that of 
the equivalent pre-graft controls (See post-graft control, Figure 5.19). AMH 
expression in the post-graft control was less intense than expected. 
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Figure 5.22. Expression of AR and AMH in a xenograft of a second trimester human 
fetal testis. Grafts were retrieved after 6 weeks and compared with testis from equivalent 
post-graft controls. Both grafts and post-graft controls expressed these markers, however 
AMH was weak in the post graft control. Scale bar = 50m.  
 
5.4.3.4. Testosterone production by human fetal testis xenografts and 
stimulation with hCG 
Castration of the host animal resulted in cessation of testosterone production from 
the host animal. The aim was to increase the host gonadotrophin levels to stimulate 
testosterone production from the grafts and enhance growth and development of 
the grafts. However as the levels of testosterone were much lower than in intact 
animals the responsiveness of the graft Leydig cells to exogenous hCG was 
assessed.  
 
Testosterone was undetectable in animals grafted with first trimester tissue.  Hosts 
grafted with second trimester tissue also had undetectable or very low levels of 
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testosterone. However hCG treatment of hosts with second trimester xenografts 
resulted in a significant increase in serum testosterone and seminal vesicle weight 




Figure 5.23. Testosterone production and seminal vesicle weights in untreated first  
(1st) and second (2nd) trimester human fetal testis xenografts and the effects of hCG 
on second trimester grafts. n=3.  Mean ± sem. Statistical analysis performed using 
ANOVA. ** p<0.01, *** p<0.001. 
 
An increase in graft weight was observed in the hCG treated animals carrying 
second trimester grafts compared to the vehicle treated controls, but this increase 
was not statistically significant (Figure 5.24). 
 
Figure 5.24. Graft weights in control and hCG treated grafts from second trimester 
human fetuses. (n=3). Mean ± sem. Statistical analysis performed using unpaired students 
t-test. p>0.05. 
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In addition to the increase in host serum testosterone level and seminal vesicle 
weight, histological examination of grafts demonstrated that there was hypertrophy 
of Leydig cells within the hCG treated grafts (Figure 5.25). These enlarged Leydig 
cells tended to be more prominent around the periphery of the grafts. In untreated 
and vehicle treated grafts the Leydig cells appeared to be involuted (Fig. 5.25) 
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Figure 5.25. H+E. Effect of hCG treatment on second trimester human fetal testis 
grafts. a) Vehicle treated and hCG treated grafts. Leydig cell hyperplasia was noted at the 
periphery of the exposed grafts (arrow). Original magnification x10. b) Comparison of Leydig 
cells(*) size and distribution in pre graft controls, untreated grafts and hCG treated grafts. 
Scale bar = 50m.  
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There was also a difference in expression of 3-HSD in grafts from second trimester 
human fetuses in which the hosts had been treated with hCG, compared with 
untreated controls (Figure 5.26). hCG treated grafts expressed 3-HSD, whilst most 
of the vehicle treated grafts were immunonegative for this enzyme. 
 
 
Figure 5.26. Effect of hCG treatment on 3-HSD expression in second trimester human 
fetal testis grafts. Scale bar = 50m.  
 
5.4.3.5. Germ cell development in human fetal testis xenografts 
Germ cell development in human fetal testis xenografts was investigated by 
calculating the germ cell to Sertoli cell ratio in addition to analysis of germ cell 
differentiation. The germ cell to Sertoli cell ratio was not significantly different 
between grafts and controls for either first or second trimester grafts (Figure 5.27). 
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Figure 5.27. Germ cell (GC) to Sertoli cell (SC) ratio in human fetal testis xenografts. 
Number of Sertoli cells per germ cell in first (1
st
) and second (2
nd
) trimester human fetal testis 
xenografts (G) and controls (C), (n=3, 20w ctrl n=2). Mean ± sem. p>0.05. w=weeks. 
 
There was evidence of differentiation of germ cells in the human fetal testis 
xenografts. Germ cells in first trimester control testes expressed OCT4, whilst VASA 
and MAGE-A4 were almost completely absent from germ cells at this age. OCT4 
expression was seen in a lower proportion of germ cells in grafts compared to pre-
graft controls. The reduction in the proportion of cells expressing OCT4 coincided 
with the appearance of expression of VASA and MAGE-A4 (Figure 5.28).  
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Figure 5.28. Expression of OCT4, MAGE-A4 and VASA in a xenograft of a first 
trimester human testis. Grafts were retrieved after 6 weeks. Note the reduction in OCT4 
expression with increasing VASA (arrows) and MAGE-A4 expression after grafting.  Scale 
bar = 50m.  
 
In second trimester grafts, the proportion of germ cells expressing OCT4 decreased 
further compared to the pre-graft control, whilst the proportion of germ cells 
expressing VASA increased and the intensity of MAGE-A4 increased (Figure 5.29) 
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Figure 5.29. Expression of OCT4, MAGE-A4 and VASA in a xenograft of a second 
trimester human fetal testis. Grafts were retrieved after 6 weeks. Note the reduction in 
OCT4 expression with increasing VASA and MAGE-A4 expression after grafting.  Scale bar 
= 50m.  
 
The change in expression of the germ cell differentiation markers was quantified by 
co-localising OCT4 with either VASA (not shown, example of OCT4/VASA staining 
is shown in Figure 5.7b) or MAGE-A4 (Figure 5.32). With both approaches the 
proportion of germ cells expressing OCT4 decreased, whilst the proportion 
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expressing VASA or MAGE increased with increasing equivalent age of control or 
graft (Figure 5.30). The proportions of germ cells expressing these markers were not 
significantly different between the grafts and the equivalent post graft control. In 
addition the proportions were not different between the second trimester grafts 
treated with hCG when compared to the vehicle treated second trimester grafts. The 
proportion of germ cells expressing both markers was less than 10% for both 
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Figure 5.30. Germ cell differentiation in human fetal testis xenografts. Proportion of 
cells expressing OCT4, VASA or OCT4 + VASA (left panels) and OCT4, MAGE-A4 or OCT4 
+ MAGE-A4 (right panels) in first (1
st
) and second (2
nd
) trimester human fetal testis 
xenografts (G) and controls (C). n=3 (20w ctrl, n=2). Mean ± sem. w=weeks. 
 
5.4.3.6. Proliferation of germ cells in human fetal testis xenografts 
Germ cells and Sertoli cells were proliferating in the human testis xenografts. 
Mitotic germ cells were seen within the grafts in addition to germ cells positive for 
Ki67 (Fig. 5.31). 
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Figure 5.31. Proliferation of germ cells from a 14 week human fetal testis xenograft. 
Grafts were retrieved after 6 weeks. Mitotic germ cells (arrow) can be seen on H+E sections. 
Ki67 was also expressed in some of the germ cells (arrowhead). Scale bar = 25m 
 
Triple staining of OCT4/MAGE-A4/Ki67 demonstrated that a proportion of all three 
subpoulations of germ cells (OCT4+/MAGE-A4-, OCT4+/MAGE-A4+ and OCT4-
/MAGE-A4+) were proliferating (Figure 5.32).  
 
It was also apparent that the proliferation rate differed between these 
subpopulations. The proliferation index was quantified in these subpopulations 
within the grafts and compared them to those of controls (Figure 5.33). It could be 
seen that the OCT+/MAGE-A4- cells were the most proliferative, whilst the 
subpopulations that expressed MAGE-A4 had very low rates of proliferation. This 
was the case for both first and second trimester grafts and the same pattern was also 
found in the pre and post-graft controls. No significant differences were seen 
between the proportions of proliferating subpopulations of germ cells within grafts 
or controls, with the exception of OCT4 expression in the second trimester grafts 
and the equivalent post graft control (Figure 5.32).  
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Figure 5.32. Proliferation in the subpopulations of germ cells in a second trimester 
human fetal testis xenograft. Expression of OCT4 (red), MAGE-A4 (blue) and Ki67 (green) 














 (white arrow) 




cells are proliferating (white arrowhead). 
The cells stained for Ki67 that are negative for OCT4 and MAGE-A4 represent proliferating 
Sertoli cells (purple arrowhead). 
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Figure 5.33. Germ cell proliferation in the subpopulations of human fetal testis 
xenografts. Proportion of proliferating cells expressing OCT4, MAGE-A4 or OCT4 + MAGE-
A4 in first (1
st
) and second (2
nd
) trimester human fetal testis xenografts (G) and controls (C). 




5.5.1. Testicular xenografts show excellent survival and provide large 
numbers of grafts 
This study has demonstrated that testicular xenografts from fetal and postnatal 
animals of various species show good survival over a period of several weeks. Our 
results for neonatal mouse allografts compare favourably with previous studies. We 
demonstrated 100% recovery of mouse grafts after 4 and 8 weeks of grafting 
compared with 100% at 4 weeks and 97% at 8 weeks in another recent study (Yu et 
al., 2006). An earlier study had reported a graft recovery at 4 weeks of 60% (Schlatt 
et al., 2003);(Honaramooz et al., 2002). The proportion of retrieved grafts that 
contain recognisable testis tubules in our study was 72%, which compared 
favourably with 65% in one of the previous studies (Schlatt et al., 2002). In addition 
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these grafts progressed to completion of spermatogenesis as has been described by 
other groups (Schlatt et al., 2003);(Honaramooz et al., 2002);(Yu et al., 2006). This 
validated our grafting protocol for use in other species. 
 
Fetal marmoset grafts have not been reported previously, however in the present 
studies, retrieval rates (90%) and the presence of seminiferous tubules within grafts 
(79%) compares very favourably with the rates described for human fetal testis 
grafts and in comparison to immature testis grafts in other species (Yu et al., 
2006);(Schlatt et al., 2003);(Honaramooz et al., 2002). In our study, survival of fetal 
human xenografts ranged from 67 to 100%. Overall 75% of human fetal grafts were 
retrieved after 6 weeks with recognisable seminiferous tubules in 72%. This 
compared with 50% retrieval (all of which had recognisable tubules) between 16 and 
19 weeks of grafting in a previous study (Yu et al., 2006).  
 
For neonatal marmoset xenografts we retrieved 100% of grafts and 72% had 
demonstrable seminiferous tubules, which is similar to previous reports in neonatal 
marmoset testis grafts retrieved after 12 weeks (Wistuba et al., 2004). In juvenile 
marmoset grafts, the retrieval rate was lower than in fetal and neonatal grafts with 
only 58% of grafts retrieved, all of which had recognisable seminiferous tubules. A 
higher retrieval rate of 78% was found in a study of infant rhesus monkeys (Rathi et 
al., 2008). This is consistent with the concept that in a variety of species, increasing 
age and maturity of the donor tissue results in less successful recovery of tissue 
(Kim et al., 2007);(Schlatt et al., 2002);(Geens et al., 2006);(Rodriguez Sosa and 
Dobrinski, 2009);(Arregui et al., 2008b). This is particularly the case for grafting of 
adult testes in which meiosis has begun. The reason for this reduced success may be 
related to the cell complement within the seminiferous tubules as they mature, or 
alternatively may be due to an increased susceptibility of mature tissue to ischaemia 
(Rathi et al., 2006).    
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5.5.2. Testis xenografts from mouse, human and marmoset produce 
testosterone  
Functional activity of the Leydig cells within the testis xenografts from each of the 
species was examined by measurement of serum testosterone and seminal vesicle 
weight. Castration of host mice prevented production of host testosterone, which 
meant that measured testosterone and seminal vesicle weights were an accurate 
bioassay of androgen produced by the grafts (Schlatt et al., 2002). Seminal vesicle 
weight showed good correlation with serum testosterone levels. Testosterone levels 
varied between tissue donor age and species, with highest levels obtained using 
mouse grafts and lower levels using human and marmoset grafts. Serum 
testosterone levels were even variable between animals that received grafts from the 
same donor, which may reflect the number and size of the surviving grafts and the 
amount of functional Leydig cell activity within the grafts, although it is recognised 
that testosterone levels can be inherently variable between mice (Schlatt et al., 2002). 
Neonatal marmoset grafts did not produce testosterone, which is consistent with 
previous reports (Schlatt et al., 2002);(Wistuba et al., 2004). This had been 
hypothesised to be due to several reasons such as the difference in the LH receptor 
in the marmoset which is not responsive to mouse LH, although administration of 
CG (to which the marmoset LH receptor is responsive) did not improve androgen 
production in the grafts (Wistuba et al., 2004). This led to the hypothesis that an 
unknown species specific factor is required for successful grafting in the marmoset. 
It is interesting to note that in the present study the fetal marmoset grafts were able 
to produce low levels of testosterone and this suggests that such a species specific 
reason for failure of neonatal grafts to produce testosterone is unlikely. It is 
therefore possible that there may be an age related factor that prevents these grafts 
from producing androgens.  
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5.5.3. Testosterone production can be increased in human fetal testis 
xenografts by the administration of hCG 
Although neonatal marmoset xenografts do not respond to exogenous hCG, the fact 
that the fetal marmoset and fetal human grafts produced low levels of testosterone 
led us to speculate that the Leydig cells of the human fetal testis xenografts may 
respond to hCG and increase testosterone production. Administration of hCG 
resulted in a significant increase in the serum testosterone levels and seminal vesicle 
weights in the host mice that had received second trimester human fetal testis 
xenografts and the graft weights were increased in these animals, compared to 
vehicle treated controls. Effects of hCG on the Leydig cells themselves was 
demonstrated by hypertrophy of the Leydig cells in the grafts from hCG treated 
hosts. Expression of 3-HSD also occurred in the grafts from mice that received 
hCG, whilst grafts retrieved from non-hCG treated mice did not express this 
steroidogenic enzyme. This demonstrates that the Leydig cells are functional and 
inducible, which may be important in the context of further studies that investigate 
the effects of various treatments on androgen production in these grafts. It has also 
been suggested that the lack of production of androgens may be responsible for the 
failure of gonadal differentiation in the neonatal marmoset (Wistuba et al., 2004) 
and therefore the induction of increased levels of testosterone could result in 
enhanced differentiation in the human fetal testis grafts.  
 
5.5.4. Seminiferous cords can form in vivo using the testis xenografting 
technique 
This study has demonstrated that xenografts from first trimester human fetal testes 
in which organisation of the testis cords is incomplete can complete cord formation 
following subcutaneous xenografting into nude mice. This is a novel finding and 
has not previously been demonstrated using testis material from any other species. 
However it is interesting to note that dissociated cells from rodent testes have been 
used to re-form testicular cords both in vitro (Gassei et al., 2006) and in vivo 
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(Honaramooz et al., 2007);(Honaramooz et al., 2007);(Kita et al., 2007);(Arregui et al., 
2008a). In these experiments the cells are dissociated and either grown in 3D culture 
systems and subsequently transplanted into host mice (Gassei et al., 2006), or 
alternatively transplanted directly into nude mice (Honaramooz et al., 2007);(Kita et 
al., 2007). These studies involved the use of testis tissue in which the cords have 
already formed prior to their dissociation. To date this technique has not been 
performed using human tissue or testis from any species prior to cord formation, or 
using pre-cord formation testis tissue. This technique has tremendous potential use 
for mixing different combinations of germ, Sertoli and Leydig cells and looking at 
the effect of altering the characteristics of the individual cells within the mixture on 
the development of the testis. This could also be applied to the first trimester human 
fetal testis in which the cords have not fully developed to recapitulate initial cord 
formation and increase understanding of how the seminiferous cords form in the 
human and how dysgenesis might arise or be induced. 
 
5.5.5. Structure and cell complement in testis xenograft 
The xenografts from all ages and species exhibited good preservation of testis 
structure. The grafted testis tissue was enclosed within a fibrous capsule and 
contained interstitial cells, including Leydig cells. The seminiferous tubules had a 
normal appearance with a basement membrane and contained germ cells, Sertoli 
cells and peritubular myoid cells, which can all be identified by immunoexpression 
of protein markers. Some of the grafts demonstrated central degeneration and in 
most of the grafts the tubules and Leydig cells tended to exhibit better preservation 
at the periphery of the grafts rather than centrally. In sheep xenografts, tubules 
containing spermatogonia were more frequent in the periphery of the grafts, whilst 
tubules in the centre contained SCO tubules (Arregui et al., 2008a). Proliferation was 
retarded until the blood supply had been restored (Rathi et al., 2005) and this may 
be the reason for the variability between tubules in different areas of the graft.  
Diffusion, prior to the establishment of a blood supply may result in improved 
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development at the periphery of the tubule, compared to central regions (Arregui et 
al., 2008a). Germ cells were present in the majority of cords and the ratio of germ 
cells to Sertoli cells was quantified for human fetal testis xenografts. The ratio of 
Sertoli cells to germ cells in the first trimester controls and grafts was 8:1 and 10:1 
respectively, which is similar to previous reports for normal human fetal testes 
(Ostrer et al., 2007);(Bendsen et al., 2003). There was no significant difference 
between controls or grafts, suggesting that there is no imbalance between the 
survival of the two cells types, however it is not known whether the total number of 
germ cells and Sertoli cells is changed with the grafting technique. Quantification of 
total germ cell number is difficult due to the fact that the grafts may also contain 
surrounding skin and muscle as well as the testis tissue, therefore deriving ‘testis’ 
weight and volume is challenging. It is likely that there is some initial loss of germ 
cells initially after grafting, but the numbers may recover in some cases over the 
grafting period. Indeed we have obtained evidence of proliferation of both Sertoli 
and germ cells within the grafts. Germ cell proliferation in second trimester human 
fetal testis xenografts, as demonstrated by Ki67 straining, was occurring in 20-30% 
of cells. In grafts from second trimester fetal testis there was a significantly higher 
germ cell proliferation rate than in the equivalent post graft control. This may 
indicate that there is a compensatory increase in germ cell proliferation in response 
to germ cell loss, or alternatively that these cells are simply continuing to behave 
like the pre-graft control. Further studies will be required if we are to accurately 
determine the germ cell and Sertoli cell numbers. The present study investigated 
proliferation but not apoptosis. Further work is required to determine the relative 
contribution of proliferation and apoptosis to germ cell numbers. 
 
5.5.6. Germ cell development in testis xenografts 
Neonatal mouse testis xenografts achieved full spermatogenesis and displayed a full 
complement of germ cells, as has been described in previous studies (Schlatt et al., 
2002);(Honaramooz et al., 2002);(Yu et al., 2006). Xenografts from human and 
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marmoset testes contained a mixture of germ cells. This included germ cells that 
were located near the basement membrane and had the appearance of 
spermatogonia, whilst occasional germ cells with a gonocyte phenotype were 
identified in the centre of some cords. Cells with the same appearances were also 
identified in grafts from the second trimester human fetal testes in previous studies, 
however further characterisation of these germ cells was not performed (Yu et al., 
2006);(Povlsen et al., 1974);(Skakkebaek et al., 1974). We investigated the identity of 
the germ cells within the grafts further by looking at the expression profiles of germ 
cell proteins described previously in chapters 3 and 4. In grafts from human fetal 
testes, we observed differentiation of germ cells following a similar pattern to 
normal germ cell differentiation. Expression of proteins such as VASA and MAGE-
A4 was not detected in most first trimester testes (Gaskell et al., 2004);(Mitchell et 
al., 2008), however expression of these proteins was apparent in some of the germ 
cells after grafting. This is clear evidence that germ cells are able to differentiate in 
testis xenografts. In addition the proportions of germ cells with an undifferentiated 
‘gonocyte’ (AP-2, OCT4) phenotype decreased in second trimester xenografts, 
whilst germ cells with a more differentiated ‘spermatogonial’ phenotype (VASA, 
MAGE-A4 expression) increased, compared to the pre-graft control. This has been 
demonstrated to occur in the normal process of fetal human germ cell 
differentiation (Gaskell et al., 2004);(Mitchell et al., 2008);(Honecker et al., 2004). In 
addition there was no significant difference in the proportions of cells expressing 
the individual phenotypes of germ cell differentiation between grafts and control 
testes. This included the identification of a transition population of germ cells that 
displayed an intermediate phenotype of co-staining of undifferentiated and 
differentiated germ cell markers. This suggests that there is no arrest of 
differentiation during this transition phase. Normal progression of germ cell 
differentiation has also been shown in testis xenografts for fetal and neonatal 
marmosets. The marmoset has already been shown to be a good model for germ cell 
development in Chapter 4 (Mitchell et al., 2008)) and therefore the use of marmoset 
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testis xenografts may provide an alternative model, which negates the use of human 
tissue. Previous studies of xenografting have demonstrated accelerated maturation 
of germ cells and spermatogenesis in some species occurring earlier than the 
equivalent time in the normal animal (Schmidt et al., 2006b), including in the 
primate (Honaramooz et al., 2004). In the current study there was no evidence of 
premature entry into meiosis in the human fetal grafts or marmoset fetal and 
postnatal grafts. However this is unsurprising given the relatively short grafting 
period.  
 
5.5.7. Juvenile marmoset xenografts survive and retain spermatogonia 
The fact that fetal and neonatal marmoset xenografts produce little or no 
testosterone may affect the development of these grafts, because if the tissue was in 
situ we would expect concentrations of testosterone to be high. Xenografts from 
more mature animals tend to result in a decrease in graft survival (Rodriguez Sosa 
and Dobrinski, 2009), and it has been suggested that this is because of the presence 
of mature germ cell types (Huang et al., 2008). However, juvenile primate testes do 
not contain meiotic germ cells and normal testis development and germ cell 
proliferation at this age does not require high levels of testosterone (Plant, 
2006);(Kelnar et al., 2002). Very few studies have been performed using pre-pubertal 
testes for grafting (Oatley et al., 2005);(Goossens et al., 2008);(Honaramooz et al., 
2002). Completion of spermatogenesis has been demonstrated in juvenile rhesus 
monkey grafts (Rathi et al., 2008) and therefore we wished to investigate whether 
the juvenile marmoset may be suitable for testis xenografting, given that germ cell 
development in this species is very similar to the human. Retrieval rates were lower 
for these grafts than for the fetal and neonatal grafts. In addition the production of 
testosterone and seminal vesicle weights were also low. Testis structure and the 
appearance of the seminiferous cords appeared similar to controls during the 10 
week grafting period and there was characteristic staining for markers of germ, 
Sertoli, Leydig and peritubular myoid cells. In addition numerous germ cells 
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expressing VASA were identified within the grafts, similar to pre- and post-graft 
controls and we were able to show that spermatogonia were able to continue to 
proliferate. Although quantification was not performed, it appeared that there was a 
higher proportion of proliferating germ cells in the grafts compared to the pre-graft 
control. This could be due to an increase in proliferation to compensate for loss of 
germ cells immediately after grafting, or alternatively it is possible that the 
proliferating germ cells survive the grafting process better than the quiescent cells. 
Spermatogonial stem cells rarely divide and GFR1 has been shown to be a marker 
of spermatogonial stem cells in testes of rodents (Buageaw et al., 2005). GFR1 may 
also represent an SSC marker in rhesus monkeys (Hermann et al., 2007);(Hermann 
et al., 2009). Unfortunately the present study was unable to identify a reliable 
antibody for GFR1 and therefore could not demonstrate the preservation of SSC in 
these grafts, although such information would be useful to determine the potential 
for subsequent spermatogenesis. There was no evidence for the germ cell 
development indicative of spermatogenesis in these grafts although they were still 
at a pre-pubertal equivalent age. However, there was initiation of lumen formation 
in the grafts similar to that seen in the post-graft controls (Kelnar et al., 2002). Testis 
xenografting using pre-pubertal human testes has produced similar results, with 
demonstration of survival of xenografts from two patients with sickle cell anaemia 
aged 10 and 11. Survival rates were 66% after grafting for 4 and 9 months and there 
were occasional surviving germ cells that expressed MAGE-A4 (Goossens et al., 
2008). Survival of spermatogonia has also been shown in testes xenografts that were 
obtained at biopsy, from 5 boys aged 7-14 years and grafted for 6 months (Wyns et 
al., 2008). In addition, this study also demonstrated proliferation of cells within the 
surviving xenografts, based on Ki67 staining. Similar results were obtained from 
xenografts of testis tissue from young cryptorchid boys (Wyns et al., 2007). 
Successful xenografting of tissue taken from the juvenile age range could have 
future clinical relevance in terms of fertility preservation in childhood cancer 
survivors (Goossens et al., 2008);(Jahnukainen et al., 2006). 
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Testis xenografting provides a unique opportunity to recapitulate normal 
development of the testis in an in vivo system. The present studies have 
demonstrated that this is applicable to the study of fetal and neonatal development 
in the marmoset and also for fetal development in the human. The system can be 
used to produce numerous grafts of developing testis tissue from species in which it 
is difficult to perform direct interventions. This is particularly important for primate 
and human studies in which tissue supply, cost, logistics and acceptability of 
studies that assess treatment response are prohibitive. We have shown that human 
and marmoset grafts can reproduce testis development and this includes the first in 
vivo model for formation of the testicular cords. The opportunity to recapitulate 
testis development and the potential to manipulate the testicular environment may 
be used in the study of disorders of sex development, which occur during initial 
gonad formation, and the origins of CIS of the testis, which occurs during fetal life. 
The next chapter will begin to explore the effects of manipulating the testis 
environment in the fetal and neonatal marmoset, in addition to the effects of these 
treatments on human and marmoset perinatal xenografts. 
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6 Effects of manipulation of the gonadal environment on perinatal 




6.1.1. In vivo models of perinatal germ cell development 
Having established in vivo models of perinatal germ cell development in both the 
marmoset (chapters 4+5) and human (chapter 5), these models were subsequently 
used to investigate the effects of various manipulations of the gonadal environment 
on testicular development. 
 
6.1.2. The effects of GnRHa treatment on testis development in the 
perinatal marmoset 
The neonatal period is an important time for germ cell development in both the 
human and marmoset. During this period the remaining gonocytes are 
differentiating into spermatogonia (Rajpert-De Meyts et al., 2004) and there is a 
relatively high rate of germ cell proliferation (section 4.4.4.2). The neonatal period is 
also a period of reproductive hormonal activity (neonatal testosterone rise or ‘mini-
puberty’) (Mann and Fraser, 1996). During this period the levels of gonadotrophins 
and testosterone are elevated (Kelnar et al., 2002). It has been shown that 
suppression of this testosterone ‘surge’ can be achieved in primates including the 
marmoset with the use of GnRHa (Lunn et al., 1994);(Marshall et al., 2005). Neonatal 
GnRHa treatment results in a significant reduction in testis weight as well as a 
reduction in germ cell number and a significant reduction in the numbers of 
prespermatogonia in the testes of treated males compared with their control co-
twins (Sharpe et al., 2003a). It is unknown whether GnRHa can affect germ cell 
differentiation and proliferation during this period and in particular whether this 
treatment can result in a delay in maturation of germ cells, which may be relevant to 
the pathogenesis of TGCT (Rajpert-De Meyts, 2006). 
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6.1.3. The effects of phthalates on testis development in the perinatal 
marmoset 
In-utero exposure of fetal rats to DBP administered to pregnant dams has been 
shown to have deleterious effects on testis development in the rat (Fisher et al., 
2003). Indeed this model of in utero exposure has been used as a model for the 
human testicular dysgenesis syndrome (TDS) because it results in three of the four 
proposed features of TDS, namely cryptorchidism, hypospadias and infertility. 
However this model does not result in testicular CIS or TGCT, which is the other 
proposed disorder in TDS.  The effect of phthalates on the human testis remains to 
be elucidated, although it has been demonstrated by epidemiological studies that 
certain changes in male reproductive function are correlated with levels of exposure 
to phthalates (Main et al., 2006). In addition, the effects phthalates on the human 
testis has been investigated using in vitro techniques. Treatment of in vitro cultures 
of human fetal testis with MEHP (a metabolite of DEHP) has been shown to result 
in a decrease in germ cell number, but with no effect on testosterone production 
(Lambrot et al., 2009). In contrast in vitro treatment with MBP/DBP has no effect on 
testosterone production by human and rat testicular explants (Lambrot et al., 
2009);(Hallmark et al., 2007). This is surprising as in vivo treatment of neonatal 
marmosets with MBP results in a decrease in serum testosterone (Hallmark et al., 
2007) and suggests that in vitro studies of the effects of phthalates may not be an 
adequate model for the in vivo situation. To date there have been no studies that 
investigate the in vivo effects of phthalates on testis development in the human. 
 
6.2. Aims of the chapter 
This chapter aimed to investigate the effects of treatment with GnRHa or phthalates 
on testis development during the fetal and neonatal period, using the in vivo 
systems developed in chapters 4 and 5. The focus was on the effects of these 
treatments on germ cell proliferation and differentiation. 
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6.3. Materials and methods 
 
6.3.1. Human fetal testis tissue collection 
Human fetal testis tissue collection for use in xenografting is described in Section 
2.4.2. Pieces of tissue from 2nd trimester (14 weeks, n=1; 18 weeks, n=1) human 
fetuses were used for the DBP exposure xenografting experiments. Oral DBP 
administration to host mice xenografted with human fetal testis is described in 
section 2.6.6.2. Treatment of host mice with hCG is described in section 2.6.6.1 
 
6.3.2. Fetal and postnatal marmoset testis collection 
Marmoset testes from newborn animals exposed in-utero to MBP (section 2.5.2) 
were obtained as described in section 2.4.1. GnRHa treatment of neonatal 
marmosets is described in section 2.5.1 
 
6.3.3. Xenografting 
Castration and xenografting of testis tissue into nude mice was performed as 
detailed in section 2.6.1 – 2.6.5. 
 
6.3.4. Haematoxylin and eosin staining 
The method for haematoxylin and eosin staining is described in section 2.9. 
 
6.3.5. Immunohistochemistry 
Single immunohistochemistry was performed with DAB detection as described in 
section 2.10.2.1 - 2.10.2.6. The primary antibodies used for these experiments are 
listed in Table 2.1. Double staining was performed with DAB and fast blue detection 
as outlined in section 2.10.3. Details of conditions for double staining experiments 
can be found in Table 2.2. 
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Double immunofluorescence was performed as described in section 2.11.1. The 
primary and secondary antibodies, and detection labels used for these experiments 
are listed in Table 2.3. 
 
6.3.7. Serum testosterone radioimmunoassay 
Serum testosterone levels were measured in host mice as described in section 2.7. 
 
6.3.8. Quantification of gonocyte proportions and germ cell 
proliferation index  
The proportion of germ cells expressing gonocyte markers in postnatal marmosets 
treated with GnRHa was calculated after double immunofluorescence for VASA 
(germ cells) and NANOG (gonocytes). The total number of NANOG positive cells 
was divided by the VASA positive cells. The procedure for this quantification is 
described in section 2.12.2.1. 
 
The proliferation index for postnatal marmosets treated with GnRHa was calculated 
following double immunohistochemistry for VASA and Ki67. The quantification 





6.4.1. The effects of gonadotrophin suppression on germ cell 
development in the neonatal marmoset testis 
 
6.4.1.1. The effects of gonadotrophin suppression on germ cell 
differentiation in the neonatal marmoset testis 
To assess the effects of neonatal GnRHa treatment on germ cell differentiation, 
expression of NANOG was investigated at 6 weeks of age and compared with that 
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of co-twin controls. NANOG and VASA co-staining allowed calculation of the 
proportion of the total germ cells that still expressed the gonocyte marker NANOG. 
The proportion of germ cells expressing NANOG was less than 1% in both control 
and GnRHa treated animals and there was no difference between the two groups 
(Figure 6.1). No NANOG positive cells were identified in three of the control testes, 
compared to one of the treated animals. Overall, an average of 1 in 742 germ cells 
expressed NANOG in the controls, compared to 1 in 163 for treated animals, 
however this was not a statistically significant difference. 
 
Figure 6.1. Effects of GnRHa treatment on differentiation of gonocytes in neonatal 
marmosets. NANOG expression in germ cells of 6 week old marmosets treated for 4 weeks 
with a GnRHa and comparison with co-twin controls, n=8. Paired t-test, mean  sem. p>0.05. 
 
6.4.1.2. The effects of gonadotrophin suppression on germ cell 
proliferation in the neonatal marmoset testis 
The hypothalamo-pituitary-gonadal axis is active during the neonatal period in both 
the marmoset and human. We investigated the effects of suppressing 
gonadotrophins and hence testosterone production in the neonatal period, on germ 
cell proliferation. Treatment with GnRHa for the first four weeks of life resulted in a 
30% reduction in germ cell proliferation, when compared to control (Figure 6.2). 
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Figure 6.2. Effects of GnRHa treatment on germ cell proliferation in neonatal 
marmosets. a) Ki67 expression in 6 week old GnRHa treated marmosets and comparison 
with vehicle treated controls, n=4. Scale bars = 50 m. Note positive (arrows) and negative 
(arrowhead) germ cells. Original magnification x20 (upper panels), x40 (lower panels). b) 
Germ cell proliferation index in 6 week old marmosets treated for 4 weeks with GnRHa and 
comparison to co-twin controls n=4. Paired t-test, mean  sem. * p<0.05. 
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6.4.2. The effects of phthalates on perinatal testis development 
 
6.4.2.1. Effects of in-utero exposure to MBP on germ cell 
differentiation in the marmoset during the neonatal period 
Newborn marmosets exposed in-utero to MBP did not demonstrate any evidence of 
malformation of the reproductive system. In addition, testis weight was not 
different when compared to controls (Fig. 6.3).  
 
Figure 6.3. Effects of in-utero exposure to MBP on neonatal testis weight in 
marmosets. Testis weight for in-utero MBP treated neonatal marmosets and comparison to 
vehicle treated controls. n=6 MBP, n=3 controls. Unpaired t-test, mean  sem, p>0.05. 
 
In terms of expression of proteins associated with androgen action, expression of 3-
HSD and androgen receptor was detected in both treated animals and controls 
(Figure 6.4). 3-HSD expression was immunolocalised to a larger proportion of 
Leydig cells in control compared to MBP-exposed animals. Although germ cell 
numbers were not affected (McKinnell et al., 2009), there was an unusual 
distribution of germ cells within the testes of some of the MBP-exposed animals. 
Large aggregates of germ cells (>10 cells/cluster) were noted within these testes 
when Sertoli cell cytoplasm was stained with AMH; germ cell clusters appear as 
unstained groups of cells (Figure 6.4). 
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Figure 6.4. Expression of AR, 3-HSD and AMH in newborn marmosets exposed in-
utero to MBP. MBP exposed animals are compared with vehicle treated controls. All three 
proteins are expressed in both groups, however AMH staining revealed clusters of unstained 
germ cells (arrows) in some MBP-exposed animals. Scale bar = 50m. 
 
Further investigation of these clusters with immunohistochemistry confirmed that 
they were germ cells and these cells expressed OCT4 and AP-2, which suggests 
that they resembled gonocytes (Figure 6.5). In addition some of these cells were also 
immunopositive for VASA, when OCT4 and VASA co-localisation was performed, 
with evidence of the intermediate population of OCT4+/VASA+ germ cells and 
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OCT4-/VASA+ prespermatogonia (Figure 6.6). In the rest of these testes expression of 




Figure 6.5. Expression of OCT4, AP2-, VASA and MAGE-A4 in MBP exposed newborn 
marmosets and controls. Germ cell clusters express OCT4 and AP2- (arrows), whilst 
VASA and MAGE-A4 are not expressed in clusters but appear uniformly distributed 
throughout the exposed testis. Original magnification x40 (AP-2 x20). Scale bars = 50m.  
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Figure 6.6. Co-expression of OCT4 and VASA in MBP exposed newborn marmosets 
and controls. Germ cell clusters express OCT4 (brown, black arrow), but are largely 
negative for VASA (blue), whilst fluorescent staining revealed that some of these OCT4 (red) 
positive cells also expressed VASA (inset, white arrow). Original magnification x20 (inset 
magnification x63). Scale bar = 50m. 
 
Germ cell clusters were further investigated for expression of KIT (Figure 6.7). KIT 
was expressed in the germ cell clusters and was demonstrated to occur in the same 
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Figure 6.7. Co-expression of KIT with OCT4 or MAGE-A4 in MBP exposed newborn 
marmosets and controls. Germ cell clusters co-express KIT (brown) and OCT4 (blue, 
upper panels), whilst KIT positive clusters (arrow) do not express MAGE-A4 (blue, lower 
panels). Scale bar = 50m. 
 
The appearance of these germ cell clusters led us to speculate that there may be a 
process of abnormal differentiation of the germ cells within these clusters and that 
these may persist in older animals. Such an effect on germ cell differentiation could 
predispose to CIS in the developing testis. In order to test this hypothesis some of 
the animals exposed in-utero to MBP were allowed to live into adulthood. However, 
examination of the adult testis failed to demonstrate persistence of either germ cell 




Chapter 6   Effects of manipulation of the gonadal environment on  
   perinatal human and marmoset testis development 
245 
Proliferation of cells within the seminiferous tubules of MBP exposed marmosets 
was also investigated by immunostaining for Ki67. Germ cell proliferation was 
evident in both the MBP exposed and vehicle treated controls and there was no clear 
difference in Ki67 expression (Figure 6.8), although quantification studies were not 
undertaken. It was also noted that the Sertoli cells were proliferating in both MBP-




Figure 6.8. Ki67 expression in neonatal marmosets exposed in-utero to MBP. Germ 
cells expressing Ki67 (arrows) are seen in both the treated animals and the vehicle treated 
controls. Sertoli cell proliferation is also present in both sections. Scale bar = 50m.  
 
6.4.2.2. Effect of 6 hours of DBP treatment on human fetal testis 
xenograft development 
Having established the xenografting approach as a good model of human fetal testis 
development investigation of the effect of treatment with phthalate on their 
development was performed. Host animals carrying second trimester (14 weeks) 
human fetal testis grafts were exposed to DBP for 6 hours (DBP-6h). Pieces of testis 
tissue from a single second trimester fetus were grafted into 6 mice (Table 6.1). The 
serum testosterone and seminal vesicle weights appeared to be related to whether 
the host animal received hCG rather than whether it received DBP 6h earlier. It was 
not possible to perform statistical analysis of serum testosterone or seminal vesicle  
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weights due to the low numbers of host animals. Although the grafts from the DBP-
6h treated animals were smaller than those from vehicle treated animals this was 
















2  x 0.46 48 9 (75) 2.24 
2 x x <0.1 18 8 (67) 1.69 
1   1.07 63 4 (67) 1.78 
1 x  0.13 18 4 (67) 1.45 
 
Table 6.1. DBP-6h treatment of host mice carrying second trimester (15 weeks) human 
fetal testis xenografts. 
 
 
Figure 6.9. Effect of DBP-6h on second trimester graft weight. Graft weights from a 
single second trimester (15 weeks) human fetal testis. Grafts from host mice treated with 
vehicle or DBP-6h. Vehicle grafts (n=17), DBP-6h grafts (n=8). Unpaired t-test, mean  sem, 
p>0.05.  
 
There was no difference in morphology of the DBP-6h exposed grafts when 
compared to the vehicle exposed controls. Grafts from animals given hCG treatment  
expressed 3-HSD and AR regardless of whether they had been exposed to DBP-6h 
or vehicle, although expression appeared less intense in the DBP treated grafts 
(Figure 6.10). There was no clear difference in germ cell differentiation  
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status between DBP-6h and vehicle exposed grafts, as evidenced by similar 
OCT4/VASA co-staining (Figure 6.11). OCT4 positive cells remained in both the 
DBP exposed and vehicle grafts and there was no observable difference between 
VASA expression between the DBP exposed and vehicle grafts. 
 
 
Figure 6.10. Effect of DBP-6h on tubule structure, 3-HSD and AR expression in 
second trimester human fetal testis xenografts. Comparison of DBP-6h and vehicle 
exposed second trimester (14 weeks) human fetal testis xenografts. Host animals also 
received hCG. H+E staining (upper panels) demonstrates similar morphology. 3-HSD and 
AR expression is comparable between DBP-6h and vehicle exposed controls. Scale bar = 
50m. Original magnification x20 (AR magnification  x40). 
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Figure 6.11. Effect of DBP-6h on germ cell differentiation in second trimester human 
fetal testis xenografts. Comparison of DBP-6h and vehicle exposed second trimester (14 
weeks) human fetal testis xenografts. Host animals also received hCG. OCT4 (brown) and 
VASA (blue) are expressed in similar proportions in both DBP exposed and vehicle exposed 
grafts. Scale bar = 50m. Original magnification x20 (Lower panels x40). 
 
Proliferation of cells within the seminiferous tubules was also investigated by 
immunostaining for Ki67. Germ cell proliferation was evident in a small proportion 
of both the DBP-6h exposed animals in addition to the vehicle exposed controls 
(Figure 6.12). There was no clear difference between Ki67 expression in the treated 
animals compared to the controls and quantification studies were not undertaken. It 
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Figure 6.12. Ki67 expression in DBP-6h exposed second trimester (14 weeks) human 
fetal testis xenografts. Germ cells expressing Ki67 (arrows) are seen in grafts from both 
DBP and vehicle exposed hosts. Sertoli cell proliferation is also present in both sections. 
Scale bar = 50m.  
 
Given that there was no clear effect of DBP-6h on human fetal testis and germ cell 
development, host mice carrying second trimester (18 weeks) human fetal testis 
xenografts were treated for 78 hours with DBP (DBP-78h). All mice received hCG. 
Serum testosterone and seminal vesicle weights were lower in castrate hosts than in 
intact hosts. When castrate and intact animals were analysed separately there was a 
higher serum testosterone in DBP-78h treated animals than in the vehicle controls 
(Table 6.2). The proportion of grafts retrieved was similar for vehicle and DBP-78h 
















1  x 0.3 65 3(50) 2.73 
1 x x 9.5 485 6(100) 3.56 
1   1.0 89 5(83) 2.40 
2 x  32.4 362 9(75) 3.17 
 
Table 6.2. DBP-78h treatment of host mice carrying second trimester (18 weeks) 
human fetal testis xenografts. 
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Graft weights were not significantly different between the four groups and this was 
also the case when all the grafts from vehicle treated animals were compared with 
DBP-78h treated animals, although DBP-78h treated grafts were slightly smaller on 
average (Fig. 6.13).  
 
Figure 6.13. Graft weights from second trimester human fetal testis grafts exposed to 
vehicle or DBP-78h. Grafts were taken from an 18 week human fetal testis. All host animals 
received hCG treatment.  Vehicle grafts (n=9), DBP-78h grafts (n=4). Unpaired t-test, mean 
 sem, p>0.05.  
 
Seminiferous cord structure was maintained in the DBP-78h grafts, with no obvious 
difference observed when compared to controls (Figure 6.14). There was also no 
difference between the grafts taken from intact or castrate hosts.  
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Figure 6.14. H+E staining of second trimester human fetal testis xenografts from intact 
and castrate hosts exposed to vehicle or DBP-78h. Grafts were taken from an 18 week 
human fetal testis and DBP exposed grafts are compared to vehicle exposed controls.  Scale 
bar = 50m. 
 
Two of the DBP-78h exposed grafts were noted to contain a multinucleated 
gonocyte within the tubule (Figure 6.15). No multinucleated gonocytes were noted 




Figure 6.15. H+E. Multinuncleated gonocyte in 
a DBP-78h treated second trimester human 
fetal testis xenograft.  
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6.5. Discussion  
 
6.5.1. GnRHa treatment of neonatal marmosets reduces germ cell 
proliferation, but does not delay differentiation of gonocytes 
It is well documented that the hypothalamo-pituitary gonadal axis is more active 
during specific periods of life in the human and non-human primate. In the human 
this includes a neonatal period of high activity, during which testosterone levels 
approach or are within the adult range (Mann and Fraser, 1996);(Forest et al., 1973). 
A similar rise occurs in the marmoset and this testosterone rise can be abolished by 
administration of GnRHa (Lunn et al., 1994). CIS and TGCT have a significantly 
increased prevalence in patients with undervirilisation syndromes. In addition, 
these patients display delay of germ cell maturation, with persistence of germ cells 
expressing gonocyte markers into childhood (Cools et al., 2006b). This includes the 
expression of OCT4, which can be detected in the centre of the tubules in patients 
with dysgenetic testis beyond the first year of life (Cools et al., 2006b);(Rajpert-De 
Meyts et al., 2004).  
 
It has been suggested that the neonatal testosterone rise is responsible for the 
ensuring that all germ cells have differentiated from gonocyte to spermatogonia by 
the end of infancy (Huff et al., 2001);(Hadziselimovic et al., 1986). The present 
studies investigated whether suppression of the neonatal testosterone rise in the 
neonatal marmoset testis delayed normal differentiation and proliferation of germ 
cells, as occurs in humans with undervirilisation syndromes (Cools et al., 2005). 
Expression of the pluripotency markers OCT4 and NANOG typically found in 
gonocytes was investigated. OCT4 is still expressed in rare germ cells at 6 weeks of 
age in the marmoset (Section 4.4.3.1) and also in GnRHa treated marmosets. The fact 
that OCT4 is still present in controls means that a large number of animals would be 
required to detect a significant difference in the proportion of germ cells expressing 
this marker. Therefore, NANOG expression was chosen for evaluation in co-twin 
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treated and control animals, because we have shown that most animals do not 
express NANOG at 6 weeks of postnatal age (Section 4.4.3.1). Less than 1% of germ 
cells expressed NANOG in either GnRHa treated or control testes and no significant 
difference was detected between the control and treated animals. It is not clear 
whether the trend for a slight increase in NANOG expression in some treated 
animals could result in persistence of occasional gonocytes beyond 6 weeks of age, 
although preliminary studies of animals treated neonatally with GnRHa and killed 
at 14 weeks of age have not demonstrated any persistence of gonocyte markers. 
These results indicate that suppression of gonadotrophins during the neonatal 
period does not delay differentiation of gonocytes. It is recognised that in patients 
with AIS, the risk of CIS and TGCT is much higher for those with PAIS than patients 
with CAIS. Indeed the malignancy risk is 50% for PAIS and only 2% for CAIS 
(Looijenga et al., 2007b). In addition, patients with hypogonadotrophic 
hypogonadism are not at increased risk of CIS/TGCT, despite having cryptorchid 
testes (Looijenga, 2009). These results suggest that delay in germ cell differentiation 
may be related to reduced, rather than a complete suppression of testosterone levels 
or testosterone action. 
 
The present studies also investigated whether germ cell proliferation could be 
affected by GnRHa suppression of gonadotrophins and testosterone activity. It has 
previously been demonstrated that GnRHa treatment of the marmoset during the 
childhood phase of development does not significantly affect the expression of 
PCNA, compared to controls (Kelnar et al., 2002). In this study the expression of 
PCNA in germ cells was evident in just over 40% of cells for both treated and 
control animals. The neonatal period has been described as a period of active 
proliferation of germ cells (Chemes, 2001) and the present studies have shown that 
animals treated neonatally with GnRHa have a significantly reduced rate of germ 
cell proliferation, compared to the controls. However complete suppression of germ 
cell proliferation did not occur. The results of the present studies are in keeping 
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with results in previous studies that demonstrated a 27% reduction in the increase 
of germ cell numbers in marmosets treated with GnRHa from birth to 18-24 weeks, 
compared to controls (Sharpe et al., 2003a). This is similar to the 30% decrease in 
germ cell proliferation in animals treated from birth to 4 weeks in the present 
studies. These results suggest that germ cell proliferation in the neonatal marmoset 
testis is partially dependent on gonadotrophins and testosterone, but that other as 
yet unidentified factors are also important. In the human there are high rates of 
germ cell proliferation in the first three months of life, which coincides with the high 
levels of gonadotrophins and testosterone in the neonatal period (Berensztein et al., 
2002). However the highest rates of proliferation are seen in the first month of life 
when these hormones are not at their peak. Therefore in addition to 
gonadotrophins, other factors that are high in the neonatal period such as growth 
hormone or prolactin may be important (Berensztein et al., 2002).  
 
The reverse situation occurs in the adult primate testis, compared with the neonatal 
testis. In adult rhesus monkeys, germ cell differentiation in spermatogonia is 
absolutely gonadotrophin dependent, whilst proliferation of Ad, Ap and B 
spermatogonia is independent of gonadotrophins (Marshall et al., 2005). 
Proliferation of these spermatogonia was unchanged when animals treated with 
GnRHa alone were compared with animals that had received GnRHa followed by 
testosterone or FSH or a combination of both (Marshall et al., 2005). GnRHa resulted 
in a failure of differentiation of germ cells beyond type A spermatogonia in adult 
rhesus monkeys, whilst the replacement of testosterone +/- FSH resulted in the 
resumption of full spermatogenesis with an increase in the numbers of 
differentiating spermatogonia in the testosterone + FSH group (Marshall et al., 
2005). In the present studies using marmosets, results have demonstrated that 
although levels of gonadotrophins and testosterone are high during neonatal and 
adult life, it appears that the mechanisms controlling germ cell proliferation and 
differentiation during these two periods are different.  
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6.5.2. In-utero phthalate treatment does not result in malformation of 
the reproductive tract or alteration of androgen levels  
In the rat model of TDS, treatment of pregnant dams with 500mg/kg DBP  results in 
high rates of reproductive tract malformations such as cryptorchidism and 
hypospadias in their offspring (Fisher et al., 2003);(Mylchreest et al., 1998). No such 
abnormalities were noted in the newborn marmosets exposed in-utero to MBP. 
Given the high percentage of DBP-exposed rats that exhibit these abnormalities it 
would be expected that if these effects also occurred in marmosets then of the 11 
marmosets that were exposed to MBP, up to 7 of them would have cryptorchidism 
and 2 would have hypospadias (McKinnell et al., 2009). The failure to find any of 
these abnormalities does not rule out the fact that MBP may have an effect, but it 
would appear that the marmoset fetus is relatively resistant to perturbations as a 
result of exposure to MBP as compared with the rat. In rats, exposure to DBP has an 
impact on androgen dependent tissues and the levels of intratesticular testosterone 
have been shown to be reduced by 70-90% in the fetus towards the end of in-utero 
treatment (Fisher et al., 2003); treatment with 1000mg/kg MBP has been shown to 
reduce fetal intratesticular testosterone levels by >90% (Shono et al., 2000). However, 
postnatal serum testosterone levels in DBP exposed rats were not significantly 
different from those of controls at 4 days of postnatal age, despite the suppression 
that had occurred during fetal life (Fisher et al., 2003). The neonatal marmosets 
exposed in-utero to MBP did not have significantly different serum testosterone 
levels to control animals at birth, although it is not known whether testosterone had 
been affected during the treatment period. However it is notable that direct 
administration of MBP to neonatal marmosets results in a significant reduction in 
serum testosterone levels 5 hours after treatment (Hallmark et al., 2007) and it is 
possible that this is the case for the in-utero treated marmosets, however this 
remains to be determined. 
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DBP (500mg/kg/day) treatment of host mice carrying second trimester human testis 
xenografts did not reduce serum testosterone production after 6 or 78 hours when 
compared to vehicle treated controls and this was regardless of treatment with hCG. 
In fact testosterone levels and seminal vesicle weights were highest in the host 
animals that received DBP. This would appear to be at odds with the results 
reported by Swan et al who demonstrated an inverse relationship between the 
anogenital index (AGI, a reflection of fetal testosterone levels) of children and the 
prenatal maternal urinary MBP level of the mothers (Swan et al., 2005). However 
another study failed to show an association between maternal MBP levels and AGD 
in male offspring (Huang et al., 2009). In the current study we also demonstrated 
that the testes from MBP treated neonatal marmosets and DBP exposed human fetal 
testis xenografts expressed both AR and 3-HSD, indicating that the tissue 
maintained a capacity for steroid biosynthesis as well as the potential to respond to 
testosterone. Expression of 3-HSD appeared to be in relatively fewer cells in DBP 
exposed human fetal testis xenografts than in vehicle exposed grafts, but this was 
not quantified. Based on our observations it appears that the effects of phthalates on 
testosterone production by marmoset and human testis are not as pronounced as in 
the rat, suggests that phthalates may have a less striking impact on developmental 
competence of the reproductive tract than that inferred from rodent studies  
 
6.5.3. Phthalate treatment may have testosterone independent effects 
on testis development 
 
6.5.3.1. In-utero MBP causes increased undifferentiated germ cell 
clustering in neonatal marmosets 
In some, but not all, newborn marmosets exposed in-utero to MBP there were 
differences in germ cell distribution with large clusters of germ cells located in 
regions throughout the testis, although quantification of germ cells revealed no 
difference in overall germ cell number (McKinnell et al., 2009). This contrasts with 
the situation in the rat in which a reduction in germ cell number is seen in DBP 
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exposed animals (Ferrara et al., 2006).  Occasional germ cell clusters occurred in the 
control animals but they were found less frequently, in fewer animals and each 
cluster contained fewer germ cells. The cells within the germ cell clusters in MBP-
exposed newborns displayed the phenotype of gonocytes as the expressed proteins 
such as OCT4, NANOG, AP2 and KIT. This included co-expression of KIT and 
OCT4, which has been shown to be characteristic of gonocytes (Honecker et al., 
2004);(Gaskell et al., 2004). This was further confirmed by the lack of expression of 
MAGE-A4 in these KIT expressing clusters (Figure 4.12). These expression profiles 
are in keeping with normal differentiation of gonocytes (OCT4+/KIT+/MAGE-A4-) 
via intermediate germ cells (OCT4low/-/KIT-/MAGE-A4-) to prespermatogonia (OCT4-
/KIT-/MAGE-A4+) (Gaskell et al., 2004). No atypical germ cell expression profiles 
were identified in the clusters. In the MBP-exposed animals, the spermatogonia 
expressing VASA or MAGE-A4 appeared to be distributed throughout the tubules 
in a similar manner to controls, although germ cells in transition (OCT4+/VASA+) 
were occasionally noted within the clusters. Prolonged expression of OCT4 in germ 
cells has been demonstrated in the DBP exposed fetal rat (Ferrara et al., 2006) and 
the appearance of these gonocyte clusters led us to investigate whether cells 
expressing gonocyte markers persisted into adulthood. There was no difference 
between the relative numbers of cells with the different phenotypes and when adult 
animals that had been exposed to MBP in-utero were analysed there were no germ 
cell clusters and importantly no germ cells were identified that expressed OCT4, 
NANOG or AP2 (McKinnell et al., 2009). This rules out the persistence of 
undifferentiated fetal germ cells and this suggests that in-utero MBP treatment 
using the current regimen does not induce CIS in the marmoset.  
 
Despite the finding of germ cell clustering in the MBP exposed marmosets, there 
were no similar effects in the DBP exposed human fetal testis xenografts. Both the 
distribution and relative proportion of the germ cells was similar in both treated 
and control grafts. This included both gonocytes and spermatogonia. Although 
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there was no such clustering it is important to note that the choice of phthalate and 
the treatment regime was different for the marmoset and human studies. We have 
already demonstrated in the previous chapter that the xenografting technique 
provides a comparable model to normal development (chapter 5) and that the 
development of germ cells within the testis is similar between the marmoset and 
human (chapter 4).  
 
6.5.3.2. Germ cell proliferation is not affected by in-utero MBP 
exposure in marmosets or by DBP in human fetal testis xenografts 
Previous studies have demonstrated an effect of phthalate exposure on perinatal 
germ cell proliferation in rats (Ferrara et al., 2006). In-utero exposure of rats to DBP 
resulted in delayed exit from quiescence in germ cells between postnatal day 4-8, 
with a 28% reduction in Ki67 expression (Ferrara et al., 2006), whilst a study of 
human fetal testes cultured for 3 days with MEHP did not demonstrate an effect on 
proliferation despite a reduction in germ cell number (Lambrot et al., 2009). We 
have shown that germ cell proliferation continues normally in newborn marmosets 
exposed in-utero to MBP and that germ cell number was not altered by treatment. 
Proliferation of VASA+ germ cells was variable between individuals within both 
groups, but there was no difference between the number of proliferating germ cells 
in MBP treated animals and controls (McKinnell et al., 2009). Importantly it was also 
noted that the germ cell clusters did not contain an abnormally high expression of 
Ki67 positive cells (McKinnell et al., 2009). In human fetal testis xenografts we 
observed proliferation of germ cells in grafts from both vehicle and DBP treated 
hosts with no clear difference between the two groups. Overall these results indicate 
that phthalate treatment as assessed using the methods described does not have any 
striking effect on germ cell proliferation.  
 
6.5.3.3. DBP may reduce human fetal testis xenograft weight 
Despite the lack of evidence that there is an effect of phthalates on androgen 
production in marmoset and human testes, we have demonstrated effects of these 
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chemicals on other aspects of testis development. Testosterone independent effects 
on germ cells have also been demonstrated in the mouse, a species in which 
testosterone production is not affected by phthalates (Gaido et al., 2007). Mice 
treated with DBP exhibit an increased number of multinucleated gonocytes per cord 
compared with controls, without a measurable decrease in testicular testosterone. 
Similarly, in vitro studies of fetal human testis showed that four days of MEHP 
treatment resulted in germ cell apoptosis without affecting testosterone production 
in the explants (Lambrot et al., 2009). Testis weight at birth has been shown to be 
significantly decreased in rats exposed to DBP (Fisher et al., 2003). In our studies 
testis weight in neonatal marmosets treated in-utero with MBP was not significantly 
different to controls. Human fetal testis grafts from hosts treated with DBP were 
smaller by 25% (DBP-6h) and 12% (DBP-78h), than the corresponding vehicle-
exposed grafts although this was not statistically significant. It is possible that the 
low numbers of human fetal testis grafts and host animals may mask a significant 
effect on graft weight and therefore the numbers should be increased. However the 
25% decrease in graft weight occurred in the grafts that had only been exposed to 
DBP for 6 hours and it is unlikely that such a short period of treatment would 
produce such an effect, so the weight changes may be incidental. 
 
6.5.4. Phthalate treatment regimes vary between studies and this may 
be reflected in the variable results 
When interpreting the results of phthalate treatment studies there are several factors 
that must be taken into account. Firstly the choice of compound is variable between 
studies. Many studies have used DBP, which requires metabolism into the active 
compound MBP. There may be differences in metabolism that could account for 
some of the differences between species. DBP treatment can result in a rat model of 
TDS. Maternal and fetal concentrations of MBP following DBP (500mg/kg) 
treatment in mice have been shown to be at least equivalent to those attained in the 
rat (Gaido et al., 2007) and it was assumed that the doses used in rats to induce TDS 
would result in equivalent exposure of the xenografts to the active metabolite.  
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However, this dose of DBP did not suppress testosterone production from the 
xenografts or from intact host mice. It is unknown how much DBP and MBP the 
graft tissue is exposed to and this may be affected by variation in metabolism of 
DBP in host mice, compared to rats. As a result the dose may need to be altered, 
particularly as the effects of DBP in the rat are dose-dependent (Mylchreest et al., 
1998). In this regard it may be useful to assess the effects of DBP on xenografts using 
a nude rat host, which has the same immunodeficiency phenotype as nude mice 
(Cash et al., 1993). Whilst DBP was used for treatment of human fetal testis 
xenografts, MBP was used for in-utero marmoset treatment because the marmoset 
has been described as a poor metaboliser of diesters into their active monoester 
metabolites (Rhodes et al., 1986). The timing of treatment is also variable between 
studies. This may be particularly important because a key window of development, 
during which suppression of androgen levels will result in reproductive tract 
abnormalities has been described for the rat (Welsh et al., 2008). The present studies 
extrapolated from the timing of the ‘masculinisation window’ in fetal rats for DBP 
exposure in human fetal testis xenografts. However, these grafts were only exposed 
during a short period of fetal development and this may explain why effects on 
germ cells were not seen as it is still possible that treatment did not coincide with a 
critical window of development.  
 
6.5.5. Conclusion 
This chapter has demonstrated that suppression of testosterone with GnRHa in the 
neonatal marmoset does not significantly affect germ cell differentiation. This 
suggests that persistence of germ cells with a gonocyte phenotype beyond infancy, 
as occurs in the pathogenesis of TGCT is not simply a consequence of suppression 
of gonadotrophins and testosterone. We have also demonstrated that germ cell 
proliferation in the marmoset is partially gonadotrophin dependent as opposed to 
other periods of life such as the childhood period. Exposure of human and non-
human primate testes to DBP/MBP in-utero or neonatally has failed to demonstrate 
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the reproductive and testicular abnormalities that are seen in the rat model of TDS, 
although there were some possible effects on germ cell development in the 
marmoset exposed in-utero to MBP. However, given the small numbers of animals 
treated these results should be considered preliminary. Further study is required to 
determine the optimum conditions for phthalate treatment including the 
appropriate phthalate ester, dose, timing and duration, before firm conclusions on 
the effects of these chemicals on human testis development can be made. 
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7 Final discussion 
 
This thesis aimed to investigate the development of the human fetal and early 
postnatal testis, with particular emphasis on the origins and pathogenesis of TGCT. 
Initial investigation focused on the origins of the pre-neoplastic CIS cells by 
analysing sections of testis taken from adult patients with TGCT (chapter 3). It 
became clear that models of in vivo testis development during fetal life would 
potentially provide more insight into the development of CIS and TGCT. Two 
approaches were used to develop such in vivo models. The first approach was to 
investigate the Common Marmoset monkey as an animal model of human testis 
development during fetal and postnatal life (chapter 4), This species was selected as 
previous  studies had determined that the organisation of spermatogenesis in adult 
marmosets closely resembles that in the human (Millar et al., 2000). A second 
approach involved the use of testicular xenografting to attempt to recapitulate 
normal testis development in the human and marmoset using a nude mouse host 
(chapter 5). Finally the thesis aimed to disrupt normal testis development in these in 
vivo models using hormonal suppression and endocrine disruptors that are known 
to affect testis development or result in testicular dysgenesis in other species 
(chapter 6). 
 
CIS cells are postulated to arise from transformed fetal gonocytes, based on several 
factors such as morphology and expression of various protein markers (Skakkebaek 
et al., 1987):(Rajpert-De Meyts, 2006), and heterogeneity in expression of these 
proteins has been described (Rajpert-De Meyts et al., 1996). Although some of these 
proteins (e.g. MAGE-A4) are described as being present in a subpopulation of CIS 
cells, others (e.g. OCT4, VASA) are described as being present in all CIS cells 
(Rajpert-De Meyts, 2006), (Looijenga et al., 2003a). The present studies have 
characterised the protein expression profiles of the subpopulations of CIS cells using 
double and triple immunohistochemical techniques. This approach has revealed 
that expression of proteins previously described as being present in the majority of 
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CIS cells, such as MAGE-A4 and VASA are only expressed in a small proportion of 
the CIS cell population. For example MAGE-A4 and VASA were only present in a 
few CIS cells, whilst most of the germ cells within a CIS-containing tubule that 
express MAGE-A4 and VASA are not CIS cells. Classification of CIS cells is based on 
morphological appearance and expression of proteins such as OCT4, which has 
been reported to be present in all CIS cells (Looijenga et al., 2003a). The present 
study has demonstrated that there is a population of CIS cells that do not express 
OCT4 and this is based on the finding that some of the OCT4 negative germ cells 
express other markers of CIS, such as PLAP. It could be argued that the OCT4 
negative CIS cells may in fact be cells that have progressed to invasive disease, 
however these OCT4 negative cells are also present in pre-pubertal patients prior to 
the formation of a tumour, which suggests that they are CIS cells. It remains to be 
determined what the relevance of the different CIS phenotypes is to the subsequent 
development of TGCT. However, there are implications for studies that rely on 
accurately identifying CIS cells, such as recent studies that use laser microdissection 
of CIS cells to analyse the gene expression profiles of these cells (Sonne et al., 2009). 
The quality of the data gained in these studies depends on being able to accurately 
discriminate between CIS and non-CIS cells. However as the present studies have 
shown that the use of expression of a single ‘CIS’ marker will not identify all CIS 
cells and conversely the lack of such protein expression does not rule out the 
possibility that a cell is a CIS cell validation and interpretation of data generated in 
studies where cell identity is important will need to take these findings into account.  
 
The present studies have also identified subpopulations of germ cells that have 
protein expression phenotypes distinct from those found in normal human fetal 
germ cells. Whilst the majority of the protein expression profiles in CIS are also 
found in fetal germ cells and support the concept of a fetal origin for CIS cells 
(Skakkebaek et al., 1987);(Rajpert-De Meyts, 2006), the finding of these unique 
expression phenotypes in CIS cells suggests that there may be downregulation of 
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some of these proteins in a subset of the CIS cells. No association was demonstrated 
between the individual subpopulations and the resulting tumour type and it 
remains to be determined what the significance of the different expression profiles 
might be. The present studies have also demonstrated that proliferation of germ 
cells is variable in the various subpopulations of CIS cells. The populations of cells 
expressing a gonocyte phenotype (OCT4+/VASA- or OCT4+/MAGE-A4-) have higher 
proliferation rates than those that express a differentiating phenotype. The 
relevance of the increased proliferation in these subpopulations of CIS cells is 
unclear but it could be related to the invasive potential of the subpopulation. 
Interestingly the proliferation rate of the various subpopulations of CIS cells was 
very similar to that demonstrated in the normal human fetal testis and includes both 
in situ human fetal testes and xenografted testes and this suggests that CIS cells may 
retain the proliferation profile of human fetal testes and that the xenografting model 
is a suitable system in which to investigate proliferation of germ cells during fetal 
life.   
 
In the normal human fetal testis, there is a mixture of germ cells with different 
phenotypes within a single tubule (Gaskell et al., 2004) and this is also the case for 
CIS cells (Rajpert-De Meyts et al., 1996). The present study has described the 
expression profiles in more detail and also identified expression profiles that have 
not been described previously. In the normal human fetal testis, differentiation of 
germ cells from gonocytes into spermatogonia occurs throughout fetal life and into 
the postnatal period and a mixture of cells at different stages of this process are 
found within an individual tubule at any given time. The prolonged period of 
gonocyte differentiation in humans may predispose to the development of CIS 
given the right circumstances (Rajpert-De Meyts, 2006). Persistence of gonocytes 
beyond the normal period of development into spermatogonia has been proposed to 
result in CIS and this is supported by the fact that delay in germ cell differentiation 
occurs in patients with DSD, a population that are at increased risk of TGCT (Cools 
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et al., 2006b). The present studies have demonstrated that the same pattern of 
prolonged and asynchronous differentiation from gonocytes to spermatogonia 
occurs in the normal marmoset testis during fetal and early postnatal life. In 
addition, the differentiation of germ cells in fetal life has been replicated in an in vivo 
xenografting model for both the human and marmoset, including the prolonged and 
asynchronous differentiation of gonocytes. The development of these in vivo 
systems provide a unique opportunity to test the hypothesis that CIS cells result 
from delayed differentiation of fetal germ cells and that asynchronous 
differentiation of these cells may predispose to the formation of CIS cells. Two 
approaches were used to attempt to induce delay in gonocyte differentiation or CIS 
using the marmoset and human testis. Previous studies have demonstrated that 
exposure of fetal rats to the phthalate DBP results in a collection of abnormalities 
characteristic of human TDS (Fisher et al., 2003). Notably, this does not include CIS 
and TGCT. If the hypothesis of asynchronous gonocyte differentiation predisposing 
to CIS is correct, then this may explain why CIS has not been described in the rodent 
and would also leave open the possibility that phthalates may induce CIS in the 
human and marmoset. The present studies explored exposure of fetal marmoset and 
human testes to the phthalate DBP (MBP) using different in vivo approaches. 
Although one exciting observation obtained during these studies was that a 
proportion of marmosets exposed in utero to MBP exhibited gonocyte clusters 
within the seminiferous cords at birth, these did not persist into adulthood and 
there was no evidence of cells with a CIS phenotype. In xenografts from fetal human 
testes exposed to DBP (via mouse hosts) there was no apparent effect on germ cell 
differentiation or proliferation. It remains unclear whether there are effects of 
phthalates on human fetal testis development or whether the lack of effect in the 
present studies is due to the choice of treatment, timing of exposure or duration of 
treatment. A programming window has been described in rats, during which 
masculinisation of the reproductive tract can be disrupted by anti-androgens (Welsh 
et al., 2008). Notably, the consequences of treatment administered only during this 
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critical period of development included some of those described for TDS, such as 
cryptorchidism and hypospadias. The timing of this programming window has 
been extrapolated from rat to human and is believed to be between 8-14 weeks 
gestation (Welsh et al., 2008). Further studies of disruption of androgen action 
should focus on treatment of hosts mice carrying human testicular xenografts taken 
from fetuses between 8-14 weeks gestation as the masculinisation programming 
window may have been missed in the current studies. 
 
The second model system used in an attempt to induce germ cell maturation delay, 
CIS and TGCT was based on the finding that TGCT are more common in patients 
with undervirilisation syndromes (Cools et al., 2005). In addition, differentiation of 
spermatogonia has been shown to be gonadotrophin dependent in the adult rhesus 
monkey (Marshall et al., 2005). These results suggest that suppression of 
gonadotrophins and testosterone may also delay germ cell differentiation in the 
perinatal period. The present study investigated the effect of GnRHa treatment of 
marmosets in the neonatal period and did not demonstrate a delay in gonocyte 
differentiation. These results suggest that gonadotrophins are not responsible for 
the differentiation of gonocytes to spermatogonia as has been suggested 
(Hadziselimovic et al., 1986), (Huff et al., 2001). The factors that result in delay in 
germ cell maturation remain to be elucidated, however it must be noted that the 
treatment was given to neonatal marmosets and this timing is not within the 
proposed male programming window as described earlier. Therefore it would be 
important to establish the effects of suppressing androgens during fetal life on germ 
cell maturation. Interestingly, GnRHa treatment of neonatal marmosets did result in 
a partial decrease in germ cell proliferation, compared to vehicle treated controls. 
Overall, the results of GnRHa treatment of neonatal marmosets showed opposite 
effects of gonadotrophins on germ cell differentiation and proliferation to those 
found in the adult rhesus monkey. The present study found that germ cell 
proliferation in neonatal marmosets is partially gonadotrophin dependent and 
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differentiation is gonadotrophin independent, whilst a previous study in the adult 
rhesus monkey demonstrated that proliferation is gonadotrophin independent, 
whilst differentiation is gonadotrophin dependent (Marshall et al., 2005). 
 
A major finding of the present studies was that xenografting of first trimester testis 
tissue could support the formation of testis cords. Seminiferous cord formation 
starts on or about 7 weeks of gestation and is variable between individuals (Gaskell 
et al., 2004). In the present studies, seminiferous cords were not fully formed at 9 
weeks of gestation, although in some fetuses the process had begun. Most of the 
understanding of the initial stages of testis development and cord formation comes 
from rodent studies (Wilhelm et al., 2007) and the present studies have provided the 
first in vivo system for investigating human testicular cord formation. This system 
can be used to investigate normal development during this period, but importantly 
it can also be used to investigate disruption of the development of the testis and 
therefore this system could be used to investigate DSD in humans. DSDs result from 
failure of normal gonadal development and/or the effects of abnormal androgen 
production, synthesis or action. One such approach may involve the use of anti-
androgens to block testosterone production during the early stages of testis 
development in order to try and reproduce the effects of impaired androgen action 
in the human testis. The present studies have not identified the age at which the 
seminiferous cords form in the marmoset, although it is clearly before 11 weeks 
gestation. The present study has shown the potential of the marmoset as a model for 
human testis development and therefore future studies to investigate cord 
formation in the fetal marmoset testis might allow the marmoset to be used as a 
complementary model for the above studies. 
 
A second approach to investigating the critical events during human testis 
development and the impact of hormones and toxicants on the process would be to 
dissociate the cells of the human fetal testes prior to xenografting. The dissociated 
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cells could be genetically manipulated or treated with factors prior to grafting. It has 
been demonstrated that dissociated fetal rat testis cells can reform testis cords after 
subcutaneous injection in nude mouse hosts (Honaramooz et al., 2007), (Kita et al., 
2007).  One intriguing possibility would be to mix isolated testicular cells from 
different stages of development prior to xenografting. This could be used to test the 
hypothesis that predisposition to CIS may be associated with asynchronous 
differentiation or delayed maturation of germ (or Sertoli) cells. Use of the marmoset 
for such studies would allow gonocytes from a fetal testis to be mixed with the cells 
from a juvenile animal to develop a model of delayed germ cell maturation in 
xenografts of these cell mixtures. This would provide a system in which the 
gonocytes would be exposed to a local environment with Sertoli cells and germ cells 
that are more advanced in their differentiation. A third approach to seminiferous 
cord disruption could be to introduce transgenes into the testis tissue. Such an 
approach has been used in bovine testis xenografts to introduce the -galactosidase 
gene (Oatley et al., 2004). This technique could be used to introduce genes that 
either promote or disrupt normal cord formation and testis development. 
 
The present studies have demonstrated that testis xenografting can recapitulate 
normal germ cell differentiation and proliferation using an in vivo system. This 
includes the use of early postnatal and juvenile marmoset testis. This means that 
xenografting may have wider implications than those already discussed in this 
thesis. One such potential use of xenografting juvenile tissue is in the study of 
fertility preservation in survivors of childhood cancer. These patients are at risk of 
infertility as a result of their treatment with cytotoxic agents. Currently, the only 
option available for fertility preservation in young males treated for cancer is semen 
cryopreservation. For pre-pubertal patients, techniques for fertility preservation 
remain theoretical and as yet unproven. Xenografting of testis material is one 
potential technique, which would involve removal of tissue prior to treatment. This 
material could be xenografted in order that the germ cells differentiate. Mature 
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germ cells could be retrieved for use in assisted reproductive technologies 
(Jahnukainen et al., 2006). In the present studies juvenile marmoset xenografts 
survived and developed as xenografts. Germ cells within these grafts are preserved 
and tubular development including lumen formation occurs. The demonstration of 
the similarity between testis development in the human and marmoset suggests that 
juvenile xenografts may be used in studies relating to fertility preservation in 
children. Differentiation of germ cells from immature testis tissue has been shown to 
be possible for several species including mice and pigs in which sperm can be 
produced in xenografts that are capable of fertilising eggs using intracytoplasmic 
sperm injection (Schlatt et al., 2003), (Honaramooz et al., 2008). This can result in the 
production of progeny from xenograft derived sperm (Schlatt et al., 2003). 
Transplantation of immature testis tissue from 13 month old rhesus monkeys, 
subcutaneously onto the back of ICR/SCID mice resulted in accelerated 
spermatogenesis with production of mature sperm. However as discussed 
previously the rhesus monkey has some differences in the organisation of 
spermatogenesis compared to the marmoset and human (Millar et al., 2000); 
(Sharpe, 2003a) and as a result developing this system in the marmoset may be more 
relevant.  
 
Previous studies by other groups have largely involved xenografting of newborn 
marmoset testes and have not been grafted for an equivalent length of time in which 
spermatogenesis would have been achieved in the intact in situ marmoset testis 
(Schlatt et al., 2002), (Wistuba et al., 2004), although autologous transplants of 
juvenile marmoset testis did initiate meiosis they failed to develop any further 
(Wistuba et al., 2006). Further studies of juvenile marmoset grafting are required 
using longer periods of grafting and manipulation of the local environment in order 
to establish whether this approach could be applied as a model of fertility 
preservation in prepubertal human patients undergoing cytotoxic treatment for 
conditions such as childhood cancer. This is the first study to have demonstrated 
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differentiation of human germ cells within testis xenografts and this is also of 
importance in the context of fertility preservation studies. Previous studies have 
shown that germ cells within the human fetal (Yu et al., 2006), (Skakkebaek et al., 
1974) and juvenile (Goossens et al., 2008), (Wyns et al., 2008) testis can survive as 
xenografts, however these germ cells did not show development during the grafting 
period. Longer periods of grafting are required to determine whether human testis 
xenografts are capable of undergoing meiosis. The demonstration that human fetal 
testis grafts produce basal and inducible testosterone means that the hormonal 
environment can be controlled in these grafts to mimic that of the normal human 
testis.  It has been shown that gonadotrophin treatment of mice receiving xenografts 
of immature rhesus monkey testis results in  termination of the childhood period of 
development and acceleration of spermatogenesis  (Rathi et al., 2008). This means 
that hormonal stimulation of immature human testis xenografts may be able to 
shorten the childhood period and allow the completion of spermatogenesis. The 
present studies have grafted human fetal testis for up to 5 months, with good 
preservation of the testis tissue. Longer periods of grafting including investigation 
of the effects of gonadotrophin stimulation are required to assess whether human 
testis xenografts can progress through meiosis.  
 
In conclusion, this study has investigated normal and abnormal germ cell 
development in the human and marmoset testis. Studies in human patients with 
TGCT have characterised various protein expression profiles of differentiation and 
proliferation in CIS cells, which support their origin from fetal germ cells, in 
addition to identifying novel expression profiles. In vivo systems have been 
developed to investigate testis development in humans and marmosets during fetal 
and postnatal life. The marmoset has been shown to be a good model for human 
fetal and postnatal testis development. Xenografting of testis tissue from human and 
marmoset testes into nude mice hosts can recapitulate the normal development of 
the testes. This includes germ cell differentiation and proliferation in addition to 
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initial formation of the seminiferous cords. Use of the marmoset provides the 
opportunity to investigate human disorders of testis development by manipulation 
of normal testis development in the intact animal, or alternatively by use of the 
xenografting approach. Xenografting of human and marmoset testis tissue may also 
be used to study the development of DSD and CIS/TGCT, which have their origins 
in fetal life, or alternatively for studies relating to fertility preservation in children. 
Initial attempts to disrupt testis development with exposure to phthalates have not 
demonstrated any effects on primates, however further investigation using the 
systems developed in this thesis is required. 
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